Key Takeaways Tesla registrations jumped 279% in France and 104% in Denmark during August.Registrations fell 79% in both Norway and Spain, while Sweden, Portugal and Italy also declined.Tesla's European sales recovery has benefited from easier comparisons, incentives and EV interest. Tesla’s (TSLA - Free Report) August vehicle registrations across key European markets delivered a mixed performance, with sharp increases in France and Denmark offset by steep declines in Norway, Spain, Sweden, Portugal and Italy.
New Tesla registrations, which are generally used as an indicator of sales, jumped 279% year over year in France and 104% in Denmark, per the data from France’s PFA and Denmark’s bilstatistik.dk.
However, registrations plunged 79% in both Norway and Spain, while Sweden, Portugal and Italy recorded declines of 41%, 37% and 36%, respectively, per the data from national automotive industry organizations OFV, Mobility Sweden, ANFAC and ACAP, and Italy's Transport Ministry.
In Norway, the steep decline may partly reflect a difficult comparison with last year, when buyers accelerated purchases ahead of a fiscal policy change scheduled for the end of 2025, per the European auto market analyst Matthias Schmidt.
Tesla’s European sales have generally recovered this year following two consecutive years of declines. The improvement has been supported by easier year-over-year comparisons, higher fuel prices, government incentives and increasing consumer interest in electric vehicles. Registration data from the United Kingdom and Germany, Europe’s two largest auto markets, is expected later this week. TSLA carries a Zacks Rank #4 (Sell) at present.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Global Sales Data of Other AutomakersBYD Company Limited (BYDDY - Free Report) reported strong growth in August, selling 440,293 new energy vehicles (NEVs), up 17.8% year over year and 5.03% from July. The figure marked BYD’s highest monthly sales total of the year and extended its recovery with a fourth consecutive year-over-year increase. Passenger NEV sales rose 16.7% year over year to 433,384 units, while BYD’s commercial NEV sales jumped 225.1% to 6,909 units, despite declining from July.
Geely Automobile Holdings Limited (GELHY - Free Report) also recorded another increase in monthly sales, with August deliveries reaching 270,194 vehicles, which increased 8.01% year over year and marked its strongest monthly performance this year. Geely’s overseas shipments were particularly strong, surging 205.2% to 110,094 vehicles. Exports hit a record for the eighth consecutive month and represented about 41% of Geely’s total sales, helping offset continued weakness in its domestic market.
Tesla’s Price Performance, Valuation and EstimatesTesla has underperformed the Zacks Automotive – Domestic industry in the last six months. Tesla has lost 11.2% compared with the industry’s decline of 5.8%.
Image Source: Zacks Investment Research
From a valuation perspective, Tesla appears overvalued. Going by its price/sales ratio, the company is trading at a forward sales multiple of 12.24, higher than the industry’s 3.24.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 and 2027 EPS has moved down 31 cents and 26 cents, respectively, in the past 60 days.
Coca-Cola ve 2. čtvrtletí zvýšila tržby na 13,38 miliardy USD a upravené EPS na 0,97 USD, čímž překonala odhad a zvedla výhled. Akcie letos stouply o 27,67 %.
Andrew Sather says most investors only understand one of the two engines driving stock returns, and missing the second one is exactly why a name as familiar as Coca-Cola keeps catching people off guard.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The least exciting name on your watchlist can outrun the flashiest one when the market has priced in nothing and the business quietly grows. Andrew Sather, co-host of The Investing for Beginners Podcast, argues that most investors understand only one of the two engines driving stock returns. Engine one is straightforward: the stock roughly tracks a growing business. Engine two pays better and confuses more people: you buy a stock whose growth the market refuses to acknowledge, and you collect the difference when sentiment catches up.
Sather says he is “starting to lean more towards” the second engine again because “there’s just more opportunities there.” His worked example is Coca-Cola (NYSE:KO | KO Price Prediction), a name so often dismissed as dead money that the framework has room to embarrass its critics. The wrinkle is that the market may already be recalibrating. Shares are up sharply this year, so the real question becomes whether the re-rating still has room to run.
Two Engines of Return Every stock return comes from either the business or the multiple. If earnings grow and the price/earnings ratio holds steady, the stock tracks earnings. If earnings hold steady and the multiple expands, the stock rises anyway.
Sather framed it this way: “it’s not always margin of safety, it’s not always high growth. It’s which combination of the two at any given point in time is going to lead to higher returns.” One factor without the other tends to disappoint.
What Margin of Safety Looks Like in Practice Margin of safety is the gap between what a business is likely worth and what the market is charging you today. You look for durable free cash flow, a share count that isn’t drifting higher, and a story most people find boring.
Coca-Cola’s free cash flow yield sits around 1.40%, and the forward dividend is $2.12. The safety comes from durability: 63 consecutive years of dividend increases and $8.8 billion paid in 2025.
Coca-Cola as the Worked Example Sather characterizes the dead-money bucket as businesses growing 4% to 6% a year, and Coca-Cola’s second quarter outran that. Revenue was $13.38 billion, up 6.7% year over year, and adjusted EPS of $0.97 against a $0.9323 consensus marked the fifth straight beat.
Guidance was raised: organic revenue growth of about 5%, comparable EPS growth of 9% to 10%, and free cash flow near $12.4 billion. The full detail sits in the Q2 2026 release filed with the SEC.
The stock has responded. Shares closed at $88.07 on September 4, up 27.67% year to date and 32.72% over the past year. Whatever dead money meant a few years ago, it does not describe the stock today.
Operating margin expanded to 34.9% from 34.1%, and net debt leverage sits at 1.4 times EBITDA. Trademark Coca-Cola volume grew 5% globally, the strongest in 17 years excluding COVID recovery, helped by a FIFA World Cup activation across 180+ markets.
At a P/E of 29x, the multiple no longer looks apologetic. If Sather’s thesis was that the market underappreciated the growth, the market has partly caught up.
When the Framework Fails A cheap stock can stay cheap, and underappreciated often turns out to mean declining. Tell the difference by checking whether unit volumes are growing, and not simply revenue.
Coca-Cola’s global unit case volume rose 5%, led by India, China, the US, and Brazil. That confirms demand is real. When volumes shrink while price carries the top line, the runway is finite.
Applying the Two-Factor Check to Your Watchlist For any stock, ask two questions. Is the business actually growing on volume and cash flow, or only on headline revenue? Is the multiple you are paying reasonable against a bearish version of that growth?
If both answers are yes, you own both engines. If growth is present but the multiple is stretched, you are paying for delivery with zero room for error. If the multiple is cheap and growth is absent, you are hoping sentiment shifts before fundamentals confirm the story.
Is KO Stock a Buy? Coca-Cola today reads as a hold. The business is executing, guidance was raised, and the balance sheet is enviable, although the re-rating Sather’s framework anticipated is already visible in the stock. A 29 P/E on a mid-single-digit organic grower leaves a thinner margin of safety than the dead-money label suggests.
Against PepsiCo, which has wrestled with volume declines, Coca-Cola is the stronger operator right now. New capital at these prices needs patience; existing holders collect a 2.32% yield backed by 63 straight annual increases, the kind of streak we screened for in our free Dividend Kings guide.
Contact [email protected] for any questions or corrections.
Coca-Cola zvýšila čtvrtletní dividendu z 0,51 USD na 0,53 USD na akcii a prodloužila sérii růstu dividend na 64 let. Výnos je kolem 2,3 %, ale akcie letos vzrostly asi o 28 %.
Coca-Cola just handed retirees their 64th consecutive dividend raise, but the share price surge this year quietly undercut part of that win. Whether this checks out as a buy, hold, or trim depends entirely on which side of the trade…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
If you own Coca-Cola (NYSE:KO | KO Price Prediction) for the income, the date that matters this week is September 15, 2026. That is the next ex-dividend cutoff, and it is the last chance to be on the books for the current payout at the newly raised rate. For a 67-year-old drawing supplemental income from a dividend stock, this is the kind of housekeeping date that quietly determines whether a check lands in October or not.
Coca-Cola declared the higher rate back on February 19, 2026, lifting the quarterly dividend from $0.51 to $0.53 per share. That works out to a forward annual payout of $2.12. It also extended one of the longest income streaks on the U.S. market: 63 consecutive years of dividend increases as of 2025, now 64 with this year’s raise.
Why the Raise Feels Smaller Than It Looks Here is the part that trips up retirees comparing statements from January to September. The payout went up, but the yield on new money went down, because the share price ran hard. Coca-Cola started the year at $69 and now trades near $88, a year-to-date gain of about 28%. Over one year the stock is up nearly 33%.
The current dividend yield sits around 2.3%. A buyer in January was locking in a materially higher yield on cost than a buyer today, even though the dollar payout is the same $2.12 either way. Two things are true at the same time. The company gave you a raise. The market took back part of the income appeal by bidding the shares up.
What Really Backs the Check A 2.3% yield is only useful if you trust it will keep growing. On that score, the coverage picture is comfortable. Coca-Cola paid $8.8 billion in dividends during 2025 against net income of $13.1 billion. Management guided to full-year 2026 free cash flow of roughly $12.4 billion, and the CFO flagged that “Our balance sheet remains strong with our net debt leverage of 1.4 times EBITDA, which is below our target range of 2 to 2.5 times.” Volume grew 5% in Q2, and comparable EPS is guided to 9% to 10% growth for the year.
Translation for a retiree: the dividend is well protected. Coverage is deep, cash generation is expanding, and the balance sheet has room. The BODYARMOR trademark impairment and the ongoing IRS tax case are real, but neither threatens the payout.
New Money Versus Old Money This is where the article earns its keep. The right move depends on which side of the trade you are on.
If you already own the shares: keep collecting. Your yield on cost is whatever it is, the payout just rose, and the tax treatment on qualified dividends stays favorable. For a retiree in the 12% or 22% federal bracket, qualified dividends generally get taxed at 0% or 15%, which is why holding a Dividend King in a taxable account has always been friendlier than pulling the same dollars from a traditional IRA.
If you are deploying new retirement cash today: understand you are buying a 26x earnings consumer staple at a 2.3% yield, with an analyst target of $95 that leaves modest room from here. Broad dividend ETFs currently offer higher starting yields with none of the single-stock concentration risk. At 67, with a portfolio you are meant to live on, one beverage company should not be the whole income engine no matter how long the streak.
Two Things to Do This Month Confirm your position size. If Coca-Cola is more than roughly 5% of your income-generating assets, the streak is doing you a disservice by encouraging concentration. Positions above that threshold leave a retirement income plan hostage to one beverage company’s execution. Mind the ex-dividend date. To collect the October payment at the raised $0.53 rate, you need to own the shares before September 15, 2026. Selling on or after that date still gets you the check. The common mistake here is treating a 64-year raise streak as a reason to add more at any price. The streak is a quality signal about durability, and it says nothing about the price you pay today. A position sized to enjoy the raises works; a position large enough to dominate a retirement income plan concentrates too much of the outcome in one beverage company.
Contact [email protected] for any questions or corrections.
Uber spustil v Londýně 3. září první řízenou autonomní přepravní službu s plně elektrickými vozy Ford Mustang Mach-E a technologií Wayve AI Driver. Firma tím ukazuje, že chce růst bez výroby vlastních aut.
This is a fair market value price provided by Massive. Learn more.
$65.41▼
$101.9916.06
$104.49
The market often misinterprets the structural evolution of logistics networks, pricing them on legacy models rather than future capabilities. This dynamic is currently playing out with Uber Technologies, Inc. NYSE: UBER. On Sept. 3, Uber initiated its first supervised autonomous ride-hailing service in London. By deploying all-electric Ford Mustang Mach-E vehicles powered by Wayve's AI Driver, Uber is demonstrating a clear pivot in its business model.
Rather than absorbing the heavy capital expenditures required to manufacture proprietary autonomous vehicles, Uber is positioning itself as the commercialization and distribution layer for third-party technology. This asset-light approach allows Uber to bridge the gap toward long-term autonomous margins while avoiding the risks of automotive manufacturing. Investors assessing the current valuation might notice a disconnect between the traditional human-driven logistics multiple and the highly scalable, AI-integrated hybrid network being built.
Get Uber Technologies alerts:
Steering Clear of ManufacturingUnderstanding the mechanics of the Wayve partnership reveals why this strategy appeals to institutional capital. Wayve utilizes an AV2.0 approach, relying on mapless, hardware-agnostic artificial intelligence (AI) that learns from complex environments rather than relying on traditional hand-coded rules. This adaptability is critical in a regulatory and geographical maze like London, where mapping every variable is nearly impossible.
The structural advantage for Uber rests on the deliberate avoidance of hardware development. Developing self-driving cars requires billions in research, development, and manufacturing overhead. By supplying the localized rider demand and the routing network, Uber allows partners like Wayve to focus on the intelligence while original equipment manufacturers like Ford NYSE: F and Nissan OTCMKTS: NSANY handle the hardware. Over 140,000 London riders have already opted in to the service, suggesting that consumer adoption barriers may be lower than previously anticipated.
This strategy extends well beyond a single city. Uber participated in Wayve's recent $1.5 billion funding round, aligning financial interests to secure global scaling rights across 12 planned markets. With upcoming integration plans for the Nissan LEAF and partnerships with over 30 external autonomous developers, Uber is on track to facilitate autonomous trips in up to 15 cities by the end of 2026. This allows Uber to scale its autonomous offerings globally without the traditional drag of severe capital expenditures.
Refueling With Free Cash FlowAn asset-light model relies heavily on network density and the ability to generate liquidity without internal cash burn. Recent financial disclosures highlight how this transition is already reflected in profitability metrics. During the second quarter of 2026, Uber generated about $2.8 billion in free cash flow and reported gross bookings of nearly $58.0 billion. This represents a 24% year-over-year increase in bookings, providing the exact liquidity framework required to fund external artificial intelligence integrations.
The ongoing shift toward third-party integration directly supports expansion of the earnings before interest, taxes, depreciation, and amortization (EBITDA) margin. Adjusted EBITDA grew 33% year-over-year to $2.8 billion for the quarter, pushing the margin to 4.9%, up from 4.5% a year prior. By letting venture capital and external partners absorb the research and development costs of autonomous driving, Uber preserves its cash flow to reinvest in market share and core platform density.
This density strategy is evident in concurrent corporate actions, such as the ongoing €41.50-per-share (approx. $46) takeover offer for Delivery Hero. Acquiring complementary logistics networks widens the multi-vertical distribution funnel. A denser network of food and freight delivery creates immediate, practical deployment routes for future autonomous fleets. This allows Uber to maximize vehicle utilization rates across a 24-hour cycle, routing autonomous cars for passenger transport during peak hours and logistics delivery during off-peak times.
Valuations Ready to AccelerateCapital flows often lead retail sentiment, and the structural support for Uber rests heavily on institutional accumulation. Institutional investors currently hold roughly 80% of the public float. Over the trailing 12 months, these buyers initiated inflows of nearly $39.12 billion, far outweighing outflows of roughly $10.36 billion. Entities like the Virginia Retirement Systems hold large positions, suggesting a long-term horizon aligned with the autonomous transition.
Current Price$73.06High Forecast$150.00Average Forecast$104.49Low Forecast$72.00Uber Technologies Stock Forecast Details
From a valuation perspective, Uber trades near $76 with a trailing price-to-earnings (P/E) ratio around 16.8. Compared with broader technology-sector platforms that often command multiples well above 30, the current pricing implies the market still views Uber as a human-reliant logistics business. As the percentage of autonomous trips increases, the marginal cost of routing a vehicle could fall substantially, shifting the business's unit economics.
Sell-side analysts appear to be factoring in this evolution in margins. Of 42 analysts covering Uber Technologies, Inc., 34 maintain a Buy rating, resulting in a consensus of Moderate Buy. A consensus price target near $104 suggests an anticipated upside of roughly 36% from current trading levels.
The recent London rollout serves as tangible proof of concept for the broader analyst community, validating the operational feasibility of replacing human drivers with software in highly congested urban environments.
Plotting the Next DestinationThe integration of Wayve's technology in the United Kingdom provides a clear template for how ride-hailing networks plan to achieve long-term profitability. Transitioning directly from human drivers to fully autonomous fleets carries severe regulatory and operational risks. By steadily phasing in third-party autonomous vehicles to operate alongside human drivers, Uber ensures consistent reliability while gradually lowering the overall cost per trip.
This hybrid approach de-risks the technological rollout while maintaining the supply density required to serve global demand. The combination of strong free cash flow, deep institutional backing, and an expanding global footprint of autonomous partners creates a compelling fundamental setup. Uber is positioning itself not as a car manufacturer, but as the essential operating system for global movement. Investors analyzing the shifting mobility sector might consider adding Uber to their watchlist as the market begins to factor in the long-term margin expansion associated with its software distribution capabilities.
Should You Invest $1,000 in Uber Technologies Right Now?Before you consider Uber Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uber Technologies wasn't on the list.
While Uber Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Uber's profits doubled and free cash flow surged past $10 billion, yet the stock keeps sliding while rivals circle the ride-hailing throne. The real question is whether Wall Street is seeing something bulls are missing, or pricing in a robotaxi…
Uber (NYSE: UBER | UBER Price Prediction) shares were last seen trading at $75.76, leaving the ride-hail and delivery platform down 7.3% year to date and off 17.6% over the trailing year. On the September 6 episode of The Investor’s Podcast (We Study Billionaires), titled “TIP844: Uber (UBER): The Autonomy Referendum: Is Mr. Market Completely Wrong?” hosts Shawn O’Malley and Daniel Mahncke argued the operating business moved sharply in the opposite direction of the tape.
Valuation Compression While Fundamentals Improved O’Malley framed the disconnect this way: “Uber’s fundamentals have dramatically improved: profits doubled, margins swung 55 percentage points, and free cash flow hit $10B, yet the stock is flat as its valuation multiple was cut in half.” Reported operating income climbed from $2.799 billion in fiscal 2024 to $5.565 billion in fiscal 2025, and Uber’s Q2 2026 filing logged net income of $2.39 billion, up 76.7% year over year, alongside free cash flow of $2.79 billion.
Against that backdrop, Uber has a market capitalization of roughly $154.7 billion and a trailing price-to-earnings ratio near 17. A multiple of operating profits simply measures how many years of current profit an investor is paying for. The hosts’ complaint is that the number contracted while the profit stream expanded.
Autonomy Scale Gap Is Wider Than Headlines Suggest The hosts spent most of the episode on autonomous vehicles (AV), because that is what the equity market appears to be pricing. Their point is that self-driving software and demand aggregation are separate problems. Demand aggregation is the work of matching millions of riders to available cars in real time across cities, weather, and payment systems. Waymo is scaling admirably, yet its weekly ride volume pales in comparison to Uber’s daily trip count, and total global autonomous trips per year are dwarfed by Uber’s annual trip growth alone. Uber reported 3.9 billion trips in Q2 2026 and 208 million monthly active platform consumers. Robotaxis still have to earn their way through rainstorms, blizzards, chaotic traffic, and developing-world roads, not just the pristine grids of San Francisco and Austin.
Mahncke sized the actual exposure directly: “If you decompose Uber’s profits and look at the top 20 US cities where robotaxis realistically operate at scale, that’s effectively 9% of Uber’s profits that are genuinely exposed to robotaxi competition in the near to medium term, maybe five to ten years.”
Bear Case the Hosts Actually Take Seriously The hosts do not wave away the threat. Waymo studied Uber’s consumer base and demand aggregation and chose to build its own app, and it is ending exclusive arrangements in Austin and Atlanta. Mahncke noted that Waymo “can afford to have terrible fleet utilization for years if that’s what it takes to displace Uber” given roughly $16 billion of fresh capital and Alphabet backing. Their real fear is a capital-burning subsidy war that produces a bleak picture for shareholder returns, and one host openly admitted he expects to keep questioning his own conviction as the story develops.
Uber’s Counter-Move on AV Partners Uber’s answer is to court every capable AV supplier. The company has grown its partner roster from 14 to more than 20 companies, including Rivian, Nuro, Nvidia, Baidu, and Pony AI, and committed more than $100 million to AV charging infrastructure. If self-driving software becomes a commodity input, meaning many providers offer roughly interchangeable capability at declining prices, the platform aggregating global demand becomes the scarce asset. Meanwhile, Uber returned capital aggressively, with $6.5 billion of buybacks in fiscal 2025 and a $20 billion repurchase authorization. Our coverage of the Q3 2025 reaction captured the same pattern of strong results meeting a skeptical tape.
What Would Falsify the Contrarian Bull Case The hosts call this their most strongly held contrarian opinion. Two developments would break the thesis: Waymo or another rival reaching Uber-scale ride volume globally would collapse the demand-aggregation moat, and a sustained price war that Uber must fund from its own cash flow would consume the buyback capacity that has supported per-share metrics. Absent those, the podcast’s argument is that the equity is priced for an autonomy apocalypse that is not arriving on the assumed schedule.
Contact [email protected] for any questions or corrections.
Tesla spustila v Austinu omezené veřejné jízdy Cybercab, čímž poprvé komerčně testuje robotaxi službu postavenou na vlastním voze bez volantu. Uber mezitím sází na partnerskou síť autonomních flotil.
Tesla Inc‘s (NASDAQ:TSLA) Cybercab has finally moved from concept to commercial service, but its biggest competitor isn’t another automaker—it’s Uber Technologies, Inc. (NYSE:UBER).
While Tesla is building a vertically integrated robotaxi business from the ground up, Uber is assembling an autonomous fleet through partnerships, setting up two very different paths to the future of ride-hailing.
Tesla’s Cybercab StrategyTesla’s robotaxi ambitions center on owning the entire ecosystem. The company develops the vehicle, the autonomous driving software, and the ride-hailing platform, allowing it to capture more of the economics if the model scales successfully.
That vision is now being tested in Austin, where Tesla has launched limited public Cybercab rides using its purpose-built, steering wheel–free vehicle. The rollout is still small, but it marks Tesla’s first attempt to commercialize a robotaxi service built around a vehicle designed exclusively for autonomous ride-hailing.
Tesla CEO Elon Musk has repeatedly argued that autonomy could eventually reduce ride costs to a fraction of today’s prices by eliminating the need for human drivers. The company’s long-term thesis depends on achieving enough scale for those lower operating costs to outweigh the substantial upfront investment in vehicles and AI.
Read Next
Uber’s Robotaxi NetworkUber is pursuing a fundamentally different strategy.
Rather than building autonomous vehicles, the ride-hailing giant has positioned itself as a marketplace for robotaxis. The company has announced partnerships with multiple autonomous driving developers, giving riders access to different autonomous fleets through a familiar app., including:
Alphabet Inc‘s (NASDAQ:GOOGL) (NASDAQ:GOOG) Google’s Waymo Wayve Amazon.com Inc‘s (NASDAQ:AMZN) Zoox Baidu, Inc‘s (NASDAQ:BIDU) Apollo Go and Nebius Group N.V.‘s (NASDAQ:NBIS) Avride Trending
That approach allows Uber to benefit from advances in self-driving technology without bearing the cost and execution risk of developing its own vehicles.
The contrast is already visible in Austin, where Tesla’s Cybercab service has begun operating.
Early rider comparisons shared online show Cybercab fares on some routes costing more than equivalent Uber rides, although pricing remains highly dynamic and reflects Tesla’s limited fleet size during the initial rollout. Those snapshots offer only a point-in-time comparison, not a definitive measure of long-term economics.
Read Next
What Investors Should WatchThe robotaxi race may ultimately be less about who builds the best autonomous vehicle than who controls the customer relationship.
Tesla is betting that owning the vehicle, software and platform will create a durable competitive advantage as autonomous driving matures. Uber, meanwhile, is betting that riders will keep valuing a single marketplace that offers access to multiple robotaxi providers, regardless of who manufactures the vehicles.
For investors, the key metric is unlikely to be today’s fare comparison. Instead, it will be whether Tesla can scale Cybercab production quickly enough to lower costs, or whether Uber’s asset-light platform model proves more resilient in capitalizing on the autonomous transportation market.
Uber klesá o 4 % na 73,10 USD, protože investoři zvažují hrozbu robotaxi od Tesly. Tesla roste o 4 % na 366,84 USD po schválení Full Self-Driving ve Slovinsku a debutu Cybercabu v Austinu.
Tesla's expanding robotaxi footprint is sending ripples through the rideshare market, and Uber shareholders are absorbing the hit even though Uber's own results gave them no reason to sell.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A single robotaxi story is pulling two of the market’s biggest mobility names in opposite directions Tuesday afternoon. Uber Technologies (NYSE:UBER | UBER Price Prediction) is sliding as investors weigh the competitive threat from a manufacturer that could run its own purpose-built fleet. Tesla (NASDAQ:TSLA) is climbing 4% to $366.84 on regulatory progress in Europe and the debut of the Cybercab in Austin.
Uber stock is down 4% to $73.10 in afternoon trading, giving back ground even as large-cap tech holds firm. Meanwhile, Tesla stock is trading higher on the very catalyst weighing on the rideshare peer. For context, the Invesco QQQ Trust (NASDAQ:QQQ) is nearly unchanged on the session at $719.16, so this reads as a name-specific rotation inside large-cap tech.
Direct rideshare peer Lyft (NASDAQ:LYFT) is also lower on the same read, even as its own autonomous-vehicle (AV) positioning leans on a Waymo partnership that began fleet operations in Nashville in June. Furthermore, the Global X Autonomous & Electric Vehicles ETF (NASDAQ:DRIV) is nearly unchanged for today’s session at $34.83, so there doesn’t appear to be a major sector-wide move in progress.
Slovenia Clearance and Cybercab Debut Drive the Split Slovenia’s traffic safety authority cleared Tesla’s Full Self-Driving system, making it the sixth European market to approve the software after the Netherlands, Lithuania, Estonia, Denmark, and Belgium, according to Reuters. The clearance was characterized as a temporary type approval, and the system still requires an attentive driver responsible for the vehicle. That’s national permission rather than an EU-wide runway, and the distinction matters to the timeline math.
Separately, Tesla introduced the Cybercab in Austin, a vehicle built specifically for autonomous ride-hailing, seating two, with no steering wheel and no pedals. On its Q2 2026 earnings call, Tesla said its unsupervised Robotaxi fleet had accumulated “more than 380,000 miles of unsupervised Robotaxi, now across six cities” with “zero notable incidents”. Robotaxi operations already run unsupervised rides in Austin, Dallas, Houston, Miami, Orlando, and Tampa across seven U.S. markets.
Tesla’s Q2 2026 report showed revenue of $28.24 billion, up 25.5% year over year, and record deliveries of 480,126 vehicles, so the FSD monetization runway sits on top of solid vehicle volume rather than propping it up. Active FSD subscriptions reached 1.48 million paid customers globally, up 56% year over year, and Tesla CEO Elon Musk said on the call that Tesla is “going as fast as humanly possible in scaling Robotaxi” while trying to avoid harm.
Where the Rideshare Case Diverges The bear case for Uber stock today isn’t about the company’s results. Uber reported Q2 2026 revenue of $14.19 billion, up 12.2% year over year, with gross bookings of $58.02 billion and 3.9 billion trips across 208 million monthly active platform consumers. The company generated free cash flow of $2.79 billion and repurchased $518 million of its stock during the quarter.
The concern is structural. If a manufacturer can operate its own robotaxi network with vehicles designed for the job, the marketplace layer Uber monetizes loses some of its scarcity value. Uber CEO Dara Khosrowshahi has framed the response as an ambition to become “the world’s leading commercialization platform for autonomous vehicles.”
Uber has committed a $10 billion multi-year AV investment, and management noted AV trips today sit at “less than 0.5%” of Uber’s 300 million weekly rides. Lyft’s own numbers underscore how narrow the peer set is when the robotaxi question intensifies. Lyft posted Q2 2026 revenue of $1.84 billion, up 16.1% year over year, with 30.5 million active riders and gross bookings of $5.5 billion.
The QQQ contrast sharpens the read. Tesla makes up 3% of the fund’s net assets, so Tesla’s rally shows up in the underlying holding while the ETF itself is essentially flat, and the Uber pain is showing up in the stock rather than sector data.
What to Watch Next The tension in this trade is worth noting. Uber is being charged for an event driven outside its own results while itself expanding AV partnerships across Europe and the U.S., and Tesla is being rewarded for regulatory progress that still requires a driver at the wheel. Whether the split survives contact with actual fleet economics remains unresolved.
Traders can watch for signs that Tesla’s Cybercab timeline firms up with U.S. federal clearance, since NHTSA approval for full Cybercab scaling has not yet been granted. Investors weighing their exposure to Uber stock should calibrate their positions carefully given that Uber trades at a P/E of 15 with a $149.5 billion market cap and no earnings miss driving today’s decline.
Contact [email protected] for any questions or corrections.
Alphabet po silných výsledcích za 2. čtvrtletí 2026 klesl za poslední měsíc o 10,39 % z nedávného maxima na 338,86 USD. Trh znepokojují kapitálové výdaje ve výši 44,92 miliardy USD, záporný volný peněžní tok 5,86 miliardy USD a růst dlouhodobého dluhu na 98,2 miliardy USD.
Alphabet just posted blowout earnings and yet the stock has shed more than 10% from its peak, leaving investors caught between soaring Cloud growth and a balance sheet that suddenly looks very different from a year ago.
Alphabet (NASDAQ:GOOG | GOOG Price Prediction) trades at $338.86 after slipping 10.39% over the past month from its recent high of $404.23. Our 24/7 Wall St. price target for Alphabet is $433.88, implying 28.19% upside over the next 12 months. The recommendation is buy at high confidence (90%). In plain terms, we view this dip as an entry opportunity.
Metric Value Current Price $338.86 24/7 Wall St. Price Target $433.88 Upside 28.19% Recommendation BUY Confidence Level 90% Why Alphabet Sold Off Despite a Blowout Quarter Alphabet is up 6.5% year to date and 57.9% over the last year, but the stock has cooled since summer. The pullback came despite strong results.
Q2 2026 revenue hit $119.80 billion, up 24.23% year over year, with EPS of $9.11 versus a $3.0427 estimate. Google Cloud grew 82% to $24.8 billion and Cloud backlog reached $514 billion.
Investors focused on the cost side: capex was $44.92 billion, free cash flow turned negative $5.86 billion, long-term debt climbed to $98.2 billion, and management suspended the buyback while guiding 2026 capex of $175 billion to $185 billion.
That level of spend has to go somewhere, and the power, cooling, and networking suppliers behind these data centers are the subject of a free report on seven AI infrastructure names that aren’t chipmakers. That fear is why GOOG is on sale.
Why Bulls See a Breakout to $450 and Beyond The bull case rests on Cloud and Gemini. Cloud growth has accelerated four straight quarters, from 34% to 48% to 63% to 82%. CEO Sundar Pichai said Alphabet is “more bullish on the opportunities ahead” for generative AI than a year ago.
Gemini API traffic now runs at 22 billion tokens per minute, and nearly 90% of the Fortune 100 use Gemini Enterprise. Analyst coverage skews strongly positive at 57 Buy and 5 Hold ratings, and our bull-case scenario tops out at $450.80.
What Could Send GOOG Back to the Low $300s The bear case starts with the balance sheet. Long-term debt more than doubled to $98.2 billion, interest expense is up roughly 5x year over year, and free cash flow went negative in Q2.
Bulls will counter that Q2 free cash flow was distorted by inventory buildup for TPU deliveries, and management expects the vast majority of TPU revenue to land in 2027. Insider activity is another yellow flag, with 205 recent transactions net selling, though executive selling at mega-caps is routine. Our bear-case price is $364.77.
How Alphabet Compares to Microsoft and Meta Microsoft (NASDAQ:MSFT) is the closest peer on cloud and enterprise AI. MSFT trades at $510.83 and commands a much richer multiple than GOOG. On the same forward P/E of 16, Alphabet looks cheap for a business where Cloud is growing 82% versus Azure’s slower comparable growth. That valuation gap is the core of our buy thesis.
Meta Platforms (NASDAQ:META) at $612.79 is the right digital-advertising comparable. Meta’s ad business is growing fast, but Alphabet pairs Search and YouTube ($11.06 billion in Q2) with a hyperscale cloud Meta cannot match. The peer set makes our $433.88 target look reasonable, arguably conservative.
Company Forward P/E Current Price Alphabet 16 $338.86 Microsoft n/a $510.83 Meta n/a $612.79 Verdict: A High-Confidence BUY Setup My verdict is buy with high confidence, and the 24/7 Wall St. price target of $433.88 reflects both the fundamentals and the factor overlay. The tipping factor is Cloud’s 82% growth against a forward multiple of 16.
The bullish scenario depends on Alphabet converting its $514 billion Cloud backlog into revenue on schedule. The bearish scenario is 2026 capex above $175 billion keeping free cash flow negative into 2027.
Looking further out, here is where our model projects Alphabet could trade, assuming Cloud continues scaling and AI monetization tracks the current trajectory.
Year 24/7 Wall St. Price Target 2026 $361.84 2027 $433.88 2028 $516.01 2029 $593.39 2030 $645.76 These projections assume Alphabet executes on Gemini adoption and Cloud backlog conversion. Significant upside could come from Waymo scaling; the largest downside risk is a regulatory forced separation of Search or ad tech.
Contact [email protected] for any questions or corrections.
NextEra Energy získala od amerického ministerstva energetiky úvěr 1,9 miliardy USD na restart jaderné elektrárny v Iowě pro Google. Restart je plánován na rok 2029.
Last October, Google said it would bring an Iowa nuclear power plant back from the dead. Now the facility’s owner, NextEra Energy, has received a $1.9 billion loan from the U.S. Department of Energy to finance the refurbishment.
The sizable loan is the second of its kind, suggesting that the Trump administration views revived nuclear power as a key source of electricity for tech companies seeking to power their AI data centers. Last year, the Department of Energy extended a $1 billion loan to Constellation Energy to restart a reactor at Three Mile Island.
James Danly, Deputy Secretary of Energy, said that the Iowa power plant’s restart in 2029 will “drive down electricity costs,” though he did not explain how. Just 50 megawatts will be set aside for the local power cooperative, NextEra CEO John Ketchum said during an earnings call last year. That capacity would cover 18% of Iowa’s demand growth since 2021, the year before ChatGPT was released.
Google is reportedly looking to build up to six data centers near the Duane Arnold Energy Center, which hasn’t operated since 2020 when an intense rainstorm damaged the power plant. Rather than repair it, NextEra decided to mothball it. At the time, cheap natural gas was flooding the market, making nuclear power economically unappealing.
A lot has changed in the last six years, though. After decades of little growth in demand, the sudden rise of AI coupled with broader electrification of the economy meant that utilities and power providers were suddenly scrambling to find new generating sources of electricity. New data centers are expected to nearly triple the sector’s electricity demand by 2035.
Shuttered nuclear power plants are becoming one of the tech industry’s favorite choices to quickly provide clean, firm power.
Microsoft signed a deal with Constellation Energy two years ago to restart a reactor at Three Mile Island that last operated in 2019. The reactor is scheduled to restart in 2028 and generate 835 megawatts.
Another facility in Illinois, Constellation Energy’s Clinton Clean Energy Center, was in danger of closing down before its parent found a new customer in Meta, which is buying all of the clean energy attributes from the 1.1 gigawatt power plant. The arrangement will see Clinton sending its electrons to the local grid, while Meta will use the certificates to offset emissions it is producing elsewhere. The tech giant’s Hyperion AI data center, for example, will need 10 natural gas power plants to operate. If completed, the data center will consume more electricity than all of South Dakota.
Duane Arnold is smaller, but in the process of refurbishment, NextEra will squeeze an additional 14 megawatts from the facility, bringing the total to 615 megawatts.
Altogether, the three power plants represent the lowest hanging fruit in the U.S. There might be one or two more, according to a report from Utility Dive, though those candidates, including San Onofre in California, have been shuttered for longer and would require more work to bring back online.
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Tim De Chant is a senior climate reporter at TechCrunch. He has written for a wide range of publications, including Wired magazine, the Chicago Tribune, Ars Technica, The Wire China, and NOVA Next, where he was founding editor.
De Chant is also a lecturer in MIT’s Graduate Program in Science Writing, and he was awarded a Knight Science Journalism Fellowship at MIT in 2018, during which time he studied climate technologies and explored new business models for journalism. He received his PhD in environmental science, policy, and management from the University of California, Berkeley, and his BA degree in environmental studies, English, and biology from St. Olaf College.
You can contact or verify outreach from Tim by emailing [email protected].
AWS ve 2. čtvrtletí utržil 42,2 miliardy USD a provozní zisk činil 16,6 miliardy USD při marži 39 %. Google Cloud sice rostl rychleji, ale zůstal menší s výnosy 24,77 miliardy USD.
AWS and Google Cloud are both burning through tens of billions in capex every quarter, but only one is converting that spending into free cash flow at hyperscale margins right now. Which model actually wins when the 2027 capacity cliff…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Amazon (NASDAQ:AMZN | AMZN Price Prediction) and Alphabet (NASDAQ:GOOGL) both reported Q2 FY2026 results that put the same question in front of investors: how fast does cloud capex turn into cash? AWS delivered its fastest growth in 18 quarters, while Google Cloud accelerated to 82% year-over-year growth. Both are spending like wartime generals. Only one is monetizing at hyperscale margins today.
AWS Prints Profit. Google Cloud Prints Growth. AWS revenue reached $42.2 billion with operating income of $16.6 billion and a 39% operating margin. Andy Jassy said the AWS backlog now sits at $496 billion, roughly two and a half times the level of Q3 2025. Trainium and Graviton are doing real work here: Graviton is used by 98% of Amazon’s top 1,000 EC2 customers, and the AI chips business already runs at more than $25 billion.
Google Cloud posted $24.77 billion in revenue, smaller than AWS but growing more than twice as fast. Sundar Pichai said nearly 90% of the Fortune 100 now use Gemini Enterprise, and the Gemini App has 950 million monthly active users. That is the full-stack pitch: models, TPUs, Search, and YouTube all reinforcing one another.
Business Driver AWS Google Cloud Q2 Revenue $42.2B $24.77B YoY Growth 36.7% 82% Segment Operating Margin 39% Not disclosed this quarter Capex Bills Come Due Differently Amazon spent $53.1 billion on cash capex in Q2 and expects to double its power capacity by the end of 2027 versus 2025. Alphabet’s capex hit $44.92 billion, up 100.1% year over year. Both companies ran negative free cash flow in the quarter.
The funding paths diverge sharply. Amazon covers its bills largely through operating cash flow of $45.4 billion plus debt. Alphabet raised approximately $70 billion in combined equity and debt, and suspended buybacks. Long-term debt jumped from $46.5 billion to $98.2 billion.
AWS Wins on Pure Profit. Alphabet Wins on Speed. Jassy said server investments break even in a little less than three years, then generate cash across a 30-plus year data-center life. That is a long, patient conversion curve backed by proven margins. Alphabet’s speed advantage is different: 82% cloud growth paired with 34% companywide operating margin means demand is compounding faster than at AWS, even if segment profitability lags.
Watching the 2027 Capacity Cliff I want to see whether Amazon’s $496 billion backlog actually flows through to free cash flow as promised, and whether Alphabet’s Gemini enterprise footprint keeps pulling ahead of the growth curve into 2027. Memory and SSD inflation, flagged by Brian Olsavsky, could squeeze both.
Why I Split the Two for Different Investors If you want proven cloud economics and a slower, surer cash payoff, AWS inside Amazon looks cleaner to me. The 39.4% AWS margin is doing real work while retail scales. If you want faster top-line acceleration and full-stack AI optionality, Alphabet fits, especially with 46.21% one-year returns already earned. I would hesitate on both if capex keeps outrunning cash into 2027.
Contact [email protected] for any questions or corrections.
Google Cloud hlásí prudce rostoucí poptávku po AI, kyberbezpečnosti a infrastruktuře. Počet nových zákazníků se meziročně více než zdvojnásobil a kontrakty nad 100 milionů USD rostly více než dvojnásobně i mezičtvrtletně i meziročně.
3 Stocks to Buy and Hold for Higher Interest RatesGoogle Cloud CEO Thomas Kurian said Alphabet NASDAQ: GOOG is seeing accelerating enterprise demand for its cloud infrastructure, artificial-intelligence products and cybersecurity offerings, citing growth in customer additions, large contracts and cross-selling across its product portfolio.
Speaking at a company conference, Kurian said Google Cloud has more than 17 product lines with annual revenue above $1 billion. He said new-customer acquisition has grown more than twofold year over year, while deals exceeding $100 million have increased more than twofold both quarter over quarter and year over year.
Get Alphabet alerts:
Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal SettlementKurian said customers that make commitments to Google Cloud typically spend more than 50% above their initial commitments, which he said reflects adoption and expansion within the existing customer base.
Integrated AI Stack Kurian emphasized Google Cloud’s strategy of offering first-party products across the technology stack, including its own tensor processing units, or TPUs; NVIDIA GPUs; Arm-based processors; Gemini models; data-management tools; security products; and enterprise applications such as Workspace.
3 Stocks Built for Higher Rates—And 2 That Could Break“Some people buy us for silicon, some people use our models, some people use our data platforms,” Kurian said, describing a business model designed to capture revenue through multiple channels as AI monetization evolves.
He said the company offers what it characterizes as 2.7 times better price performance for AI training, 80% better price performance for inference and 30% better price performance for CPUs. Kurian attributed the economics to Google Cloud’s ability to co-design technology across the stack.
Google Cloud’s accelerator business, including TPUs, is more than twice the size of the next-largest hyperscaler’s TPU business, Kurian said. He added that aggregate payback on AI servers is less than two years, while payback on Google’s own silicon is roughly half that period. Most infrastructure contracts are long-term commitments of about five years, he said.
Gemini Enterprise Adoption Kurian said Google Cloud’s Gemini Enterprise platform is used by more than 90% of the Fortune 100 and by thousands of smaller businesses. The platform is designed to help companies deploy AI agents that can analyze company data, execute workflows, generate content and assist with security tasks.
According to Kurian, 80% of Google Cloud customers use its AI products. Customers using AI use 1.8 times as many Google Cloud products as those that do not, he said, while the company estimates that the five-year lifetime value of a cloud customer using its Gemini portfolio is 1.5 times higher.
Kurian cited use cases including Signal Iduna’s claims and underwriting analysis, PepsiCo’s supply-and-demand planning, and Macy’s retail-commerce activities. He also described Citigroup’s work on a Gemini Enterprise-based wealth-adviser platform that combines an AI avatar, financial-data analysis, security tools and infrastructure designed for real-time streaming.
Google Cloud differentiates Gemini Enterprise by enabling customers to select different AI models for different tasks, rather than relying on a single model, Kurian said. He argued that using multiple models can be particularly important in cybersecurity, where different models may identify different vulnerabilities.
Cybersecurity and Infrastructure Models Kurian said Google Cloud’s acquisition of Wiz was driven by the growing ability of AI systems to understand software code and system configurations, potentially making them more effective at finding vulnerabilities.
Wiz helps organizations identify applications, assess risk, prioritize systems for review and find vulnerabilities, he said. Google Cloud has also developed a product called CodeMender with Wiz to repair code and test whether vulnerabilities have been addressed.
“You can only defend a threat from an AI model by using a combination of a security platform and an AI system,” Kurian said. He said more than 90% of the Fortune 100 use Google Cloud’s cyber-defense tools.
On infrastructure deployment, Kurian said Google Cloud offers TPU systems through cloud subscriptions, capital purchases for customer data centers and neocloud offerings. He said the company has established a neocloud with Blackstone.
Providing systems in customer data centers can be important for high-performance computing and capital-markets customers that need infrastructure close to large existing data sets or trading venues, Kurian said. Hardware sales can also reduce Google Cloud’s need to fund data-center space and power for those deployments, he added.
Partner and Industry Focus Kurian said Google Cloud is using forward-deployed engineers to work with major customers on industry-specific AI applications, build reusable implementation tools, and develop training and certification programs for partners. He said the company recently announced an agreement with Accenture to build a Gemini Enterprise business group.
Going forward, Google Cloud is concentrating its partnership strategy on eight industries, systems integrators and AI specialists, and data providers. In financial markets, Kurian cited data providers including Bloomberg, FactSet and MSCI as examples of firms whose information is available on Google Cloud’s platform for AI-driven analysis.
About Alphabet (NASDAQ:GOOG)Alphabet Inc NASDAQ: GOOG is a multinational technology holding company headquartered in Mountain View, California. Formed in 2015 through a corporate restructuring of Google, Alphabet serves as the parent to Google LLC and a portfolio of businesses collectively known as "Other Bets." Google was originally founded in 1998 by Larry Page and Sergey Brin; Alphabet is led by CEO Sundar Pichai, who oversees Google and the broader company while the founders remain prominent shareholders and influential figures in the company's history.
Alphabet's core business centers on internet search and advertising, with Google Search and the company's ad platforms (including Google Ads and AdSense) generating the majority of revenue by connecting advertisers with consumers worldwide.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Alphabet Right Now?Before you consider Alphabet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphabet wasn't on the list.
While Alphabet currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Google investuje nejméně 13 miliard eur do AI infrastruktury ve Finsku během příštích dvou let a uzavřel svou první jadernou smlouvu mimo USA. Dohoda zahrnuje 22letý odběr až 50 % výroby jedné ze dvou finských jaderných elektráren.
Alphabet's (GOOGL.O) Google will invest at least €13 billion ($15.1 billion) in artificial intelligence infrastructure in Finland over the next two years and has signed its first nuclear power contract outside the U.S., it said on Wednesday.
The Finnish deal includes a 22-year purchase agreement for up to 50% of the energy output of one of Finland's two nuclear plants, its operator Fortum (FORTUM.HE) said separately.
Nuclear power, as a source of large amounts of low-carbon energy, is one of the attractions Finland offers as companies including Microsoft (MSFT.O) and TikTok owner ByteDance as well as Google seek sites for data centres while containing energy costs and meeting climate goals.
"This is Google's first nuclear energy deal outside of the United States, and we think it's a really important cornerstone to everything that we are doing here," the U.S. company's Chief Investment Officer Ruth Porat told reporters in Helsinki.
Fortum and Google will also explore the development of new nuclear and renewable energy in Finland, the companies said.
Fortum's share price rose 10% by 0825 GMT, outperforming a 1.4% increase in the Helsinki benchmark stock index.
BIGGEST DEAL SO FAR IN EUROPE
Alphabet this year increased its global investment to between $195 billion and $205 billion as it seeks to capture growing computing demand. Google said the AI investment deal in Finland is the biggest yet in Europe.
The investments will include data centres, electricity grid improvements and clean energy and battery projects driving services such as Gemini, Search, Maps and YouTube, Google said in a statement.
"The new digital infrastructure will serve as building blocks for Finnish and broader European digital readiness, innovation, and AI development," the company said.
The investment, to be undertaken in 2027 and 2028, will contribute some $3.6 billion to Finland's gross domestic product during the construction phase, and is projected to support some 7,000 jobs annually once operational, Google said.
Finland's Prime Minister Petteri Orpo said in a statement Google's decision was "a clear testament to our strengths".
"The value of the data economy extends far beyond direct investment into spurring innovation, research, and development," he added.
In its statement utility Fortum said the long-term purchase deal provided economic certainty for a lifetime extension and upgrade of the Loviisa power plant through 2050. The plant is situated near Google's Hamina data centre.
Apart from copious amounts of low-emission power, Finland's cold climate lowers costs because it reduces the amount of energy needed to cope with the heat produced by data centres.
Sergey Brin je podle zdrojů stále vlivnější v řízení Gemini a tlačí Google k rychlejšímu a praktičtějšímu vývoji AI. Interní kuchyňka se mezitím stala neoficiálním velitelským centrem.
Sergey Brin launched Google from a garage nearly three decades ago. Lionel Hahn/Getty Images; BI
Hugh Langley You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Read in app
Google's AI destiny is being cooked up in a California kitchen.
On the second floor of Gradient Canopy, a tent-like structure that rises east of Google's Mountain View headquarters, is a microkitchen filled with many of the typical fixings: coffee beans, grinders, an espresso machine, a fridge. Less typical is the U-shaped formation of desks, used by Google cofounder Sergey Brin and a handful of mission-critical leaders who are steering Google through an AI race it can't afford to lose.
Google CEO Sundar Pichai visits the break-turned-war-room several times a week. Employees from other parts of the building sometimes saunter in for an extended snack break, hoping to overhear gossip that could reveal Google's next big move. There are whispers that cofounder Larry Page has been spotted there.
This unlikely nerve center has gained more influence in the weeks since Google shook up its AI leadership.
Google DeepMind CEO Demis Hassabis, who was helping steer the company's AI efforts from London, relinquished his title and became Alphabet's chief scientist. Koray Kavukcuoglu, who moved from London to the US last year and now sits alongside Brin in the microkitchen, was appointed SVP of Google DeepMind, effectively replacing Hassabis. Jeff Dean, Google's longtime chief scientist, left the company after 27 years.
Brin's role in the new power structure went unmentioned.
However, the man who helped launch Google from a garage nearly three decades ago has become increasingly influential over Gemini, eight current and former employees told Business Insider, in part thanks to his unique ability to pull resources for critical work and cut through the tech giant's bureaucracy. The latest changes at the top, some of them said, could give Brin even more sway over Gemini.
It's a role seen by some inside Google as necessary after the 2023 merger of the company's two central AI labs led to friction over the direction of Gemini that slowed progress and prompted a stream of departures. Some of Mountain View's leaders became frustrated with Hassabis and other researchers in London, believing they weren't as pragmatic about making Gemini more competitive to rivals, two people familiar with the matter said.
Up against the corporate machinery of Google, the microkitchen has acted as something of a startup inside the larger company, allowing Brin, Kavukcuoglu, and other leaders to make decisions faster. "The promise of the kitchen is that it can help you cut through the politics," said one former employee familiar with the setup.
Many of Google's top AI researchers work in the Gradient Canopy building. Jane Tyska/Bay Area News Group Such decisions are more crucial than ever. Google has fallen behind the frontier, which is putting more pressure on it to make its next model, Gemini 4, a blockbuster event. The company has lost top talent in recent months, including star computer scientists John Jumper and Noam Shazeer. Against this backdrop, Brin has urged employees to double their efforts on Gemini.
"Demis is obviously very talented, but he's moving farther away, not closer, to the operational part. This glimmer of hope is this notion that Sergey will get more involved," said Gil Luria, head of technology research at the investment bank D.A. Davidson. "They need a big change that will cut through that bureaucracy."
Google declined to comment on this story, and declined to make Brin and other leaders available for interviews.
Letting Brin cookBrin's position is highly unusual.
He no longer holds an executive title at Google, yet he and Page have decisive influence over the company's board due to a special controlling stock.
After he and Page stepped back from running Alphabet in 2019, Brin spent his time building airships, partying at Burning Man, and writing about physics. When ChatGPT launched in late 2022, and Google was suddenly playing catch-up, Brin said the temptation to return to the trenches was just too much. "As a computer scientist I've never seen anything as exciting as all of the AI progress that's happened in the last few years," he said during the All-In Summit in Los Angeles in 2024.
Brin's unique perch inside Google makes him a powerful ally for any Googler who wants to accrue more support for their project or idea. Getting access to Google's chips, even for the Gemini team, can be difficult. The official route is to submit a formal document and get buy-in from higher-ups. Another route is to strike a deal with a different team inside Google to use their chips in exchange for, say, building Gemini features for their products, two people familiar with such arrangements said.
The other, less official route is to go to Brin.
"Koray has more explicit power in the hierarchy, but Sergey is the founder of Google," said a former senior employee. "He's able to cut through bureaucracy and clear red tape in a way no one else can." People who have worked at Google DeepMind said Kavukcuoglu and Brin have a good rapport, and that when Brin wants something done, he will often do it through Kavukcuoglu. However, Brin usually gets his way, three people said.
Koray Kavukcuoglu became SVP of Google DeepMind in the August reshuffle. Lester Cohen/Getty Images for Breakthrough Prize Over the past two years, the microkitchen's gravitational pull has grown stronger. Kavukcuoglu moved from London to Mountain View last year and now sits close to Brin. Sebastian Borgeaud, a research engineer, also moved across the Atlantic last year and was appointed to lead work on improving Gemini's coding abilities, two people familiar with the move said. A huddle of desks was set up for the coding strike team inside the microkitchen, close to Brin and Kavukcuoglu, a person familiar with the matter said.
"Sergey wants to run Gemini like a startup," said a former employee with direct knowledge of the arrangement. "If you want to be part of the startup, you have to be in the microkitchen."
Emanuel Taropa, a Google fellow and a legendary name in the AI research community, often sits in the kitchen, two people said. So does Enrique Piqueras, a senior research engineer on Gemini, who insiders described as an especially close ally of Brin's. Another oft-spotted face in the kitchen is Rahul Arya, a physics Olympiad who has played a central role in improving Google's AI chips. Insiders say that Google has made a concerted effort not to publicize some of its most important stars for fear of them being poached.
If you can't handle the heatBrin has largely involved himself in the technical aspects of Gemini, weighing in on discussions about model sizes, release windows, and paths to artificial general intelligence, according to current and former employees. He also got involved in some internal disagreements last year over how Gemini should be integrated into Google products, two people said.
One idea Brin pushed earlier this year was to use software to monitor some Google employees as they coded, believing it could be a useful reinforcement learning technique to improve Gemini's coding abilities, a person familiar with the project said.
At times, Brin has made calls that have frustrated some staff. In 2025, Dean, Google's now-former chief scientist, was leading efforts to build a chip that would embed a version of the Gemini model architecture directly onto the silicon, a project internally codenamed Frozen. The project was unpopular among some Gemini leaders, two former employees said. Brin made the call to cut the project — a decision that frustrated Dean, who told some colleagues around that time he was considering leaving the company, said one of the people who heard the remarks.
The project was later revived as Frozen v2; however, some of its resources were stripped away from it earlier this year, the person added. Dean left Google in August to launch his own startup. He declined to comment on this story.
Jeff Dean left Google in August after 27 years to launch his own startup. Bloomberg/Getty Images Some employees bristled at a post Brin made in an internal Google DeepMind work channel in 2025, stating that working about 60 hours a week is the "sweet spot" for productivity, which was first reported by The New York Times. One former manager said that they told their employees to ignore Brin's memo.
Earlier this year, during a Q&A session at San Francisco's AGI House, Brin was asked how he was splitting his responsibilities with Kavukcuoglu and Hassabis. Brin said he worked closely with Kavukcuoglu and would often "poke and prod" the teams when he was unhappy with their direction, describing himself as "sometimes a little bit disruptive."
"I'll be honest, I'm a little bit of a rabble-rouser," he said.
Brain trustWhen Google announced in 2023 that it would combine DeepMind with its core Brain AI team, it capped a near-decade journey for Hassabis. Since selling DeepMind to Google in 2014, the Nobel laureate had fought to keep his lab independent, determined to pursue research free of Google's bureaucracy and untethered from products he considered irrelevant to his north star: building artificial general intelligence.
The 2023 merger was evidence to some inside DeepMind that any hopes of exercising independence under Google were misplaced. It was also around this time that Brin began showing up to work on Gemini. While Google said nothing publicly about Brin's return, there were clues. A March 2023 post on LinkedIn showed Luxembourg Deputy Prime Minister Xavier Bettel meeting Pichai, Google's global affairs president Kent Walker, and — wearing sweatpants — Brin.
Google was in wartime mode, but there was also a battle brewing within. Brain and DeepMind had different cultures, three people who worked there at the time said. Brain typically worked more closely on improving Google's products, and teams in DeepMind had focused more on longer-term research that often didn't have near-term commercial viability. "There was tension in the DNA of what DeepMind wanted to be," said a former employee. "Do they want to be a 10-year research bet working on things that make humanity incredible, or are they going to win this 3-6 month horizon race between the labs?"
Demis Hassabis is now Alphabet's chief scientist. Karl Mondon / AFP via Getty Images In 2023, Kavukcuoglu chose to build Gemini using some of the people and infrastructure behind Chinchilla, a prior language model developed by the London DeepMind team, rather than on Google's PaLM 2. The decision was unpopular with some researchers in Mountain View, who saw it as favoritism toward the London group, two people said.
After Brin returned to the trenches in 2023, he began working in the microkitchen. Taropa, the Google fellow, was also a core founding member of the kitchen office. Over time, more desks were added, and the space became the de facto command center, often referred to by staff as "Sergey's microkitchen." At one point, an overflow space was added because many employees wanted to be closer to what had quickly become the power center of Gemini.
'AGI-pilled'Brin has spent less time in the kitchen in recent months, sometimes showing up on alternating weeks, according to two people who have seen him there. Ahead of a possible new billionaire's tax, the Google cofounder moved some of his personal assets out of California last December and purchased homes in Florida and Nevada.
The measure, if it passes on a November ballot, would impose a one-time tax on California residents with a net worth exceeding $1 billion. Brin, who has mounted a large-scale opposition effort against the tax, could be liable to pay $14 billion if he were considered a resident.
Ahead of the recent leadership shuffle, Brin appeared frustrated with the pace at which Google is moving on Gemini and has pushed employees for more focus on recursive self-improvement (RSI), the point where systems can improve themselves, current and former employees said. "He's very invested in RSI. He's very AGI-pilled," said one former employee. Reuters previously reported on some of Brin's remarks around RSI.
Sergey Brin and Larry Page launched Google out of a suburban Silicon Valley garage in 1998. JOKER/Martin Magunia/ullstein bild via Getty Images Insiders described the August reorg as a win for the more technical side of the company and the further erosion of DeepMind's independence, underscoring the commercial reality of the AI race. In recent weeks, the company has shown signs of positive progress. It recently rehired Barret Zoph, the Thinking Machines Labs cofounder, in what some insiders said could be a big win for Google. The company has said its latest Gemini model shows "significant" improvements in coding.
Will it be enough? Google is still bleeding talent. The AI coding software market has fast become crowded, which could make it harder for Google to break in meaningfully, said Luria, the analyst. What Google needs, he said, is a major breakthrough that will vault its models to the state of the art. "Short of that, everything is tactical, and they'll continue to need to catch up," he said.
The September release of ChatGPT's Astra model appears to have pushed the frontier forward again, and OpenAI CEO Sam Altman has suggested even smarter models are waiting in the wings.
Google needs momentum, and with Brin more involved than ever, some employees are hopeful it will find it. From a garage to a kitchen, Google's most consequential work has a habit of happening in unlikely rooms.
Have something to share? Contact this reporter via email at [email protected] or Signal at 628-228-1836.
Google Artificial Intelligence AI More Big Tech Exclusive Most popular
Business Insider tells the stories you want to know about the world of business, technology, and finance
Business Insider tells the stories you want to know about the world of business, technology, and finance
Business Insider tells the stories you want to know about the world of business, technology, and finance
Business Insider tells the stories you want to know about the world of business, technology, and finance
Business Insider tells the stories you want to know about the world of business, technology, and finance
Business Insider tells the stories you want to know about the world of business, technology, and finance
Hugh Langley You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Hugh is a senior correspondent at Business Insider where he writes about Google, tech, and wealth. His work has been cited by The New York Times, Bloomberg, Reuters, The Wall Street Journal, and other outlets.Get an alert whenever I publish a story.Got a tip? You can reach him using the secure messaging app Signal (hughlangley.01) or email ([email protected]). We can keep sources anonymous.
The multigeneration partnership expands AWS's silicon bench, but disclosed economics stop at bandwidth--not revenue, pricing or deployment dates. Summary
AWS gains another chip designer while Qualcomm becomes a larger cloud customer.
Amazon AMZN, the e-commerce and cloud-computing powerhouse, expanded its custom-chip ambitions Tuesday by bringing Qualcomm into a multigeneration partnership. The alliance targets AI inference silicon and optical networking capable of reaching 1.6 terabits per second. Amazon shares fell approximately 1.3% to $255.13 in early trading.
AWS delivered $42.2 billion in second-quarter revenue, up 37%, while operating income reached $16.6 billion. Amazon said both its chip franchise and broader AI business had crossed annual revenue run rates of $25 billion. Qualcomm will deepen the relationship from both directions, helping design Amazon hardware while using more AWS infrastructure and AI services to develop its own semiconductors.
The real prize is cheaper inference, not another headline-grabbing chip specification. AWS posted an operating margin of roughly 39.3%, so every efficiency gain could protect the profit engine financing Amazon's AI buildout. The chart shows the stock trading only 2.96% above its $247.80 GF Value, leaving limited valuation cushion as infrastructure spending keeps trailing free cash flow negative. Qualcomm may strengthen Amazon's chip arsenal and expand its customer base, but the companies disclosed no pricing, purchase commitments or deployment timetable.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Amazon čelí žalobě kvůli údajné systematické diskriminaci těhotných zaměstnankyň, včetně odpírání přestávek a propouštění po absencích. Firma tvrdí, že vyhověla více než 99,9 % žádostí o úpravy.
Amazon was sued on Tuesday in a proposed nationwide class action accusing the retailer of systematically discriminating against thousands of pregnant employees, including by firing some it claimed took too much time off.
According to a complaint filed by four former warehouse employees, Amazon routinely violates federal and New York worker-protection laws by denying pregnant workers basic accommodations such as chairs, bathroom and water breaks, and time off for prenatal appointments.
The complaint said Amazon threatens and regularly fires pregnant employees who miss too much work, and illegally demands medical documentation from those seeking accommodations. It said these actions violate the federal Pregnant Workers Fairness Act and New York labor law.
According to a complaint filed by four former warehouse employees, Amazon routinely violates federal and New York worker-protection laws by denying pregnant workers basic accommodations such as chairs, bathroom and water breaks, and time off for prenatal appointments. Getty Images “Amazon is one of this country’s largest employers, [and] it is no surprise that many of its workers become pregnant,” according to the complaint filed in the Brooklyn, New York, federal court. “Yet Amazon violates the law at every turn.”
Kelly Nantel, an Amazon spokesperson, said the retailer provides pregnancy-related accommodations to tens of thousands of employees annually, and approved more than 99.9% of requests in the last year. “Ensuring the health and well-being of our employees is one of our greatest responsibilities,” she said.
The lawsuit seeks lost pay and benefits, punitive damages, and an injunction against discrimination against pregnant employees.
Amazon has long faced complaints in court about its treatment of employees, including those seeking to unionize.
The Seattle-based retailer is the second-largest US private employer, trailing Walmart, with 1.58 million full-time and part-time employees at the end of 2025. AP Photo/Michael Sohn The Seattle-based retailer is the second-largest US private employer, trailing Walmart, with 1.58 million full-time and part-time employees at the end of 2025.
Hospitalization led to dismissal, lawsuit says Tuesday’s lawsuit was filed by A Better Balance, a nonprofit that advocates for workers’ rights.
It came 11 months after New Jersey sued Amazon, accusing it of widespread discrimination against warehouse employees who had disabilities or were pregnant. New York filed a similar case in 2022.
Amazon has long faced complaints in court about its treatment of employees, including those seeking to unionize. USA TODAY Network via Reuters Connect One plaintiff, Willamina Barclay, said Amazon gave her a termination warning on June 17, 2025, one day after she was taken in a wheelchair out of its Rochester, NY, warehouse and hospitalized with a pregnancy-related emergency.
Barclay said she was suffering severe abdominal pain from lifting heavy objects, but Amazon claimed the hospital visit pushed her over her limit for unpaid time off, and docked her because she “worked partially that day.”
Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more.
Thanks for signing up!
She was fired five days later, the complaint said.
Nantel said the four plaintiffs’ accounts “contain inaccuracies and omit important details.”
The Equal Employment Opportunity Commission plans in November to propose changes to regulations underlying the Pregnant Workers Fairness Act.
That agency has aligned itself with President Trump’s policies, and EEOC Chair Andrea Lucas said in 2024 that the regulations for pregnant employees are too broad.
The EEOC did not immediately respond to requests for comment. The office of New Jersey Attorney General Jennifer Davenport, whose predecessor filed that state’s lawsuit, did not immediately respond to similar requests.
Amazon (AMZN.O) started selling sterling bonds for the first time on Wednesday, according to the banks managing the deal, as hyperscalers rush to diversify their funding sources to finance the AI boom.
The deal is the latest example of how hyperscalers are increasingly selling bonds across markets outside of the U.S. this year, from euros to Swiss francs and the yen, as they make sure they can raise capital wherever they can, given their huge funding needs.
They have already issued more than $200 billion of debt this year, more than doubling from the whole of 2025, according to LSEG data.
Initial price guidance on the Amazon deal was set at around 70 basis points over British government bonds on a three-year bond, around 90 basis points over for a six-year bond, around 105 basis points over for a 12-year bond and around 110 basis points over for a 19-year bond, according to a memo sent by three of the banks seen by Reuters.
The deal will price later on Wednesday, the memo said.
The pound is the latest currency Amazon has added to its funding programme after tapping the euro and Swiss franc bond markets.
The European Central Bank warned earlier in September that hyperscalers' push into the euro zone bond market could potentially crowd out other borrowers and push up their financing costs.
Google-parent Alphabet (GOOGL.O), which has led the way in selling non-U.S. dollar bonds, was the first hyperscaler to tap the sterling market in February, when it raised £5.5 billion from a five-part deal, including a rare 100-year bond. It has also raised Japanese yen, Canadian and Australian dollar debt this year.
It is Amazon's first bond sale since July, according to LSEG data, when it received weaker demand than in the past for a $25 billion offering, in one of several signs that the heavy pace of hyperscaler borrowing started to test the limits of investor demand.
AMD uvedla novou platformu Ryzen AI Halo s 192 GB sdílené paměti, která má na desktopu zvládnout modely s až 300 miliardami parametrů. Cílí na citlivé AI úlohy mimo cloud.
AMD just announced a workstation that could pull sensitive AI workloads out of the cloud entirely, and the buyers it has in mind reveal exactly who stands to lose the most.
AMD is talking up a new workstation-class system built around data-center-grade accelerators, pitched as capable of running very large AI models on a desk rather than in a hyperscaler cloud. Secondary coverage has run with a “trillion parameter” framing, but that specific claim is not confirmed in AMD’s primary communications, and pricing has not been publicly verified either.
On the August 4, 2026 earnings call, CEO Lisa Su said the next-generation Ryzen AI Halo platform, powered by the new Gorgon Halo processor, features 192 gigabytes of unified memory and can run models with up to 300 billion parameters. That extends the earlier Ryzen AI Max+ and Ryzen AI Halo developer platform, previously scoped for models up to 200 billion parameters locally.
Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) closed Friday, September 4, 2026 at $477.57, up 4.69% in that session. US markets were shut Monday for Labor Day, so the first full trading response is still ahead. The stock is already up 123% year to date and 195.18% over one year, so a lot of AI optimism is already priced in.
What Investors Should Do About It The real story is compute moving on-premise for buyers who will not send sensitive workloads to a cloud: defense contractors, hospitals, banks, and sovereign research labs where latency, cost, and data privacy outweigh cloud convenience. Treat it as a strategic signal for AMD’s client roadmap; the near-term revenue impact looks immaterial next to the data-center business. AMD posted Data Center revenue of $6.72 billion in Q2, 58% of total revenue and up 107% year over year, with Q3 guidance of roughly $13 billion, up about 41%. That is where the AI money is actually being made.
All of that data-center buildout still has to be powered, cooled, and networked by someone other than the chipmaker itself, which is the angle we took in a free report on seven suppliers riding the same wave: 7 Stocks Powering the AI Boom (That Aren’t Chipmakers).
Contact [email protected] for any questions or corrections.
Chris Lange
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
AMD uvedla, že její celkový adresovatelný trh může do roku 2030 dosáhnout 3 bilionů USD, což poslalo akcie v úterý o 6 % výše. Firma tak zvýšila dřívější odhad zhruba 2 bilionů USD.
AMD stock surged 6% on Tuesday after Advanced Micro Devices said its total addressable market could reach $3 trillion by 2030, up from its previous estimate of roughly $2 trillion.
Shares rose 6.45% to $508.38, bringing their gains for the year to more than 120%.
The revised market opportunity reflects rising demand for graphics processing units (GPUs), central processing units (CPUs) and AI-enabled PCs, according to Chief Financial Officer Jean Hu.
AMD had estimated in July that its total addressable market could reach approximately $2 trillion by 2030.
Speaking at a conference on Tuesday, Hu said the figure could potentially reach as high as $3 trillion.
“This AI super investment cycle is at the very beginning, and over time, we're going to continue to see strong demand for AMD's product,” Hu said.
A key part of AMD’s outlook is the shift in AI workloads from model training toward inference, where AI models execute tasks after training.
According to a Citi summary of the event, AMD management said, “In the past twelve months, Inference has become the majority driver of AI computing,” with workloads also moving beyond basic chatbots toward more autonomous AI systems.
AMD expects its data center business to more than double next year.
The company plans to launch its next-generation MI450 GPU this quarter, with production expected to ramp up during the fourth quarter and into 2027.
The company is also benefiting from stronger demand for server CPUs.
Hu said AMD has increased supply in the constrained CPU market, supporting expected growth of more than 80% in the business during the second half of this year compared with the same period in 2025.
Server CPU growth is expected to exceed 70% next year.
AMD is also seeing strong demand for its rack-scale Helios systems.
Meta Platforms and two unnamed AI labs are anchor customers, and all three have provided demand forecasts above their initial purchase agreements.
Helios volume expectations for 2027 have already exceeded initial projections, while AMD is seeing additional demand from newer “neo-cloud” providers.
Data center GPUs currently generate profit margins below AMD’s corporate average.
However, growth in higher-margin server and embedded businesses has helped offset that pressure, with strong double-digit growth expected in the second and third quarters.
AMD is also developing its future AI accelerator pipeline.
Management said it is engaged with its three leading customers on next-generation MI500 and MI600 chips. The company has also disclosed a partnership with Cerebras and indicated plans to target the low-latency inference market.
AMD’s shares have gained more than 230% over the past year, although the stock has fallen nearly 5% over the past week and about 6% over the past month.
The decline has followed strong gains and comes as investors weigh valuation alongside risks including AI accelerator export controls, memory supply constraints and tariffs.
The company’s Gaming segment also remains a drag, with revenue down 31% year over year to $779 million.
Despite those risks, AMD has become a credible second source for AI computing, supported by 107% year-over-year growth in Data Center revenue and a 6GW GPU agreement with OpenAI.
The stock has five strong-buy ratings, 36 buys and 10 holds, with no sell ratings and an average price target of $613.84.
Nokia uvedla, že plánuje do konce roku uzavřít téměř všechna pracoviště v pevninské Číně. Akcie jsou stále 42 % pod 52týdenním maximem, ale za poslední měsíc přidaly 7,2 %.
Nokia stock sits 42% below its summer peak, but the China retreat reports blamed for the slide arrived months after the selloff began. The real question is whether the rally that preceded it was ever built on something real.
Nokia (NYSE:NOK | NOK Price Prediction) closed most recently at $10.03, down 42.5% from its 52-week high of $17.45. Yet over the trailing month, the stock is actually up 7.2%, and it rose 2.7% in last Friday’s session. The China-exit reports that hit in mid-August did not cause the summer drawdown. The real question is whether the spring rally was ever earned.
Nokia is up 54.1% year to date, up 120.4% over one year, and 67.7% higher over five years. This is a stock that ran hard and gave part of it back. The bulk of that decline happened between late May and early August, before any China site-closure reporting.
Case That the Rally Was Earned Q2 2026 revenue of $5.49 billion (€4.8 billion) beat estimates by 13.8%, with EPS of $0.08 (€0.07). That is three consecutive quarters of beats after Q2 2025 missed EPS by 38.2% and forced a guidance cut. AI & Cloud customer revenue more than doubled to $508.96 million (€446 million), and Q2 order intake reached €2.8 billion. The Infinera acquisition built the optical transport franchise (the long-haul fiber gear that moves data between and inside data centers), and Nokia has an agreement to acquire NXP’s Chandler, Arizona, campus for indium phosphide production. Patent licensing (Technology Standards at €407 million, up 14%) throws off cash regardless of equipment cycles.
Case That the Rally Was a Story The Nvidia strategic investment and AI-RAN partnership (adding GPU acceleration to radio access networks) drove the re-rating, and it came with new share issuance that diluted existing holders. Retail piled in: Reddit sentiment hit “very bullish” around the May 29 peak on posts calling Nokia “the backbone of AI infrastructure.” A partnership with Anduril reported by The Motley Fool on May 13, 2026, added fuel. Partnerships lack the recurring revenue that would justify a re-rating.
What the China Exit Actually Means The South China Morning Post reported on August 18, 2026, that Nokia plans to close almost all mainland China sites by year end. Fierce Network on August 19 framed the retreat as a bigger bet on AI and optical networks, while Light Reading warned the same day about thousands of China jobs shed at likely 6G cost. Fierce Network noted on August 28 that Nokia defended Bell Labs after a former chief blasted cuts. Nokia reports in euros while a majority of its sales are dollar-denominated, which is why this Helsinki-headquartered stock can move on FX swings alone.
What Must Go Right for Shares to Reclaim the Peak Network Infrastructure must keep compounding on AI and cloud customers rather than relying on telecom capex. AI-RAN pilots (10 public customers, commercial in 2027, volume in 2028) must convert. The departure from China needs to show up in group margin. Optical pricing must hold. A stalled Network Infrastructure quarter, or slipping Nvidia milestones, undermines the bull case.
Verdict Nokia’s operating turn is genuine. The spring valuation priced a story the fundamentals had not yet delivered. The current level looks more defensible than the share price of $17.45 did.
Contact [email protected] for any questions or corrections.
Boeing v srpnu dodal 51 letadel, méně než v červenci i před rokem, protože klesly dodávky 787 Dreamlinerů. Firma stále čeká, že letos dodá 90 až 100 kusů.
Boeing (BA.N) said on Tuesday that it delivered 51 jets in August, a slight dip from the previous month and down from 57 jets a year earlier, as the number of 787 Dreamliners handed to customers declined.
The U.S. planemaker delivered only four 787s, down from nine the prior August. A spokesperson said the drop in deliveries was not due to any production, supply chain or certification problems. That brought total deliveries of its popular wide-body in 2026 to 54 through August.
The company still expects to deliver 90 to 100 787s by the end of the year, the spokesperson said.
Increasing output of the highly profitable twin-aisle jet is crucial to Boeing's financial turnaround.
European rival Airbus (AIR.PA) delivered 57 jets and booked 67 orders in August.
August deliveries included 41 737 MAX planes, Boeing's best-selling jet. Nine were delivered to Southwest Airlines (LUV.N), eight to United Airlines (UAL.O) and five to lessor AerCap (AER.N).
Through August, Boeing has delivered 418 aircraft, the most since 2018, when it delivered 481 jets through the first eight months of the year.
Boeing booked 15 new orders in August - two 737 MAX and 13 787 jets. All were for unidentified customers. There were no cancellations in the month.
Through August, Boeing has booked 453 orders after adjusting for cancellations in 2026.
Archer Aviation kupuje od Boeingu Wisk Aero, Insitu a SkyGrid v all-stock dohodě, která dá Boeingu 16,5% podíl. Insitu přináší přes 200 milionů USD ročních výnosů a zisk.
Archer Aviation (ACHR +2.10%) is a pioneering player in the electric vertical take-off and landing (eVTOL) aircraft space. The company is betting that it can scale eVTOL sales and services into a substantially profitable business over the long term, but it still has a lot of work to do before its operations are set up to generate reliable earnings. One piece of good news is that the company doesn't have to rely entirely on growing organically in order to achieve its goals.
Last month, Archer announced that it had entered into a deal to acquire Boeing's Wisk Aero, Insitu, and SkyGrid subsidiaries. The move immediately spurred a substantial jump for Archer's share price, but what will it mean for the company and its shareholders over the long term?
Image source: Archer Aviation.
Archer's latest acquisition push looks encouraging Of the three units Archer acquired from Boeing, Wisk is the most clearly specialized in eVTOL aircraft. In the press release announcing the acquisitions, Archer describes Wisk as "the only company that has designed, built, and flown six generations of eVTOL aircraft, amassing 1,700+ flight tests." Meanwhile, SkyGrid is touted in the press release for its air-traffic management solution and its foundational potential for the future of automated airspace, and Insitu's pioneering role in the design and manufacturing of uncrewed aircraft systems (UAS) is touted.
Archer is acquiring these units from Boeing in an all-stock deal. With the completion of the purchases, Boeing will receive newly created Archer stock that will give it a 16.5% stake in the company. In addition, Boeing will receive warrants that grant it the right to purchase up to $200 million in additional stock. With the Archer issuing so much new stock in order to fund the acquisitions, that means that there will be a substantially dilutive impact for current shareholders. On the other hand, it could wind up being well worth it.
While heavy dilution means that shareholders will see the percentage-based size of their stake in Archer reduced, having Boeing as a large stakeholder and active partner comes with a wide range of potential benefits. As part of the deal, the two companies will enter into a technology-sharing agreement. Boeing will also retain access to Wisk's autonomous flight software for defense and commercial projects, which has positive aspects for Archer because it should support the continued integration and evolution of the tech.
Archer is rapidly diversifying Since going public in 2021 through a merger with a special purpose acquisition company (SPAC), Archer's growth story has primarily centered around the development, testing phases, and timeline for the commercial debut of its Midnight eVTOL aircraft. While Midnight is still important for Archer, the story surrounding the company and its stock has been changing rapidly through partnerships and acquisition moves.
Premium Feature
Moneyball Superscore
59/100
Today's Change
(
2.10
%) $
0.12
Current Price
$
5.83
As noted by Archer CEO Adam Goldstein in the press release announcing the purchases from Boeing, the acquisitions are "the next big step forward in becoming a diversified platform, rapidly growing our revenue base, and bringing scale" to the business. Insitu alone is generating over $200 million in annual revenue, operating in 35 different countries, and generating profits. With the acquisition of the business, Archer's sales profile will immediately get a substantial boost -- and its margin profile should see meaningful improvement.
The partnership with Boeing and integration of Insitu, SkyGrid, and Wisk should provide valuable infrastructure that has complementary impacts across the company's business. In addition to presenting growth opportunities in their own right and supporting the evolution of the Midnight eVTOL project, the units that will be integrated into Archer will likely also help support the hybrid VTOL Halo and Thunder crafts that it developed in conjunction with Anduril and its ZEE aviation AI software model.
Along with expanding its manufacturing partnership with Stellantis, Archer's diversification moves are better positioning the company for long-term viability. The company's chances of achieving profitability solely on the back of its Midnight eVTOL while having to handle scaling manufacturing to the point of even achieving positive gross margins always looked like a long shot, and relying more on partnerships and other avenues to growth in the aviation space is a smart move. Archer stock is still a high-risk play, but its bets on autonomous aerial technologies could pay off over the long term even if ramping for the commercial eVTOL market proceeds at a relatively slow pace.
Akcie Nike letos klesly o 38,12 % a za posledních 12 měsíců o 47,35 %, ale Needham má stále doporučení Buy a cílovou cenu 75 USD, což znamená asi 95% růstový potenciál.
Nike has shed nearly half its value in a year, but one Wall Street analyst sees a path to almost doubling from here while the rest of the Street stays cautious. The question is whether this is a historic buying…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nike (NYSE:NKE | NKE Price Prediction) trades at $38.40, well below Wall Street’s average analyst price target of $50.46, a gap that implies roughly 31% upside.
Nike is the world’s largest athletic footwear and apparel brand, and its “Win Now” turnaround under CEO Elliott Hill has become one of the most closely watched consumer stories on Wall Street. At least one prominent shop thinks that consensus target is far too conservative.
How a Blue-Chip Turnaround Story Lost Nearly Half Its Value Nike shares are down 38.12% year to date and 47.35% over the past twelve months, against an S&P 500 up 12.94% and 18.65% across the same windows. Forbes recently flagged Nike’s removal from the S&P 100 as a possible capitulation signal.
The damage is fundamental. Fiscal Q1 2027 revenue slipped 1.1% year over year to $10.97 billion. Greater China fell 12% reported and 17% on a currency-neutral basis. Converse collapsed 32%. Nike Direct shrank 7%, with digital down double digits. The headline EPS beat of $0.72 versus $0.13 consensus looked flattering only because a one-time $986 million IEEPA tariff recovery added $0.52 per share. Strip that out and EPS was $0.20.
Why Needham Sees Nike Nearly Doubling Needham’s Tom Nikic carries a Buy rating and a $75 price target, a level that implies roughly 95% upside from here. His thesis rests on three pillars: wholesale channel realignment, franchise cleansing, and a strategic re-rating tied to Elliott Hill’s operational pivot.
Wholesale is already showing early proof. Nike’s retail-sales comparison at Foot Locker turned positive for the first time in four years in Q4 fiscal 2026, and North America wholesale grew 10%. Needham sees renewed shelf space at Dick’s Sporting Goods, Foot Locker, and specialty running stores as the primary volume engine, reversing years of over-indexing on direct-to-consumer.
Franchise cleansing is the harder story. Nike pulled roughly $2 billion of classic footwear off shelves in fiscal 2026, clearing space for performance platforms like Vomero and Pegasus. Nike Sportswear and Jordan Streetwear, together about half of total revenue, are expected to stay negative through the first half of fiscal 2027.
Consensus stays restrained. Ratings skew Hold-heavy across 39 analysts, and revisions have leaned lower with seven downward EPS cuts in the past 30 days. Nike’s investor day is scheduled for mid-November, and management has said Win Now actions will sunset by the end of calendar 2026. Both are potential re-rating catalysts.
Athletic Peers That Fell Even Harder The premium athletic space has been repriced across the board. Nike has plenty of company on the downside.
Lululemon Athletica (NASDAQ:LULU) is the deepest bruise in the group, down 51.59% year to date including a 17.38% single-session drop after Q2 revenue missed and guidance was cut. LULU trades near $100.61 against a $127.35 average target, implying about 27% upside. Ratings skew defensive: 1 Buy, 29 Hold, 3 Sell, and 1 Strong Sell.
On Holding (NYSE:ONON) is a growth story going through a valuation reset. Q2 revenue climbed 13.5% with a 65.4% gross margin. Shares are off 39.78% YTD at $27.99, versus a $44.69 target, an implied upside of roughly 60%. Analysts stay bullish with 7 Strong Buy and 16 Buy.
Deckers Outdoor (NYSE:DECK), parent of HOKA and UGG, has held up best, off 17.23% YTD. At $85.81 against a $122.81 target, implied upside sits near 43%.
The largest consensus upside in the group sits with On at roughly 60%, then Deckers at 43%, then Nike at 31%. Needham’s outlier $75 target on Nike would make it the biggest opportunity of the four if it plays out.
What the Consensus Really Says About Nike Nike trades at $38.40 with an average analyst target of $50.46, implying about 31% upside. Trailing P/E is 18, forward P/E is 23. Fiscal 2027 EPS consensus sits at $1.72 and fiscal 2028 at $2.23. Nike’s -38.12% YTD trails the S&P 500’s +12.94% by roughly 51 points.
The 39-analyst breakdown:
Strong Buy: 1 Buy: 10 Hold: 25 Sell: 1 Strong Sell: 2 My Take on Nike at Free-Fall Levels Nike looks compelling at these levels if Elliott Hill’s Win Now reset actually sunsets on schedule and North America wholesale momentum proves durable. The bull path is clean: Foot Locker and Dick’s shelves fill with fresh performance product, Vomero and Pegasus scale, China stops sliding, and the November investor day delivers a growth framework worth re-rating on. Get those, and Needham’s $75 stops looking heroic.
But the setup looks like a value trap on several fronts. Revenue is still shrinking. Greater China went from a 7% decline to a 12% decline in two quarters. Converse is in freefall. Nike Digital keeps shrinking. Rivals like On and HOKA keep taking running share. A 4.2% dividend yield and an $18 billion buyback leave a broken top line untouched.
The setup looks cautiously constructive at these levels. Consensus offers real if unspectacular upside, and the Needham call is a genuinely asymmetric bet if the wholesale reset holds. What keeps me off the table is that fiscal 2027 estimates are still being cut. One clean quarter of revenue stabilization would change that.
Contact [email protected] for any questions or corrections.
Nike čelí návrhu akcionářů na přísnější kontrolu charitativních partnerství kvůli vazbám na skupiny podporující genderově afirmativní péči pro nezletilé. Společnost doporučuje hlasovat proti.
A former college soccer player who has emerged as a leading California critic of transgender participation in women’s sports is bringing her fight to Nike — backing a shareholder measure as investors scrutinize corporate ties to groups that support gender-transition care for minors.
Sophia Lorey, 26, was set to address Nike shareholders Tuesday on behalf of a proposal from Christian investment firm Inspire Investing that calls for greater scrutiny of the sneaker giant’s charitable partnerships.
The Vanguard University alum was expected to focus on Nike’s relationship with the Human Rights Campaign, arguing that the company’s support for the LGBTQ advocacy organization clashes with its marketing of women’s athletics, according to Bloomberg, which obtained a recording of her planned remarks.
Sophia Lorey, a former Vanguard University soccer player and outreach director for the California Family Council, has been tapped to speak in support of an investor proposal at Nike’s annual meeting Tuesday. Instagram/@sophiaslorey The Nike vote is part of a wider pressure campaign by Inspire, which manages $5.4 billion and has been questioning scores of major corporations about their policies on transgender issues.
The investment firm and its allies have contacted 242 employers seeking information about whether their health insurance plans pay for gender-related surgeries for minors, Bloomberg reported.
That campaign is separate from the Nike proxy measure backed by Lorey, a proposal that focuses on potential risks stemming from the company’s charitable giving.
Lorey was set to invoke Nike campaigns including “Play Like a Girl” and “Get Her in the Game” while challenging the sports giant’s association with groups that support transgender women competing in women’s fields, according to Bloomberg.
The shareholder proposal cites an Equal Employment Opportunity Commission investigation involving allegations of systemic race discrimination at Nike.
Former college soccer player Sophia Lorey has become a prominent advocate against allowing transgender athletes to compete in girls’ and women’s sports. Vimeo/Inspire
Nike is urging shareholders to reject a proposal calling for greater scrutiny of risks associated with the sneaker giant’s charitable partnerships. SOPA Images/LightRocket via Getty Images “Given the EEOC’s current high-profile investigation into Nike over ‘systemic race discrimination allegations’ occurring partially as a result of the company’s diversity, equity, and inclusion initiatives, investors are right to be concerned about what further brand politicization could do to company performance,” the proposal states.
Nike has told shareholders to reject the measure, maintaining that another examination of its charitable relationships would duplicate safeguards already in place.
“Charitable partnerships are approved … only after a robust due diligence review of the proposed recipient organization,” Nike’s board said in a regulatory filing cited by Bloomberg.
Sophia Lorey (center) is seen in front of the Supreme Court Building in Washington, D.C., in a photo posted to Instagram on Jan. 14, 2026. Instagram/@sophiaslorey Lorey brings an athletic background to the campaign.
The 5-foot-4 defender played women’s soccer at Vanguard from 2018 through 2021 and majored in business administration, according to university records. Vanguard competed in the NAIA during her career.
She joined the California Family Council as outreach director in 2022 and has since become a prominent advocate against transgender athletes competing in girls’ and women’s sports.
Her advocacy has also extended into schools. In July, a podcast she co-hosts promoted a campaign helping parents seek exemptions for their children from what the program called “gender ideology lessons, CRT, DEI programming” and other curriculum conflicting with their religious beliefs.
Meanwhile, Inspire has broadened its corporate campaign with backing from investors that collectively oversee more than $100 billion, according to the firm’s director of corporate engagement, Tim Schwarzenberger.
The 242 companies approached by the coalition were identified partly through the Human Rights Campaign’s Corporate Equality Index, Bloomberg reported. Inspire is seeking disclosures about their insurance coverage and other policies involving transgender issues.
Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more.
Thanks for signing up!
“We feel that this is an important topic, there’s regulatory, legal and financial risks,” Schwarzenberger told Bloomberg. “We think shareholders have a right to know, have a right to transparency.”
According to Inspire, Walmart told the group that its plans do not pay for gender surgeries for minors. Charles Schwab told the group it previously offered such coverage but had stopped, Bloomberg reported. Neither company commented to the outlet.
Nike has become the latest target of a conservative investor campaign scrutinizing corporate policies involving transgender issues. Getty Images The Human Rights Campaign has pushed back against the campaign, arguing that conservative shareholder initiatives targeting diversity and LGBTQ policies have failed to attract significant support from investors.
“There is no question that extraordinary political and legal pressure has made some companies less willing to publicly document their LGBTQ+ workplace practices,” HRC senior vice president Jonathan Lovitz told Bloomberg.
“But less disclosure doesn’t mean … that they have actually changed practices internally,” he added.
Akcionáři Nike odmítli návrh na větší transparentnost klimatických cílů, podpořený norským státním fondem. Společnost zároveň čelí slabým tržbám a její akcie letos klesly asi o 40 %.
Nike (NKE.N) shareholders have rejected a proposal urging more transparency on its climate goals, including disclosing details on how the sportswear maker intends to reach emissions-reduction targets, the company said on Tuesday.
The shareholder resolution resurfaced questions about the extent to which Nike, which for decades has positioned itself as a climate leader, is prioritizing its environmental targets as it faces financial strain, U.S. political pressure and global regulatory scrutiny of misleading environmental claims.
Oregon-based Nike said in 2019 it aims to reduce its carbon emissions by 65% across its own operations and by 30% across its supply chain by 2030. In a fiscal 2024 update, it said its supply chain emissions had fallen 11% from a 2015 baseline.
The company, which has a market capitalization of about $56 billion, did not release shareholder vote tallies.
Norway's wealth fund, Nike's 11th-biggest shareholder according to LSEG data, this week said it would back the push for more transparency.
"It's not that we think Nike is completely dropping the ball here. It's more that we want to know what's really going on," said Giovanna Eichner, shareholder advocate at Green Century Capital Management, which introduced the climate proposal. "It's unclear if there's that same level of commitment toward achieving the goals."
Nike's impact report in 2024 detailed its efforts to use recyclable polyester and rubber and help factories in its supply chain source renewable energy. Last year, details about those climate initiatives were replaced by a list of data points on emissions and waste.
Nike's board urged shareholders to vote against the proposal, arguing in a filing that the company remains committed to reducing greenhouse gas emissions and management is "best positioned to determine the targets and related disclosures that are appropriate."
The athletic footwear maker is grappling with slumping sales, eroded market share and a push by CEO Elliott Hill to reinvigorate product innovation nearly two years into his tenure. Shares have fallen about 40% so far this year.
EXECUTIVE COMPENSATION APPROVED
Shareholders on Tuesday ultimately supported the company's contested proposal to approve executive compensation. Hill's total compensation was more than $36 million for fiscal 2026.
Norway's wealth fund had said it would vote against executives' compensation, arguing that Nike's board "should ensure that all benefits have a clear business rationale." Proxy advisers Glass Lewis and Institutional Shareholder Services had recommended voting against the compensation packages.
A proposal from a group of conservative investors urging Nike to exclude gender-transition surgery for minors in employee health plans also failed to pass. The resolution, part of a broader campaign against employers, added to scrutiny of Nike over its diversity policies.
Akcie Nvidia v úterý klesly asi o 1,5 % na zhruba 227 USD, zatímco AMD, Intel i Broadcom rostly. Pokles přišel po třech dnech růstu a při tlaku širšího trhu.
Nvidia stock fell about 1.5% on Tuesday to around $227, taking a breather after three consecutive sessions of gains as broader markets came under pressure from rising oil prices and renewed Middle East tensions.
The pullback was notable because several major semiconductor stocks moved higher.
Intel surged more than 8% after Northland Capital Markets analyst Gus Richard upgraded the stock to Outperform from Market Perform.
AMD gained about 5%, while Broadcom rose roughly 3%. The PHLX Semiconductor Sector index was also up around 2%.
The broader market moved in the opposite direction. The Dow Jones Industrial Average fell 574 points, or 1.1%, while the S&P 500 declined 0.4% and the Nasdaq Composite slipped 0.3%.
US markets were closed on Monday for the Labor Day holiday.
Oil prices remained a key source of pressure for equities on Tuesday as West Texas Intermediate crude futures rose for a sixth consecutive session, extending their longest winning streak since March.
Brent crude was trading around $98 a barrel as tensions between the US and Iran escalated over the weekend.
Against that backdrop, Nvidia’s decline comes after a strong run over recent months.
The stock is up about 24% over the past six months and remains just below its record high of $236.54.
However, Nvidia has significantly underperformed some semiconductor peers over the same period, with both AMD and Intel gaining more than 100%.
Cantor maintains $350 Nvidia targetCantor Fitzgerald reiterated its Overweight rating on Nvidia and maintained a $350 price target.
The firm highlighted continued demand for AI infrastructure while acknowledging supply constraints across the semiconductor industry.
Analyst C.J. Muse said investors remain divided over the durability of the AI investment cycle as macroeconomic and debt concerns weigh on markets.
Cantor also emphasized Nvidia’s position as TSMC’s largest customer and argued that the stock trades at the cheapest valuation among compute companies based on calendar 2028 earnings estimates.
The firm also believes Nvidia remains under-owned by both hedge funds and long-only investors.
Muse addressed Nvidia’s high-bandwidth memory specifications, characterizing HBM de-specification as an economic decision aimed at optimizing gross margins and GPU sales around a finite number of bits.
Earlier this month, Morningstar raised its fair value estimate to $310 from $280, implying roughly 30% upside from the stock’s current level.
Nvidia reported $96 billion in fiscal second-quarter revenue, up 106% from a year earlier and above its $91 billion guidance.
The company expects October-quarter revenue of $108 billion, ahead of FactSet consensus of $105 billion.
Morningstar identified Nvidia’s fiscal 2028 outlook as the most significant part of the earnings report.
Nvidia expects revenue growth of 70% next year, implying nearly $700 billion in total revenue compared with Morningstar and FactSet estimates of roughly $570 billion.
The outlook reinforces the longer-term bullish case, even as Nvidia’s shares pause after their recent gains.
Velké banky chtějí AI systémy na vlastních počítačích odpojených od internetu kvůli kontrole a ochraně dat. Perplexity říká, že budoucí AI výpočetní výkon se tak přesune i mimo cloud.
Big banks are demanding AI systems they can physically disconnect from the internet, and the CEO of one of Nvidia's newest partners says that changes everything about where the next trillion dollars in AI compute actually gets built.
The CEO of AI search startup Perplexity handed retail investors a sharp counterpoint to the cloud data center boom behind NVIDIA (NASDAQ:NVDA | NVDA Price Prediction)’s $5.48 trillion market cap. Speaking on CNBC’s Squawk on the Street on September 4, 2026, Perplexity CEO Aravind Srinivas argued that data centers alone cannot carry AI’s next phase. Big banks, he said, want part of that computing power on their own premises, in machines they control and can physically unplug.
Terawatt Problem Looms Over AI Srinivas framed the ceiling clearly, saying, “If a billion people need to run 24 over seven agents, they’re going to need a terawatt of power and a lot of memory. And so you’re not going to be able to do this just with data centers.” His fix is hybrid: route privacy-sensitive workloads to local hardware while keeping cloud access for frontier models. He noted that “there’s a lot of ram in our own devices, there’s a lot of power in our own offices, in our own homes that we’re not actually tapping into for AI inference today.”
Why Banks Want the Plug For banks, the appeal of running AI closer to home begins with control. Srinivas shared that firms like Morgan Stanley or JPMorgan want “air gapped implementation”, disconnected boxes running “the product, the model, the agent, everything” on-premises because they fear “their ip leaking to frontier labs.” The hardware he pointed to is NVIDIA’s DGX Spark, the desk-side box built for local inference.
NVIDIA’s Q2 FY27 numbers show this on-prem market is substantial. CFO Colette Kress told analysts that “on a trailing 12-month basis, on-prem revenue in the automotive vertical reached $8 billion, while financial services, manufacturing, and healthcare combined contributed $7 billion in revenue.” She named Hudson River Trading and Jane Street as trading firms running quantitative workloads on NVIDIA AI factories.
Funding Both Sides of the Compute Equation NVIDIA is bankrolling both ends of the spectrum. Finance chief Kress said non-hyperscaler categories, sovereign AI, regional neoclouds, enterprise edge and air-gapped data centers will make up roughly half of the data center business. NVIDIA has also lined up heavy-hitters Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to mobilize over $500B for centralized AI infrastructure (the power, cooling, and networking suppliers behind that buildout are the subject of a free report on seven AI infrastructure names that aren’t chipmakers). Its Confidential Computing GPUs power Apple (NASDAQ:AAPL) Private Cloud Compute, the hybrid architecture former CEO Tim Cook described as running “on device” and “on servers using private cloud compute.”
What to Watch Next Jensen Huang’s pitch on the Q2 FY27 call was that NVIDIA is “an entire AI factory platform” that customers “can use in any cloud” or run anywhere. If workloads migrate to the desk, NVIDIA still sells the silicon. The stock is up 35% over the past year and 21.7% year to date. Q3 FY27 guidance sits at $108B in revenue (±2%). The question is whether an on-prem shift compresses the hyperscaler capex that has driven Data Center revenue to $89.02B (+117% YoY), or routes it through a different SKU on the same invoice. Banks may pull some workloads out of the cloud. NVIDIA is betting its chips will still power the machines running them.
Contact [email protected] for any questions or corrections.
Nvidia podle článku dál rychle roste: ve čtvrtletí zvýšila tržby o 56 % a tržby datových center o 117 %. Firma navíc očekává růst tržeb o 70 % v příštím roce.
There's no shortage of naysayers when it comes to Nvidia (NVDA -2.01%). Just 1.18% of its outstanding shares are currently being shorted, but think about what that means for a company with a market cap just above $5.5 trillion.
There are nearly $57 billion in short positions out there, and that doesn't include put options, bearish ETFs, or other derivative activity. The actual number of shares sold short has actually increased 40% over the past year, and the value of those bearish wagers has risen another 35% on top of that.
The bears are everywhere, but I see that as more of an opportunity than a threat. Let's go over some of the knocks on Nvidia. I want to counter by pointing out what the worrywarts might be missing.
Image source: Getty Images.
1. Nvidia is priced for perfection There is nothing that I love more than when a bear argues that a stock is "priced for perfection." The assumption is that current expectations are too high and that the stock is bumping up against the ceiling, with so much air below it on the way down to the floor.
Last month's fiscal second quarter was a perfect example of Nvidia stock perpetually scaling the wall of worry. Bears were banking on analysts aiming too high by targeting 97% in top-line growth. It would be the fourth consecutive quarter of accelerating year-over-year growth.
How is that possible with a company as large as Nvidia? Expectations were high. Reality was kinder. Here's a look at the company's top-line growth:
Q2 FY 2026: 56% Q3 FY 2026: 63% Q4 FY 2026: 73% Q1 FY 2027: 85% Q2 FY 2027: 106% The late-August financial update gets even better. Those same analysts tagged by bears as overly ambitious are serial lowballers. They projected revenue would decelerate sharply to just 45% for fiscal year 2028, which starts in February. Nvidia shattered those crystal balls two weeks ago by forecasting 70% growth for next year.
Perfection isn't the ceiling. Market winners thrive in the debunking process.
Premium Feature
Moneyball Superscore
94/100
Today's Change
(
-2.01
%) $
-4.63
Current Price
$
225.73
2. Rivals will gain market share at Nvidia's expense It would be naive for a bull like me to assume that Nvidia will be the king of the hill forever. Competitive advantages can weaken over time, just as they have been strengthening for years. A disruptor can pioneer a better mousetrap for the AI revolution or whatever giant tech trend comes next.
The one thing that's fair to say is that it's not happening now. Let's have Advanced Micro Devices (AMD +5.90%) enter the chat. AMD has a colorful history of needling the market leader, and it's certainly cashing in on the AI boom Nvidia is championing.
AMD stock has outperformed Nvidia over the past year by more than tripling. However, in its latest quarter -- and I'll point out that their fiscal quarters ended about a month apart -- AMD's overall revenue rose just 50%, half of Nvidia's top-line growth.
I'll beat the bears to what they're thinking. Zoom in on AMD's data center business, which now accounts for more than half (58%) of its revenue, and that business skyrocketed 107% for the quarter. That's awesome, but Nvidia's data center revenue, which accounts for 93% of its results, soared 117%.
In the end, AMD's data center business delivered $3.5 billion in incremental revenue compared to a year earlier. Nvidia tacked on $48 billion in incremental data center revenue.
3. Margins will inevitably contract Let's close on a margin of error. Nvidia's gross margin was 75% in its latest quarter. The adjusted net margin was a jaw-dropping 56%. It's easy to question the sustainability of those levels. Unlike the flawed "priced for perfection" argument, there is a clear ceiling here: Gross margin will never exceed 100%, and the after-tax adjusted bottom line will naturally be well below that.
The reasonable bear case is that growth may continue but decelerate. Margins will contract, so earnings will grow even slower than the slowing top line -- if not eventually turn into negative year-over-year earnings growth.
Set aside that high bandwidth memory (HBM) makers riding Nvidia's coattails are currently generating gross margins approaching 85%. With competition percolating, Nvidia will need to keep innovating and fortifying its moat. It probably has more pricing flexibility now than the bears think. With third-party HBM becoming a larger cost component in the AI build-out, won't it make it even riskier for a company to bank on non-Nvidia AI chips and accelerators?
In the meantime, you can buy the stock for less than 15 times next year's projected earnings. This is why the bears aren't arguing that Nvidia is too expensive, as it's trading at a discount to the overall market despite growing substantially faster. Nvidia will be volatile, but it's built to win.
AMD po konferenci Citi vyskočila o více než 6 % poté, co firma uvedla, že tržby z datových center mají v roce 2027 dosáhnout 70 miliard USD. Tahounem mají být AI GPU a serverové CPU.
One enormous forecast just changed the market's expectations almost overnight Summary
AMD stock surged after the chipmaker forecast $70 billion in 2027 data-center sales, supported by AI GPUs and rapidly growing server CPU demand
Advanced Micro Devices AMD stock jumped more than 6% Tuesday after the chipmaker outlined a bullish AI outlook at Citi's 2026 Global TMT Conference. Investors focused on AMD's near-term targets, alongside its $2 trillion AI opportunity estimate for 2030.
AMD expects its data-center business to double to $70 billion in 2027. AI graphics processors could contribute sales in the low $40 billion range, with server CPUs supplying the remainder. That gives AMD two paths into AI spending beyond accelerators.
AMD's 2027 Forecast Raises the StakesThe MI450 rollout bridges that forecast. Production shipments started during the third quarter of 2026, with a larger ramp expected in the fourth quarter and another increase in the first quarter of 2027. AMD has named Meta Platforms (META), OpenAI, and Anthropic as AI customers.
The server opportunity is equally important. AMD increased its 2030 server CPU market estimate to $220 billion from $60 billion. It expects server CPU revenue to grow more than 80% year over year during the second half of 2026 and more than 70% in 2027, helped by agentic AI workloads.
Yet the guidance exposes AMD's central constraint. Demand is running ahead of supplies of advanced wafers, high-bandwidth memory, and chip packaging. The company has secured $29 billion to $30 billion in purchase commitments to support its expansion.
Chief Financial Officer Jean Hu described “the pace, the scale, and the rise of the AI” as “unprecedented.” That opportunity comes with a near-term profitability tradeoff. AMD expects gross margin to edge lower during the fourth quarter and in 2027 as MI450 production expands, although total gross profit dollars should rise.
For investors, the rally reflects confidence that AMD can narrow Nvidia's (NVDA) AI advantage while strengthening its CPU franchise. The targets are powerful, but fulfilling them requires supply, customer deployments, and manufacturing execution to move together on schedule.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Nvidia je zhruba 4,6 % pod rekordem a 10. září bude klíčové: Jensen Huang vystoupí na konferenci Goldman Sachs, kde trh čeká signály o poptávce po AI a dalším hardwaru.
Buy NASDAQ:NVDA. The stock is near highs but still “cheap” versus compute peers on 2028 earnings, and Sep 10 is a clear catalyst: Huang’s Goldman fireside chat can push AI demand and next-hardware confidence higher, keeping the market willing to pay up for accelerating earnings. This is a momentum + valuation support setup.
Key Risk: Huang fails to lift growth expectations (enterprise adoption and next-platform demand sound flat), so the “cheap” multiple compresses fast.
Hugging Face deal as a hedge
Buy NASDAQ:NVDA with a focus on the $12.93B Hugging Face angle. If Huang reinforces that Nvidia can broaden beyond hyperscalers via open-weight models and enterprise distribution, the market will price in a more durable revenue stream and less customer concentration risk—secondarily supporting NVDA’s long-term margins and stickiness.
Key Risk: The Hugging Face strategy doesn’t translate into measurable enterprise traction (or the deal faces regulatory/implementation delays), so concentration risk stays unresolved.
Nvidia stock NASDAQ:NVDA is sitting less than 5% below its record high, but the next catalyst arrives on September 10.
Chief executive Jensen Huang will participate in a fireside chat at Goldman Sachs’ Communacopia + Technology Conference at 8:50 a.m. PT, where investors will listen for signals on AI demand, enterprise adoption and Nvidia’s next hardware.
Nvidia closed at $225.73 on Tuesday, down 2.01%, leaving the stock about 4.6% below its $236.54 all-time high.
Nvidia’s shares are close to a record after another AI-driven rally, yet some analysts argue earnings expectations are rising even faster than the stock.
Cantor Fitzgerald analyst C.J. Muse reiterated an Overweight rating and a $350 price target on September 8. Muse said Nvidia trades at the “cheapest” valuation among compute names based on calendar-2028 earnings estimates.
Cantor also argued that Nvidia remains under-owned by hedge funds and long-only managers.
That makes Huang’s appearance more important.
If he reinforces expectations for accelerating revenue or a widening customer base, investors may continue to view Nvidia as inexpensive relative to future earnings.
But that support depends on estimates continuing to rise. If growth expectations flatten, the stock becomes harder to defend.
Nvidia’s next leg depends on proving AI demand is expanding beyond a small group of hyperscalers.
Recent results from Dell strengthened that argument. Dell raised its annual outlook after reporting record revenue and a large AI-server backlog.
D.A. Davidson analyst Gil Luria told MarketWatch that Dell’s results were another sign the enterprise AI-compute market has momentum “beyond the current hyperscaler market.”
They will listen for commentary on enterprise adoption, sovereign AI, supply constraints and Feynman, Nvidia’s next architecture.
A broader customer base would make Nvidia’s growth story more durable.
If AI spending remains concentrated among Microsoft, Amazon, Meta and other technology giants, investors will keep worrying about concentration.
Customer concentration remains the uncomfortable riskThe bullish case has a major weakness, as Nvidia’s latest regulatory filing showed that three direct customers represented 16%, 15% and 13% of total revenue in the first half of fiscal 2027.
Investor Dan Niles highlighted the same issue this week, noting that Nvidia’s largest customers are increasingly designing their own application-specific chips.
That creates an unusual tension: the companies funding Nvidia’s growth also have the strongest incentives to reduce their dependence on its GPUs.
Nvidia’s planned $12.93 billion acquisition of Hugging Face could help address that risk by giving the company access to more than 18 million developers and a stronger route into enterprise AI.
Niles said that open-weight models could eventually dominate LLM usage, allowing Nvidia to sell a broader stack directly to enterprises rather than relying heavily on hyperscalers.
The U.S. streaming giant faces fresh regulatory scrutiny in South Africa as authorities examine the cost of digital media and communications services for consumers.
South Africa’s telecommunications regulator plans to investigate prices charged by so-called over-the-top service providers, including Netflix and Meta Platforms Inc.’s (NASDAQ:META) WhatsApp, Bloomberg reported on Monday, citing Business Day.
South Africa Reviews Digital Service CostsThe Independent Communications Authority of South Africa plans to assess what consumers pay for digital services as part of the inquiry, according to the report.
The regulator will separately investigate telecommunications-service costs, potentially affecting major operators including MTN Group Ltd., Vodacom Group Ltd., Telkom SA SOC Ltd. and Cell C Holdings Ltd.
South Africa’s telecommunications-service costs rank among the highest globally, according to the report.
Regulator Builds on Earlier Pricing ReviewsThe inquiry follows previous regulatory reviews of data-service costs and monitoring of prices after authorities allocated high-speed internet spectrum and introduced measures aimed at increasing competition.
The latest move also follows an effort by South Africa’s communications minister to bring in experts to identify policies and other interventions that could lower consumer prices.
The planned review places Netflix and other digital-service providers under closer scrutiny as regulators examine the affordability of services delivered over telecommunications networks.
The regulator had not provided additional comment when Bloomberg sought a response outside normal business hours.
Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price forecast of $90.67. Recent analyst moves include:
Wolfe Research: Outperform (Raises target to $95 on Aug. 25) Baird: Outperform (Lowers target to $90 on July 22) Morgan Stanley: Overweight (Lowers target to $83 on July 17) Top ETF Exposure REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI): 6.86% Weight Global X PureCap MSCI Communication Services ETF (NYSE:GXPC): 4.55% Weight Pathfinder Focused Opportunities ETF (NASDAQ:PFOE): 4.72% Weight Significance: Because Netflix carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.
NFLX Price ActionNetflix shares were down 2.28% at $76.47 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo: Shutterstock
Read Next
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Netflix uvedl, že jeho reklamně podporovaný plán nyní oslovuje více než 250 milionů měsíčně aktivních diváků. Firma čeká, že tržby z reklamy letos zhruba zdvojnásobí na asi 3 miliardy USD.
Streaming giant Netflix (NFLX -1.89%) told advertisers in May that its ad-supported plan now reaches more than 250 million monthly active viewers, up from 190 million last November.
And the money is following the audience. Management expects advertising revenue to roughly double this year, to about $3 billion. It's a small piece of the company's forecast of about $51 billion in total revenue for 2026 -- but easily the fastest-growing piece.
I don't think the doubling stops this year, either. I predict Netflix's advertising revenue passes $6 billion in 2027.
The case rests on three things the company already discloses: a growing viewer base, more countries to sell ads in, and ad revenue per viewer with plenty of room to rise.
Image source: Netflix.
The audience is still growing quicklyA monthly active viewer, in Netflix's definition, is a member who watched at least one minute of ads in a month, multiplied by the estimated number of people in that household. The household estimate comes from Netflix's own research, not a third-party firm.
The definition matters because it changed. In May 2025, Netflix counted 94 million monthly active users (profiles, not people), and Amy Reinhard, the company's president of advertising, said at the time that the figure translated to about 170 million viewers.
In other words, the audience didn't nearly triple over the past year, as the headline numbers suggest. Measured viewers against viewers -- a close but not perfect comparison -- it grew by about half. And that's still impressive growth for an audience this large.
The ad plan is also where new members go. Notably, Netflix said more than 60% of sign-ups choose it in the countries where it's available, and more than 80% of ad-plan members watch every week.
More countries are on the way, too. Starting next year, the plan is set to launch in 15 more, including Sweden, Poland, Indonesia, and the Philippines -- on top of the dozen markets where it sells ads today.
Can the revenue double again?In 2025, only the company's third year selling advertising, ad revenue grew to over $1.5 billion (more than 2.5 times its 2024 level). And this year's forecast calls for a rough doubling on top of that.
About $3 billion spread across more than 250 million viewers works out to about $12 per viewer a year, or about a dollar a month. Meanwhile, members pay $8.99 a month just for the U.S. ad plan's subscription, following a price increase in March. (That price is per account, while the ad figure counts every viewer in a household.) In other words, the advertising half of this business still brings in very little per viewer. Even doubling ad revenue on today's audience would only take that figure to about $2 a month.
Advertisers appear willing to pay up. Netflix said in August that commitments from its U.S. upfront (the annual negotiation in which advertisers lock in spending early) nearly doubled this year. Reinhard told advertisers in May that 44% of the members who see an ad on Netflix never see that ad on broadcast TV or other streaming services.
Sure, new ad markets typically start slowly, and a weak economy could cut advertising budgets faster than subscriptions. But if the audience keeps climbing and Netflix earns a bit more ad revenue per viewer, $6 billion is within reach.
Premium Feature
Moneyball Superscore
79/100
Today's Change
(
-1.89
%) $
-1.48
Current Price
$
76.77
Even $6 billion wouldn't fix everythingAdvertising matters this much because growth elsewhere is cooling. Netflix's second-quarter revenue grew 13% year over year, down from a 17.6% pace in the fourth quarter of 2025, and management forecasts 11.7% for the third quarter. Each quarter has been slower than the last.
Another doubling would mean about $3 billion of new revenue in 2027, or about 6 percentage points of growth on this year's forecast base. For the growth stock, that could be the difference between total growth sliding toward single digits and holding in the low teens.
What advertising can't do is carry the company. Advertising ultimately sells attention, and attention is barely growing. Netflix members watched more than 97 billion hours of content from January through June, up just 2% from the same period of 2025.
Even at $6 billion, advertising would be barely more than a tenth of the streaming service's revenue. Memberships and pricing still set Netflix's growth rate.
So, does Netflix's advertising revenue pass $6 billion in 2027? I believe it does. The audience keeps growing, and the ad revenue per viewer is still tiny.
As for Netflix stock, it trades near $77 as of this writing, or about 20 times expected 2027 earnings. That's arguably a reasonable price. But with growth cooling outside the ad line, I'll watch from the sidelines for now.
Visa rozšiřuje datové služby pro blockchainové věřitele, aby urychlila financování firem kolem stablecoinových karet. Počet těchto programů už přesáhl 160, což je téměř o 200 % více než loni.
Visa said Tuesday morning it will make more data available to companies lending on the blockchain as stablecoin-linked cards are met with strong demand.
The payments giant will pair its settlement data with onchain lending infrastructure, giving lenders greater insight into the financial performance of digital asset-focused fintech firms and card issuers. The program aims to speed up borrowing for these businesses as they grow rapidly.
Visa currently operates more than 160 stablecoin-linked card programs for issuers and program managers, a nearly 200% increase year over year as more crypto businesses launch cards for customers.
"Stablecoin-linked cards are in hypergrowth mode," Cuy Sheffield, head of crypto at Visa, told CNBC in an exclusive interview. He said there are new issuers, including stablecoin neobanks and fintech firms, joining the network and launching cards every week.
To meet the demand surge and need for capital, the company is establishing partnerships to allow new issuers access to financing programs through smart contracts and onchain credit, Sheffield said.
"We've been running a pilot with a company called Credit Coop that is enabling a credit facility for stablecoin-linked card providers, which we think is a positive step forward for how onchain credit can start to come into our network," Sheffield said.
V year to date
Credit Coop says it has processed $2.7 billion in total volume on its platform through smart contracts and no borrower has ever defaulted.
Over the past six years, nearly $700 billion in stablecoin-denominated loans have been sent through onchain lending protocols, according to Visa. The company said much of that activity remains concentrated within crypto markets, but this new offering can help lenders better understand how a business is operating, which could simplify the process of evaluating financing opportunities.
Last year's passage of the GENIUS Act established U.S. stablecoin regulation and turbocharged adoption of the technology. Sheffield called the legislation a "huge" turning point.
"We're seeing banks, we're seeing some of the largest payment companies in the world that are coming to us that want to be able to engage and work with Visa, leveraging stablecoins within our existing products or build new products together with them," he said.
Visa in July launched its stablecoin platform, which allows for settlements, expands stablecoin-linked card programs and aims to help financial institutions access new digital asset capabilities. With that, the payments giant joined traditional competitors like Mastercard, which is also investing heavily in stablecoins and has its own platform. PayPal and Circle also operate their own stablecoin platforms.
Visa rozšiřuje program Agentic Ready, aby si udržela roli v platbách pomocí AI, i když agenti začnou volit levnější platební infrastrukturu. Firma už testovala stovky skutečných transakcí iniciovaných agenty s více než 100 partnery.
Visa Inc. (NYSE:V) expects millions of consumers to use AI agents to complete purchases by the 2026 holiday season. The question for investors is what happens when those agents start deciding not only what to buy, but how to pay for it.
In February, Citrini Research published a hypothetical scenario in which AI agents identified the cost attached to card transactions and shifted settlement toward cheaper stablecoin infrastructure. Visa, Mastercard Inc. (NYSE:MA), American Express Company (NYSE:AXP) and DoorDash Inc. (NYSE:DASH) fell after the report.
There is an important distinction in Visa’s case. The company does not earn the 2% to 3% interchange fee, which moves from acquirers to issuing banks. Visa says in its annual report that the fees it receives from issuers and acquirers are not derived from interchange or merchant discount rates.
The more serious bear case is that agents unbundle the payment stack. If an agent can choose a cheaper settlement rail while sourcing identity, authorization and fraud protection elsewhere, Visa loses volume without ever having collected the interchange fee.
Visa Wants To Make Its Trust Layer Harder To RemoveVisa launched Agentic Ready in Europe on March 17, then expanded it to Asia Pacific, Latin America and Canada. More than 50 issuers joined the Asia Pacific rollout alone. The program lets banks test enrollment, tokenization, authentication and transaction controls before agent-led purchases reach volume.
The strategic objective is to keep the credentials, permissions and protections surrounding an agent transaction attached to Visa’s infrastructure. Consumer caution helps that case. A Visa survey published in April found only 27% of Americans were comfortable letting an AI agent spend without limits, while 60% would not allow an agent to spend any amount without approval.
Early Tests And The Copyability ProblemIn December, Visa said it had completed hundreds of real-world agent-initiated transactions with more than 100 partners. DBS Group Holdings Ltd (OTC:DBSDF) has piloted agent-initiated purchases with Visa in Singapore, and on Aug. 19 DBS Hong Kong announced a partnership with Visa and Preface to extend that work to consumers.
For Visa, copyability cuts both ways. If no single bank can build a lasting moat around agentic features, value may migrate to the infrastructure that lets many banks deploy them. The opposite outcome is also possible: large banks could build more of the stack themselves and connect it to non-card rails. Mastercard is already there, having introduced Agent Pay for Machines in June to settle across cards, accounts and stablecoins.
Stablecoins Make Citrini’s Scenario More CredibleOn Sept. 1, 21 financial institutions including Bank of America, Citi, Goldman Sachs and Wells Fargo announced plans for a bank-issued dollar stablecoin targeting a first-half 2027 launch. The institutions on the issuing side of today’s card ecosystem are building another settlement option, and software can compare rails on every transaction in a way people do not.
Visa is hedging. It joined more than 140 companies behind the Open USD stablecoin in June and launched its own Stablecoin Platform in July. Its Intelligent Commerce Connect product, introduced in April, accepts both Visa and non-Visa cards across four agent protocols. The company appears to be preparing for a world in which the rail underneath a transaction changes while Visa still supplies the identity, tokenization and trust layer around it. That role may come with thinner economics.
What Investors Should WatchVisa enters this transition from strength. Fiscal third-quarter net revenue rose 14% to $11.6 billion, and processed transactions rose 10% to 71.7 billion. Agentic payments are far too small to move those numbers yet.
Watch how many Agentic Ready issuers move from testing into production, how quickly banks copy DBS, and whether Visa starts disclosing agent-initiated volume. The decisive evidence will come when an agent picks something other than a card. If Visa still earns on identity, authentication and orchestration in that transaction, Citrini’s scenario changes the business without displacing it. If those functions can be bought more cheaply elsewhere, the bear case gets much harder to dismiss.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.
Visa představila nový model Onchain credit pro stablecoinové kartové programy a fintechy, aby jim pomohla získat provozní kapitál prostřednictvím infrastruktury Onchain lending a dat Visa. Od roku 2020 se tímto segmentem prošlo více než 694 miliard USD.
VISA Inc. (NYSE:V) on Tuesday introduced a new Onchain credit model. It is aimed at helping stablecoin-linked card programs and fintech companies access working capital through Onchain lending infrastructure and Visa data.
• Visa stock is facing resistance. What’s driving V stock lower?
Ties VisaNet Data to Onchain Lending for Card PaymentsOnchain lending has become a rapidly expanding area of digital finance. Since 2020, more than $694 billion in stablecoin-denominated loans have been processed through onchain lending protocols, according to the Visa Onchain Analytics Dashboard, creating a global credit market operating 24/7.
By combining VisaNet settlement data with Onchain credit infrastructure, Visa aims to give lenders greater insight into how programs operate, helping them assess financing opportunities and provide capital aligned with business needs.
Rubail Birwadker, global head of Growth Products and Partnerships at Visa, said combining trusted payment data with Onchain technology can unlock new liquidity options and help businesses access capital that is more transparent, programmable and suited to the pace of modern commerce.
The initiative builds on Visa’s broader stablecoin strategy, including the recent launch of the Visa Stablecoin Platform, which supports stablecoin settlement, expands stablecoin-linked card programs and enables financial institutions to access new digital asset capabilities.
Read Next
V Stock Technical Outlook: Key Levels and MomentumVisa is sitting right on top of its short-term trend lines, trading 0.1% below the 20-day SMA ($372.24) and just under the 20-day EMA ($372.96), which often turns the $372–$374 area into a near-term "decision zone." The bigger-picture trend is still constructive, with the stock 2.2% above the 50-day SMA ($363.90), 8.2% above the 100-day SMA ($343.52), and 11.2% above the 200-day SMA ($334.32).
Momentum is neutral: RSI at 51.43 suggests the stock isn’t stretched in either direction, so price tends to respond more cleanly to support/resistance than to "overbought/oversold" mean reversion. That fits the current setup after the golden cross in July, with the stock consolidating below its August swing high and not far from the 52-week high of $385.57.
Key Resistance: $374 — Nearby round-number/pivot area that lines up with the stock’s tight trade around its 20-day averages. Key Support: $358 — Nearby level that sits close to the 50-day SMA/EMA zone where trend buyers often look to defend pullbacks Visa Earnings Preview and Wall Street Analyst TargetsLooking further out, the next major catalyst for the stock arrives with the Oct. 27, 2026 (estimated) earnings report.
EPS Estimate: $3.43 (Up from $2.98 year-over-year) Revenue Estimate: $12.08 billion (Up from $10.72 billion YoY) Valuation: P/E of 31.9x (Indicates premium valuation relative to peers) Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average consensus price forecast of $409. Recent analyst moves include:
RBC Capital: Outperform (Raises target to $466 on Aug. 31) Wolfe Research: Outperform (Raises target to $460 on Aug. 25) Truist Securities: Buy (Raises target to $406 on Aug. 5) How Visa Ranks on Momentum, Quality, Value and GrowthBelow is the Benzinga Edge scorecard for Visa, highlighting its strengths and weaknesses compared to the broader market:
Momentum: Moderate (Score: 67.37) — The trend is generally supportive, but the stock is currently digesting gains near short-term resistance. Quality: Strong (Score: 84.35) — The scorecard flags Visa as a high-quality name, which often helps on pullbacks when markets get choppy. Value: Weak (Score: 9.01) — The market is paying up for the business, so upside can be more sensitive to execution and guidance. Growth: Weak (Score: 16.8) — Growth is viewed as less of the "main pitch" here versus durability and scale, which can cap multiple expansion. The Verdict: VISA’s Benzinga Edge signal reveals a quality-led profile with decent momentum, but a clearly expensive valuation backdrop. For longer-term bulls, that often means waiting for cleaner pullbacks toward support rather than chasing strength into resistance.
Top ETFs Holding Visa Stock and Why It Matters State Street Financial Select Sector SPDR ETF (NYSE:XLF): 7.29% Weight Corgi Digital Banking & Fintech Infrastructure ETF (NASDAQ:KYC): 9.38% Weight Akre Focus ETF (NYSE:AKRE): 6.94% Weight Significance: Because V carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.
V Stock Price Today: Visa Shares Trade LowerVisa shares were down 1.87% at $368.07 at the time of publication on Tuesday, according to Benzinga Pro data.
Visa v poslední seanci klesla o 1,6 % na 369,08 USD, tedy více než S&P 500. Trh čeká hospodářské výsledky s odhadovaným EPS 3,43 USD a tržbami 12,07 mld. USD.
In the latest trading session, Visa (V - Free Report) closed at $369.08, marking a -1.6% move from the previous day. This move lagged the S&P 500's daily loss of 0.58%. On the other hand, the Dow registered a loss of 1.18%, and the technology-centric Nasdaq decreased by 0.32%.
The stock of global payments processor has risen by 3.81% in the past month, leading the Business Services sector's loss of 1.01% and the S&P 500's loss of 0.36%.
Investors will be eagerly watching for the performance of Visa in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $3.43, marking a 15.1% rise compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $12.07 billion, indicating a 12.56% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $13.16 per share and revenue of $45.83 billion, which would represent changes of +14.73% and +14.58%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Visa. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.13% higher. Right now, Visa possesses a Zacks Rank of #3 (Hold).
With respect to valuation, Visa is currently being traded at a Forward P/E ratio of 28.5. This denotes a premium relative to the industry average Forward P/E of 13.56.
One should further note that V currently holds a PEG ratio of 2.01. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. As of the close of trade yesterday, the Financial Transaction Services industry held an average PEG ratio of 0.87.
The Financial Transaction Services industry is part of the Business Services sector. This industry, currently bearing a Zacks Industry Rank of 184, finds itself in the bottom 26% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Visa uvedla, že těží z rostoucích přeshraničních transakcí, silné spotřebitelské poptávky a vyššího zájmu o AI a kyberbezpečnost. Přeshraniční růst zrychlil na zhruba 14 % meziročně.
AST SpaceMobile Stock Soared 12%—This Was the CatalystVisa NYSE: V CEO Ryan McInerney said the payments company is seeing continued strength in consumer spending, accelerating cross-border activity and growing demand for cybersecurity, processing and other value-added services as it invests in artificial intelligence and new payment technologies.
Speaking at a company news event, McInerney attributed Visa’s performance to a strategy developed several years ago, organizational changes and execution by its global leadership team. He said Visa reorganized around areas including value-added services, CMS and consumer payments, while dedicating product and engineering teams to build and launch new offerings.
Get Visa alerts:
Vertiv’s UIG Deal Targets the Next Big Constraint in AI Data Centers“We have a strategy that’s working,” McInerney said. “We have a leadership team that’s very experienced and focused on executing that strategy. We have enormous opportunities ahead of us.”
Consumer Spending Remains Stable McInerney characterized consumer spending conditions as marked by “strength and stability,” despite uncertainty related to affordability, elections and broader economic conditions.
3 AI Infrastructure Stocks to Watch Beyond NVIDIAIn the U.S., Visa’s business has grown roughly 6% to 8% over the past year and a half, he said. The company’s U.S. business grew 10% in the most recent quarter and was growing about 9% quarter-to-date through the end of August. McInerney described Visa’s U.S. business as roughly $7 trillion in size.
Globally, payment transaction growth was running at approximately 10% year over year through the end of August, he said. Cross-border growth accelerated to about 14%, compared with approximately 12% in the prior quarter. E-commerce has continued to grow faster than travel, according to McInerney.
He also pointed to cross-border opportunities across consumer payments, Visa Direct and commercial payments. Visa Direct has 18 billion endpoints globally, including accounts, cards and wallets, McInerney said.
AI Adoption and Cybersecurity Demand McInerney said Visa has used artificial intelligence for decades and was an early adopter of generative AI tools following the emergence of ChatGPT. The company made a range of models and tools available to employees and provided training, support and coaching, he said.
According to McInerney, Visa has seen measurable productivity gains in its product and technology organizations, including:
An 80% increase in code commits; An 80% reduction in the time required to design and build a product; and Feature development occurring 65% faster. He said AI-related productivity improvements are also occurring across functions including human resources, marketing, finance, disputes and client service.
Cybersecurity has become one of the top three issues raised by clients worldwide, McInerney said. Visa participated in Project Glasswing and used the Mythos model to test for vulnerabilities, he said. While the company did not identify vulnerabilities that could be exploited externally, it identified internal system vulnerabilities and developed a “harness” intended to identify, remediate and fix issues.
Visa later open-sourced that harness through GitHub, according to McInerney. The company has also introduced the Visa Threat Intelligence Harness, which uses Visa’s cyber and fraud capabilities to help clients protect their environments.
McInerney said Visa’s planned acquisition of BioCatch would expand its ability to address identity-related risks before a transaction occurs. BioCatch serves companies with billions of users, he said.
Value-Added Services and Pismo Expansion McInerney said Visa’s value-added services businesses are performing well across issuer services, acceptance, risk and identity, and advisory offerings. He highlighted issuer benefits platforms, credential growth, tokenization and the Pismo platform as contributors to the company’s strategy.
Pismo, which Visa acquired after identifying demand for cloud-based banking technology and global issuer-processing capabilities, is being used to offer integrated debit, credit, prepaid and commercial issuer processing. In the U.S., McInerney said Visa sees an opportunity to combine Pismo with Visa DPS for small and midsize banks and fintechs seeking a single issuer-processing platform.
Visa expects larger and more sophisticated issuers to continue using separate, highly customized credit and debit stacks, he said, while Visa DPS remains positioned for debit processing.
On core banking, McInerney said relatively few large banks globally have moved their core systems to the cloud, but many are considering doing so. He said cloud-based core systems can enable banks to operate more agilely and introduce products more quickly.
Agentic Commerce, Stablecoins and Europe McInerney said consumers are increasingly using large language models for product discovery and comparison shopping, though autonomous payments have not yet gained comparable adoption. The principal barrier, he said, is trust among both merchants and consumers.
Visa is developing tools including the Trusted Agent Protocol and Trusted Agent Directory to help merchants identify legitimate, purpose-driven agents. McInerney said Visa planned to announce a “Visa Trust Index” the following day. He said research found that three out of four consumers do not trust agentic platforms to make payments independently using their financial information, while 61% said they would trust an agent to make payments if Visa were involved.
The company also sees product-market fit for stablecoins in countries where consumers and businesses seek access to U.S. dollars and in cross-border remittances and business-to-business payments. McInerney said Visa has more than 200 stablecoin issuance programs in 50 countries and is building capabilities across blockchains, issuance, wallets, infrastructure and applications.
In Europe, McInerney said Visa is responding to payment sovereignty concerns by investing locally. The company recently announced a €500 million incremental investment in the region, including a European data center, additional offices, a Frankfurt headquarters and an innovation center in Poland. He said the region remains highly competitive, with domestic card networks, digital wallets and the emerging Wero wallet offering alternatives.
McInerney said Visa’s recent workforce reduction was part of a multiyear effort to operate more efficiently and free resources for investments in marketing, product development, sales, offices and data centers.
About Visa (NYSE:V)Visa Inc is a global payments technology company that operates one of the world's largest electronic payment networks. The company connects consumers, businesses, financial institutions and governments, enabling transactions through credit, debit, prepaid and commercial payment products. Visa generally does not issue cards, extend credit or set consumer interest rates; instead, it provides the network, technology and services that support payments.
Visa's products and services include Visa-branded cards, digital payment solutions, tokenization, fraud prevention, risk management, data analytics and payment acceptance tools.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Visa Right Now?Before you consider Visa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Visa wasn't on the list.
While Visa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Artificial intelligence may be changing where consumers decide what to buy before it changes where they pay for it.
“We are seeing adoption for shopping, but not yet for autonomous payments,” Visa CEO Ryan McInerney said Tuesday (Sept. 8) at the Goldman Sachs Communacopia + Technology Conference.
Consumers are using large language models and other platforms to compare products, shop and identify items, McInerney said, but are still moving to sellers’ websites to complete transactions. Getting beyond that point presents a trust problem on both sides. Sellers need to know that agents entering their sites are legitimate and have been empowered by consumers to transact. Consumers have to trust agents with their money and financial information.
“The barrier to that, if I had to describe it in one word, would be trust,” McInerney stated during the appearance at the conference.
He said three-quarters of consumers surveyed didn’t trust agentic platforms to make payments autonomously with their money and financial information. When asked whether they would trust an agent to make payments if Visa were involved, 61% said yes. McInerney said that figure exceeded 70% among consumers who use LLMs at least weekly.
Fraud prevention is also moving further upstream. McInerney said Visa has traditionally provided banks and merchants with tools to identify transaction fraud, while clients are now seeking products that address identity risk before it results in a fraudulent transaction.
“Identity has become a critical area of vulnerability,” he said in discussing Visa’s planned BioCatch acquisition. McInerney said BioCatch can help clients protect identities on mobile devices before identity theft leads to a fraudulent transaction.
Cybersecurity ranks among the most pressing issues McInerney hears from financial institutions, which he called a “top 3 issue” for every client he talks to around the world. Visa is also applying newer AI tools internally. McInerney said its teams are producing 80% more code commits, reducing the time required to design and build a product by 80% and developing features 65% faster.
Tokens Give Payment Networks Another Route to Customers Tokens are also giving Visa a way to distribute services beyond the payment credential itself.
“As we’ve scaled our tokens around the world, that gives us a distribution platform for more risk-and-identity solutions, as well as transaction solutions,” McInerney said.
He said Visa has captured only a “very low single digits” share of the addressable markets it sees across issuer services, acceptance, risk and identity, and advisory. Global credential growth has been running at roughly 6% to 7%-plus, which McInerney said helps fuel further growth in issuing revenue.
We’d love to be your preferred source for news.
Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!
Processing represents another part of that expansion. McInerney said two issues drove Visa’s decision to acquire Pismo. Many bank CEOs were deciding whether to move their technology to the cloud, while FinTechs expanding rapidly into emerging markets and other countries were struggling to find issuer-processing technology capable of expanding with them.
“They couldn’t find an issuer processing stack that was global enough, nimble enough, and cloud-native,” he said.
In the U.S., McInerney said Visa sees a market among small and mid-sized banks and FinTechs seeking integrated credit and debit issuer processing. He expects the largest, more sophisticated issuers to continue operating customized credit and debit stacks separately. Visa is also encountering demand for integrated issuer processing outside the U.S.
Core modernization has proceeded more slowly. McInerney said few large banks globally have moved their cores to the cloud, although many are considering or working on such moves. Cloud-based cores, he said, can make banks more agile and allow them to deploy products more quickly.
The scope of issuer negotiations reflects that broader set of products. McInerney said issuers are looking beyond consumer payments to commercial payments, Visa Direct, value-added services and processing, including issuer and core technology.
Money movement adds another set of markets. McInerney put the remaining addressable market in consumer payments at roughly $2 trillion, much of it still represented by cash and checks in markets around the world. Visa Direct, he said, reaches 18 billion endpoints across accounts, cards and wallets and supports P2P, B2C and C2B transactions. He also identified higher-value cross-border B2B payments as an opportunity.
Stablecoins could serve some of those cross-border use cases. McInerney said Visa sees product-market fit in two areas. One is what he described as probably 50 countries where consumers, families and businesses have wanted to hold U.S. dollars but have faced cost, availability or other barriers to doing so through bank accounts. The second is cross-border money movement, including remittances and B2B payments.
The newer businesses are developing against consumer spending that McInerney described as showing “strength and stability.” He said Visa’s U.S. business has grown roughly 6% to 8% for about a year and a half, reached 10% growth in the latest quarter and was running at approximately 9% through August. Cross-border growth accelerated from about 12% in the previous quarter to 14% through August, with eCommerce continuing to grow faster than travel.
Competition also extends beyond other global payment networks. McInerney said payment sovereignty has become a more prominent subject in Europe, where domestic card networks and digital wallets already compete with international networks and Wero is developing another European alternative.
“The market is competitive, and it’ll get more competitive,” he said.
For all PYMNTS AI coverage, subscribe to the daily AI Newsletter.
Public Employees Retirement System of Ohio ve 2. čtvrtletí snížil podíl v Johnson & Johnson o 7,2 % a prodal 75 986 akcií. Po transakci držel 983 704 akcií v hodnotě 249,8 mil. USD.
Public Employees Retirement System of Ohio lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 7.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 983,704 shares of the company’s stock after selling 75,986 shares during the quarter. Johnson & Johnson accounts for 0.7% of Public Employees Retirement System of Ohio’s investment portfolio, making the stock its 17th largest holding. Public Employees Retirement System of Ohio’s holdings in Johnson & Johnson were worth $249,831,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in JNJ. Elefante Mark B boosted its stake in shares of Johnson & Johnson by 9.8% in the second quarter. Elefante Mark B now owns 28,686 shares of the company’s stock valued at $7,285,000 after buying an additional 2,563 shares in the last quarter. World Investment Advisors raised its position in Johnson & Johnson by 19.6% in the fourth quarter. World Investment Advisors now owns 161,343 shares of the company’s stock worth $33,390,000 after acquiring an additional 26,450 shares in the last quarter. Signal Advisors Wealth LLC raised its position in Johnson & Johnson by 76.1% in the first quarter. Signal Advisors Wealth LLC now owns 15,126 shares of the company’s stock worth $3,697,000 after acquiring an additional 6,539 shares in the last quarter. Gradient Investments LLC lifted its holdings in Johnson & Johnson by 9.9% in the second quarter. Gradient Investments LLC now owns 152,831 shares of the company’s stock valued at $38,815,000 after acquiring an additional 13,737 shares during the period. Finally, Louisiana State Employees Retirement System purchased a new stake in shares of Johnson & Johnson during the 1st quarter worth $30,017,000. Hedge funds and other institutional investors own 69.55% of the company’s stock.
Wall Street Analyst Weigh In A number of equities analysts have recently issued reports on JNJ shares. Argus set a $300.00 price target on shares of Johnson & Johnson in a report on Wednesday, July 29th. Wall Street Zen downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Royal Bank Of Canada upped their target price on shares of Johnson & Johnson from $265.00 to $287.00 and gave the stock an “outperform” rating in a research report on Monday, July 13th. Raymond James Financial set a $280.00 target price on shares of Johnson & Johnson in a report on Monday, August 3rd. Finally, Scotiabank reissued an “outperform” rating and set a $305.00 price target on shares of Johnson & Johnson in a research note on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $272.83.
Get Our Latest Research Report on JNJ Insider Buying and Selling at Johnson & Johnson In other Johnson & Johnson news, EVP Vanessa Broadhurst sold 23,054 shares of the stock in a transaction on Monday, July 20th. The stock was sold at an average price of $251.27, for a total transaction of $5,792,778.58. Following the sale, the executive vice president owned 23,003 shares in the company, valued at approximately $5,779,963.81. This represents a 50.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kathryn E. Wengel sold 10,000 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $241.15, for a total value of $2,411,500.00. Following the completion of the transaction, the executive vice president directly owned 114,288 shares of the company’s stock, valued at approximately $27,560,551.20. This trade represents a 8.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 97,569 shares of company stock worth $25,476,044. 0.16% of the stock is currently owned by insiders.
Johnson & Johnson Trading Down 0.0% NYSE:JNJ opened at $275.12 on Tuesday. The company has a market capitalization of $663.01 billion, a PE ratio of 31.88, a price-to-earnings-growth ratio of 2.63 and a beta of 0.24. The company has a quick ratio of 0.81, a current ratio of 1.09 and a debt-to-equity ratio of 0.44. Johnson & Johnson has a 52-week low of $173.33 and a 52-week high of $281.07. The stock has a fifty day simple moving average of $262.32 and a 200-day simple moving average of $245.30.
Johnson & Johnson (NYSE:JNJ – Get Free Report) last issued its quarterly earnings data on Wednesday, July 15th. The company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.84 by $0.06. Johnson & Johnson had a net margin of 21.48% and a return on equity of 32.42%. The firm had revenue of $25.31 billion for the quarter, compared to analysts’ expectations of $25.06 billion. During the same period in the prior year, the company earned $2.77 EPS. The firm’s revenue was up 6.6% on a year-over-year basis. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. On average, equities research analysts expect that Johnson & Johnson will post 11.61 earnings per share for the current fiscal year.
Johnson & Johnson Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 25th will be given a $1.34 dividend. The ex-dividend date is Tuesday, August 25th. This represents a $5.36 annualized dividend and a dividend yield of 1.9%. Johnson & Johnson’s dividend payout ratio is currently 62.11%.
Johnson & Johnson Profile (Free Report)
Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.
The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.
Featured Articles Five stocks we like better than Johnson & Johnson 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
Jefferies Financial Group ve 2. čtvrtletí snížila podíl ve společnosti Johnson & Johnson o 8,9 % na 68 010 akcií v hodnotě 17,272 mil. USD. Institucionální investoři nyní vlastní 69,55 % akcií.
Jefferies Financial Group Inc. lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 8.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 68,010 shares of the company’s stock after selling 6,617 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Johnson & Johnson were worth $17,272,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Blueline Advisors LLC acquired a new stake in shares of Johnson & Johnson during the fourth quarter worth about $25,000. Matrix Trust Co grew its position in shares of Johnson & Johnson by 56.2% in the 2nd quarter. Matrix Trust Co now owns 150 shares of the company’s stock valued at $38,000 after purchasing an additional 54 shares during the period. E Fund Management Hong Kong Co. Ltd. increased its stake in Johnson & Johnson by 946.7% during the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 157 shares of the company’s stock worth $32,000 after purchasing an additional 142 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Johnson & Johnson during the 4th quarter worth approximately $37,000. Finally, Semmax Financial Advisors Inc. raised its holdings in Johnson & Johnson by 55.0% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 203 shares of the company’s stock worth $31,000 after buying an additional 72 shares during the period. 69.55% of the stock is currently owned by institutional investors.
Johnson & Johnson Stock Down 0.0% JNJ stock opened at $275.12 on Tuesday. The company has a market cap of $663.01 billion, a price-to-earnings ratio of 31.88, a P/E/G ratio of 2.63 and a beta of 0.24. Johnson & Johnson has a twelve month low of $173.33 and a twelve month high of $281.07. The business has a 50 day moving average price of $262.32 and a two-hundred day moving average price of $245.30. The company has a quick ratio of 0.81, a current ratio of 1.09 and a debt-to-equity ratio of 0.44.
Johnson & Johnson (NYSE:JNJ – Get Free Report) last released its quarterly earnings data on Wednesday, July 15th. The company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.84 by $0.06. Johnson & Johnson had a return on equity of 32.42% and a net margin of 21.48%.The company had revenue of $25.31 billion during the quarter, compared to the consensus estimate of $25.06 billion. During the same quarter in the prior year, the firm posted $2.77 EPS. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. Analysts anticipate that Johnson & Johnson will post 11.61 EPS for the current fiscal year. Johnson & Johnson Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 25th will be paid a $1.34 dividend. The ex-dividend date is Tuesday, August 25th. This represents a $5.36 dividend on an annualized basis and a yield of 1.9%. Johnson & Johnson’s dividend payout ratio (DPR) is currently 62.11%.
Insider Buying and Selling In other news, EVP Elizabeth Forminard sold 15,918 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $257.00, for a total transaction of $4,090,926.00. Following the transaction, the executive vice president directly owned 16,994 shares in the company, valued at $4,367,458. The trade was a 48.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Jennifer Taubert sold 15,000 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $263.36, for a total transaction of $3,950,400.00. Following the completion of the sale, the executive vice president directly owned 194,451 shares in the company, valued at approximately $51,210,615.36. The trade was a 7.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 97,569 shares of company stock worth $25,476,044. Corporate insiders own 0.16% of the company’s stock.
Wall Street Analyst Weigh In JNJ has been the subject of several research analyst reports. Royal Bank Of Canada upped their price target on shares of Johnson & Johnson from $265.00 to $287.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Weiss Ratings raised shares of Johnson & Johnson from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, July 24th. Morgan Stanley upped their target price on shares of Johnson & Johnson from $284.00 to $294.00 and gave the stock an “overweight” rating in a research note on Thursday, July 16th. Raymond James Financial set a $280.00 target price on Johnson & Johnson in a report on Monday, August 3rd. Finally, Wells Fargo & Company lifted their price target on Johnson & Johnson from $272.00 to $282.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $272.83.
Get Our Latest Stock Analysis on Johnson & Johnson
Johnson & Johnson Company Profile (Free Report)
Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.
The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.
Recommended Stories Five stocks we like better than Johnson & Johnson 3 Under-the-Radar Defense Stocks With Record Backlogs This Korea ETF Has Soared, But the Rally May Not Be Over Why Guidewire’s Post-Earnings Plunge May Not Last Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
Johnson & Johnson oznámila 24 abstraktů s klinickými daty z neuropsychiatrie na Psych Congress Annual Meeting 2026 (15.–19. září 2026). Největší pozornost přitahuje první prezentace dat fáze 3 přípravku CAPLYTA u dospělých s bipolární mánií.
First presentation of pivotal Phase 3 CAPLYTA ® data in adults with bipolar mania underscores the asset's potential across mood disorders
New SPRAVATO ® analyses and schizophrenia research emphasize a focus on complex, high-burden neuropsychiatric conditions
, /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that 24 abstracts featuring clinical data and real-world evidence across the neuropsychiatry portfolio will be presented at the 2026 Psych Congress Annual Meeting (September 15-19, New Orleans, LA).
Among the featured presentations are new pivotal Phase 3 data evaluating the efficacy and safety of CAPLYTA® (lumateperone) in bipolar mania, alongside additional CAPLYTA® data across bipolar depression and major depressive disorder that further reinforce the breadth of studies for the asset across mood disorders. Data evaluating the effect of SPRAVATO® (esketamine) CIII nasal spray on depressive symptoms such as anhedonia, and Phase 3 clinical trial data for seltorexant in major depressive disorder (MDD) with insomnia symptoms will also be presented. Together, the presentations reflect the Company's continued commitment to advancing research across mood disorders, with a focus on areas where patients and clinicians still face significant treatment challenges.
"People living with neuropsychiatric disorders often face complex, overlapping symptoms that can make identification, treatment selection and long-term management especially challenging," said Jane Tiller, MD, Vice President, Global Head of Development, Neuroscience, Johnson & Johnson. "By advancing clinical and real-world evidence across our portfolio and pipeline, we aim to help move psychiatry forward so that clinicians can continue to make more informed decisions for the patients they serve."
Psych Congress Annual Meeting highlights include:
CAPLYTA® New data from a pivotal Phase 3 study investigating CAPLYTA® in the acute treatment of patients with manic episodes or manic episodes with mixed features associated with bipolar I disorder will be presented,1 alongside additional data evaluating adjunctive CAPLYTA® in MDD across depressive symptoms, remission, patient subgroups, and metabolic outcomes.2-8 New real-world evidence study evaluating treatment patterns among patients with bipolar depression receiving CAPLYTA®, including dosing and duration in line with routine clinical practice.9 SPRAVATO® New analyses examining real-world evidence on the impact of SPRAVATO® in treating anhedonia, a core symptom of depression associated with poorer treatment outcomes.10,11 Long-acting Injectables (LAIs) Real-world studies evaluating schizophrenia-related hospitalizations in young dual-eligible patients prior to LAI initiation and subsequent risk of relapse, as well as treatment satisfaction with LAIs.12,13 Seltorexant Real-world data providing insights into MDD with insomnia symptoms, including disease burden, patient management and treatment outcomes.14-16 The full list of Johnson & Johnson data presentations at Psych Congress is available on JNJ.com. The Company will also support a variety of educational programs, in-booth presentations and training opportunities for attendees, including interactive visualizations of PRIDE LAI data, and the latest CAPLYTA® schizophrenia and network meta-analysis (NMA) findings.
ABOUT BIPOLAR MANIA
Bipolar disorder affects an estimated 37 million people worldwide—approximately 1 in 200 individuals—with 4.4% of U.S. adults experiencing the condition in their lifetime.17,18 Mania, a key feature of Bipolar I disorder, is characterized by at least a week-long period of elevated or irritable mood and/or increased energy, as well as symptoms including grandiosity, decreased need for sleep, racing thoughts, distractibility, and risk-taking behavior.19 These noticeable behavioral changes often differ markedly from an individual's baseline and are frequently first recognized by those close to them. In severe cases, manic episodes may require hospitalization for safety and treatment.20
ABOUT MAJOR DEPRESSIVE DISORDER (MDD)
MDD is one of the most common psychiatric disorders and a leading cause of disability worldwide, impacting an estimated 332 million people—or about 4 percent of the population.21,22,23 In 2023, approximately 22 million adults in the U.S. had at least one major depressive episode.24 While depression is typically treated with a "one-size-fits-all" approach, no two cases are the same. MDD is a complex, heterogeneous disorder involving multiple regions of the brain and presenting with as many as 256 unique symptom combinations. As a result, responses to treatment vary widely.25,26 Only 1 in 3 patients reach remission with their first antidepressant—and rates continue to decline further with each subsequent treatment, leaving many to spend years cycling through multiple treatments trying to find complete, sustained symptom relief.27 Moreover, MDD is a risk factor for the development and worsening of a range of comorbidities, illustrating the importance of integrating mental and general health care.28
Anhedonia, a loss of interest or pleasure in previously enjoyed activities, is one of two defining symptoms of a major depressive episode.29 Anhedonia is associated with poorer treatment outcomes, including lower remission rates, greater functional impairment, and higher suicide risk.30 Notably, 40-70% of people with MDD experience anhedonia.30
MDD often includes sleep disturbances such as insomnia or hypersomnia, with approximately 60 percent of MDD patients experiencing clinically relevant insomnia symptoms despite being on an SSRI/SNRI.31 Disturbed sleep and insomnia symptoms have a significant impact on a patient's quality of life and exacerbate the risk of depressive relapse and suicide.32,33
Approximately one-third of adults with MDD will not respond to oral antidepressants alone and are considered to have treatment-resistant depression (TRD), which is often defined as inadequate response to two or more oral antidepressants that were administered at an adequate dose for an adequate duration.34,35 TRD has a significant negative impact on the lives of those affected and has one of the highest economic burdens of all psychiatric disorders.35 Patients often cycle through multiple oral medications, waiting 4-6 weeks for potential relief.36 Based on the STAR*D study, after their third line of treatment, approximately 86 percent of patients do not achieve remission.36
ABOUT SCHIZOPHRENIA
Schizophrenia is a complex, chronic brain disorder that affects how people think, feel, speak, and act. It affects up to an estimated 2.8 million adults in the United States yet remains widely misunderstood and insufficiently treated.37 Symptoms vary by person, but confusion and distortions in perceptions, emotions, and behavior are common.38 Evidence shows that the first three to five years after diagnosis — "the critical period" — from symptom onset are key for a patient's treatment, as this is when the condition progresses most rapidly.39,40 A comprehensive treatment plan, which may include medication, therapy, and psychosocial services, is critical in delaying the time to relapse for adults with schizophrenia.41
ABOUT CAPLYTA® (lumateperone)
CAPLYTA® 42 mg is an oral, once daily atypical antipsychotic approved in adults as an adjunctive therapy with antidepressants for major depressive disorder (MDD), schizophrenia, and depressive episodes associated with bipolar I or II disorder (bipolar depression), as monotherapy, or as adjunctive therapy with lithium or valproate.
While the mechanism of action of CAPLYTA® is unknown, the efficacy of CAPLYTA® could be mediated through a combination of antagonist activity at central serotonin 5-HT2A receptors and partial agonist activity at central dopamine D2 receptors.
A supplemental New Drug Application (sNDA) for CAPLYTA® with long-term data evaluating the safety and efficacy of the medication for delayed time to relapse in schizophrenia was recently approved by the U.S. Food and Drug Administration. The medication is also being studied for other neuropsychiatric disorders. CAPLYTA® is not FDA-approved for these disorders.
ABOUT SPRAVATO® (esketamine) CIII NASAL SPRAY
SPRAVATO® is approved by the U.S. Food and Drug Administration as monotherapy or in conjunction with an oral antidepressant for adults with MDD when they have inadequate response to at least two oral antidepressants (TRD) and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior in conjunction with an oral antidepressant. It is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and is believed to work differently than traditional antidepressants by acting on a pathway in the brain that affects glutamate. The mechanism by which esketamine exerts its antidepressant effect is unknown. To date, SPRAVATO® has been approved in over 70 markets and administered to more than 250,000 patients worldwide.
ABOUT J&J'S SCHIZOPHRENIA LONG-ACTING INJECTABLE (LAI) PORTFOLIO
Johnson & Johnson's portfolio of long-acting injectable (LAI) offerings for schizophrenia offers a varied range of dosing options and the longest-lasting schizophrenia treatments with each dose available, including INVEGA SUSTENNA® (1-month paliperidone palmitate), INVEGA TRINZA® (3-month paliperidone palmitate), and INVEGA HAFYERA® (6-month paliperidone palmitate), all of which are administered in a clinical setting by a medical professional.42,43,44
ABOUT SELTOREXANT
Seltorexant, an investigational first-in-class therapy, is a selective antagonist of the human orexin-2 receptor currently being developed as an adjunctive treatment for adults with MDD with insomnia symptoms. Seltorexant selectively antagonizes the orexin-2 receptors, potentially improving mood symptoms associated with depression and restoring sleep without next-day sedation.45 When orexin-2 receptors are stimulated for too long or at inappropriate times, their activation can cause hyperarousal manifestations, including insomnia and excessive cortisol release, which may contribute to depression.46,47 Seltorexant is the only investigational therapy under study for the treatment of MDD that is believed to work by normalizing the overactivation of the orexin-2 receptors, thereby targeting the underlying biology that contributes to depression and insomnia symptoms.
CAPLYTA® IMPORTANT SAFETY INFORMATION
What is CAPLYTA (lumateperone)?
CAPLYTA® (lumateperone) is a prescription medicine used in adults along with an antidepressant to treat major depressive disorder (MDD); to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate; or to treat schizophrenia. It is not known if CAPLYTA is safe and effective in children.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about CAPLYTA?
Medicines like CAPLYTA can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA is not approved for treating people with dementia-related psychosis. CAPLYTA and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Patients and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when CAPLYTA or an antidepressant medicine is started or when the dose is changed. Report any changes in these symptoms to your healthcare provider immediately. • thoughts about suicide or dying
• acting aggressive, being angry or violent
• panic attacks
• new or worse depression
• new or worse anxiety
• new or worse irritability
• feeling very agitated or restless
• suicide attempts
• acting on dangerous impulses
• trouble sleeping
• an extreme increase in activity and talking (mania)
• other unusual changes in behavior or mood
Do not take CAPLYTA if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (e.g., rash, itching, hives, swelling of the tongue, lip, face, or throat).
What are the possible side effects of CAPLYTA?
CAPLYTA may cause serious side effects, including:
Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death. Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of a rare but potentially fatal condition. Contact your healthcare provider or go to the emergency room if you experience signs and symptoms of NMS. Uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA. It may also occur after you stop taking CAPLYTA. Problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA. Extremely high blood sugar levels can lead to coma or death. Call your healthcare provider if you have any of the following symptoms of high blood sugar: feeling very thirsty, hungry, sick to your stomach, needing to urinate more than usual, weak/tired, or confused, or your breath smells fruity. Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment with CAPLYTA. Decreased blood pressure (orthostatic hypotension). You may feel lightheaded, dizzy, or faint when you rise too quickly from a sitting or lying position. Falls. CAPLYTA may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause broken bones or other injuries. Seizures (convulsions). Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities. Problems controlling your body temperature so that you feel too warm. Avoid getting overheated or dehydrated while taking CAPLYTA. Difficulty swallowing that can cause food or liquid to get into the lungs. The most common side effects of CAPLYTA include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea.
These are not all the possible side effects of CAPLYTA.
Before taking CAPLYTA, tell your healthcare provider about all of your medical conditions, including if you: have or have had heart problems or a stroke, high or low blood pressure, diabetes, or high blood sugar, problems with cholesterol, have or have had a low white blood cell count, seizures (convulsions), or kidney or liver problems.
CAPLYTA may cause fertility problems in females and males. You should notify your healthcare provider if you become pregnant or intend to become pregnant while taking CAPLYTA. There is a pregnancy registry for females who are exposed to CAPLYTA during pregnancy. CAPLYTA may cause abnormal involuntary movements and/or withdrawal symptoms in newborn babies exposed to CAPLYTA during the third trimester. Talk to your healthcare provider if you breastfeed or are planning to breastfeed as CAPLYTA passes into breast milk.
Tell your healthcare provider about all the medicines you're taking. CAPLYTA may affect the way other medicines work, and other medicines may affect how CAPLYTA works, causing possible serious side effects. Do not start or stop any medicines while taking CAPLYTA without talking to your healthcare provider. You are encouraged to report negative side effects of prescription drugs. Contact Intra-Cellular Therapies, Inc. at 1-800-526-7736 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
CAPLYTA is available in 42 mg, 21 mg, and 10.5 mg capsules.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for CAPLYTA.
cp-548761v3
INVEGA SUSTENNA®, INVEGA TRINZA®, INVEGA HAFYERA® IMPORTANT SAFETY INFORMATION
INDICATIONS
INVEGA HAFYERA® (6-month paliperidone palmitate) is a prescription medicine given by injection every 6 months by a healthcare professional and used to treat schizophrenia. INVEGA HAFYERA® is used in adults who have been treated with either:
INVEGA SUSTENNA® (paliperidone palmitate) a 1-time-each-month paliperidone palmitate extended-release injectable suspension for at least 4 months INVEGA TRINZA® (paliperidone palmitate) a 1-time-every-3-months paliperidone palmitate extended-release injectable suspension for at least 3 months INVEGA TRINZA® is a prescription medicine given by injection every 3 months by a healthcare professional and used to treat schizophrenia. INVEGA TRINZA® is used in people who have been adequately treated with INVEGA SUSTENNA® for at least 4 months.
INVEGA SUSTENNA® is a prescription medicine given by injection by a healthcare professional.
INVEGA SUSTENNA® is used to treat schizophrenia in adults.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA®?
INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® may cause serious side effects, including:
Increased risk of death in elderly people with dementia-related psychosis.
INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® increase the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® are not for the treatment of people with dementia-related psychosis. Do not receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® if you are allergic to paliperidone, paliperidone palmitate, risperidone, or any of the ingredients in INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. See the end of the Patient Information leaflet in the full Prescribing Information for a complete list of INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® ingredients.
Before you receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®, tell your healthcare professional about all your medical conditions, including if you:
have had Neuroleptic Malignant Syndrome (NMS) have or have had heart problems, including a heart attack, heart failure, abnormal heart rhythm, or long QT syndrome have or have had low levels of potassium or magnesium in your blood have or have had uncontrolled movements of your tongue, face, mouth, or jaw (tardive dyskinesia) have or have had kidney or liver problems have diabetes or have a family history of diabetes have Parkinson's disease or a type of dementia called Lewy Body Dementia have had a low white blood cell count have had problems with dizziness or fainting or are being treated for high blood pressure have or have had seizures or epilepsy have any other medical conditions are pregnant or plan to become pregnant. It is not known if INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® will harm your unborn baby If you become pregnant while taking INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®, talk to your healthcare professional about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry. Infants born to women who are treated with INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® may experience symptoms such as tremors, irritability, excessive sleepiness, eye twitching, muscle spasms, decreased appetite, difficulty breathing, or abnormal movement of arms and legs. Let your healthcare professional know if these symptoms occur. are breastfeeding or plan to breastfeed. INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®
can pass into your breast milk. Talk to your healthcare professional about the best way to feed your baby if you receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® may affect the way other medicines work, and other medicines may affect how INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® works.
Your healthcare provider can tell you if it is safe to receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® with your other medicines. Do not start or stop any medicines during treatment with INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® without talking to your healthcare provider first. Know the medicines you take. Keep a list of them to show to your healthcare professional or pharmacist when you get a new medicine.
Patients (particularly the elderly) taking antipsychotics with certain health conditions or those on long-term therapy should be evaluated by their healthcare professional for the potential risk of falls.
How will I receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®?
Follow your treatment schedule exactly as your healthcare provider tells you to. Your healthcare provider will tell you how much you will receive and when you will receive it. What should I avoid while receiving INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®?
INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® may affect your ability to make decisions, think clearly, or react quickly. Do not drive, operate heavy machinery, or do other dangerous activities until you know how INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® affects you. Avoid getting overheated or dehydrated. INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® may cause serious side effects, including:
See "What is the most important information I should know about INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA®?" stroke in elderly people (cerebrovascular problems) that can lead to death Neuroleptic Malignant Syndrome (NMS). NMS is a rare but very serious problem that can happen in people who receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. NMS can cause death and must be treated in a hospital. Call your healthcare professional right away if you become severely ill and have any of these symptoms: high fever; severe muscle stiffness; confusion; loss of consciousness; changes in your breathing, heartbeat, and blood pressure. problems with your heartbeat. These heart problems can cause death. Call your healthcare professional right away if you have any of these symptoms: passing out or feeling like you will pass out, dizziness, or feeling as if your heart is pounding or missing beats. uncontrolled movements of your tongue, face, mouth, or jaw (tardive dyskinesia) metabolic changes. Metabolic changes may include high blood sugar (hyperglycemia), diabetes mellitus and changes in the fat levels in your blood (dyslipidemia), and weight gain. low blood pressure and fainting changes in your blood cell counts high level of prolactin in your blood (hyperprolactinemia). INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® may cause a rise in the blood levels of a hormone called prolactin (hyperprolactinemia) that may cause side effects including missed menstrual periods, leakage of milk from the breasts, development of breasts in men, or problems with erection. problems thinking clearly and moving your body seizures difficulty swallowing that can cause food or liquid to get into your lungs prolonged or painful erection lasting more than 4 hours. Call your healthcare professional or go to your nearest emergency room right away if you have an erection that lasts more than 4 hours. problems with control of your body temperature, especially when you exercise a lot or spend time doing things that make you warm. It is important for you to drink water to avoid dehydration. The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory tract infections, feeling restlessness or difficulty sitting still, slow movements, tremors, stiffness and shuffling walk.
The most common side effects of INVEGA TRINZA® include: injection site reactions, weight gain, headache, upper respiratory tract infections, feeling restlessness or difficulty sitting still, slow movements, tremors, stiffness and shuffling walk.
The most common side effects of INVEGA SUSTENNA® include: injection site reactions; sleepiness or drowsiness; dizziness; feeling of inner restlessness or needing to be constantly moving; abnormal muscle movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements of your eyes.
Tell your healthcare professional if you have any side effect that bothers you or does not go away. These are not all the possible side effects of INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. For more information, ask your healthcare professional or pharmacist.
Call your healthcare professional for medical advice about side effects. You may report side effects of prescription drugs to the FDA at 1-800-FDA-1088.
General information about the safe and effective use of INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet.
Do not use INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® for a condition for which it was not prescribed. You can ask your pharmacist or healthcare professional for information about INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA® that is written for healthcare professionals.
For more information, go to www.invegahafyera.com, www.invegatrinza.com or www.invegasustenna.com or call 1-800-526-7736.
Please click to read the full Prescribing Information, including Boxed WARNING, for INVEGA HAFYERA®, INVEGA TRINZA® and INVEGA SUSTENNA® and discuss any questions you have with your healthcare professional.
cp-256259v4
SPRAVATO® IMPORTANT SAFETY INFORMATION
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
with or without an antidepressant taken by mouth, to treat adults with treatment-resistant depression (TRD) with an antidepressant taken by mouth, to treat depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Sedation, dissociation, and respiratory depression. SPRAVATO® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation), breathing problems (respiratory depression and respiratory arrest) Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out. Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO®. Your healthcare provider will decide when you are ready to leave the healthcare setting. Abuse and misuse. There is a risk for abuse and misuse with SPRAVATO®, which may lead to physical and psychological dependence. Your healthcare provider should check you for signs of abuse, misuse, and dependence before and during treatment. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction. SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS). Because of the risks for sedation, dissociation, respiratory depression and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. Patients treated in outpatient healthcare settings (such as medical offices and clinics) must be enrolled in the program. Increased risk of suicidal thoughts and actions. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. SPRAVATO® is not for use in children. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a higher risk of having suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions. How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member? Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms. Tell your healthcare provider or get emergency help right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
thoughts about suicide or dying new or worse depression feeling very agitated or restless trouble sleeping (insomnia) acting aggressive, being angry or violent an extreme increase in activity and talking (mania) suicide attempts new or worse anxiety panic attacks new or worse irritability acting on dangerous impulses other unusual changes in behavior or mood Do not take SPRAVATO® if you:
have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs) have an abnormal connection between your veins and arteries (arteriovenous malformation) have a history of bleeding in the brain are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®. If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
have heart or brain problems, including: high blood pressure (hypertension) slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting history of heart attack history of stroke heart valve disease or heart failure history of brain injury or any condition where there is increased pressure in the brain have liver problems have ever had a condition called "psychosis" (see, feel, or hear things that are not there, or believe in things that are not true). are pregnant or plan to become pregnant. SPRAVATO® may harm your unborn baby. You should not take SPRAVATO® if you are pregnant. Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO®. If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO®. There is a pregnancy registry for women who are exposed to SPRAVATO® during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO® and their baby. If you become pregnant during treatment with SPRAVATO®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research- programs/pregnancyregistry/antidepressants/. are breastfeeding or plan to breastfeed. SPRAVATO® passes into your breast milk. You should not breastfeed during treatment with SPRAVATO®. Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking SPRAVATO® with certain medicines may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
You will take SPRAVATO® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Your healthcare provider will show you how to use the SPRAVATO® nasal spray device. Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it. Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to. During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting. You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®. If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule. Some people taking SPRAVATO® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®. If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO®. What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See "What is the most important information I should know about SPRAVATO®?"
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See "What is the most important information I should know about SPRAVATO®?"
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
feeling disconnected from yourself, your thoughts, feelings and things around you dizziness nausea feeling sleepy spinning sensation decreased feeling of sensitivity (numbness) feeling anxious lack of energy increased blood pressure vomiting feeling drunk headache feeling very happy or excited If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
cp-170363v4
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
Learn more at https://www.jnj.com/ or at www.innovativemedicine.jnj.com. Follow us at @JNJInnovMed.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 related to product development and the potential benefits and treatment impact of CAPLYTA® (lumateperone), SPRAVATO® (esketamine) CIII nasal spray, and seltorexant. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behavior and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
References:
Brown D, Chen C, Chen M, et al. Lumateperone Treatment for Manic Episodes or Manic Episodes With Mixed Features in Bipolar I Disorder: Results From a Double-Blind, Placebo-Controlled, Randomized, Phase 3 Trial. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Black D, Namjoshi M, Obando C, et al. Changes in Mean Total Score on the PHQ-9 Among Bipolar Depression Patients Treated with Lumateperone in the United States: An Electronic Health Records Study. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Chen C, Durgam S, Earley WR, et al. Adjunctive Lumateperone 42 mg Treatment in Major Depressive Disorder: A Pooled Analysis of Efficacy Across Patient-Reported Depression Symptoms. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Armas-Datorre J, Durgam S, Earley WR, et al. Lumateperone 42 mg in Major Depressive Disorder: Demographic and Clinical Subgroups Efficacy Analysis in a Phase 3 Randomized Placebo-Controlled Trial. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Bhagwagar Z, Chen C, Durgam S, et al. Lumateperone 42 mg in Patients With Major Depressive Disorder: Analysis of Remission in Short- and Long-Term Trials. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Dutheil S, Snyder G. Assessment of Lumateperone Partial Agonist Activity at Presynaptic Dopamine D2 Autoreceptors: Reversal of Haloperidol-Induced Tyrosine Hydroxylase Phosphorylation in Mouse Striatum. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Chepke C, Durgam S, Earley W, et al. Metabolic Profile of Adjunctive Lumateperone 42 mg in Major Depressive Disorder: A Pooled Analysis of 2 Randomized, Placebo-Controlled Trials. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Chen H, Namjoshi M, Wu E, et al. Total Cost per Remitter of Lumateperone Versus Cariprazine for the Treatment of Major Depressive Disorder in the United States. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Liu Z, Namjoshi M, Obando C, et al. Real-World Lumateperone Dosing Patterns and Treatment Duration in Bipolar Depression. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Chepke C, Fu DJ, Himedan M, et al. Montgomery-Åsberg Depression Rating Scale Anhedonia Factor Score Following Esketamine Nasal Spray Monotherapy in Adult Patients With Treatment-Resistant Depression: A Post Hoc Analysis. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Cutler AJ, Drzayich J, Fu DJ, et al. Esketamine Nasal Spray on Anhedonia and Functional Outcomes: Findings from the Ventura Real-World Evidence Study. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Benson C, Doshi J, Geng Z, et al. Association of Schizophrenia-Related Hospitalization Before Long-Acting Injectable Antipsychotic Initiation and Outcomes Among Young Dual Eligibles. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Citrome L, Cline F, Han J, et al. Treatment Satisfaction, Quality of Life, Satisfaction with Participation in Social Roles, and Caregiver Burden In Adults with Schizophrenia Treated with Paliperidone Palmitate Long-Acting Injectables. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Cambron-Mellott J, Dwibedi N, Hamilton J, et al. Incidence of cardiometabolic events among adults with major depressive disorder with and without insomnia symptoms: a real-world evidence study. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Benson C, Campbell A, Johnston K, et al. Association of Insomnia Symptoms in Major Depressive Disorder with Healthcare Resource Use and Cardiovascular and Metabolic Conditions - Analysis of National Health & Nutrition Examination Survey. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. Creel S, Hebert Z, Johnston K, et al. Understanding Insomnia Management in Major Depressive Disorder Through Patient-Provider Discourse. Psych Congress 2026 Annual Meeting; Sept. 15-19, 2026. World Health Organization. Bipolar disorder. September 2025. Accessed August 2026. https://www.who.int/news-room/fact-sheets/detail/bipolar-disorder National Health Institute. Bipolar Disorder. Accessed August 2026. https://www.nimh.nih.gov/health/statistics/bipolar-disorder#part_2606 Oliva V, Fico G, De Prisco M et al. Bipolar disorders: an update on critical aspects. Lancet Reg Health Eur. 2024;48. doi:10.1016/j.lanepe.2024.101135. Cleveland Clinic. Mania. April 2026. Accessed August 2026. https://my.clevelandclinic.org/health/diseases/21603-mania World Health Organization. Mental disorders. Accessed May 2026. https://www.who.int/news-room/fact-sheets/detail/mental-disorders National Alliance on Mental Health. Mental health by the numbers. Accessed May 2026. https://www.nami.org/mental-health-by-the-numbers/ World Health Organization. Depressive disorder (depression). Accessed October 2025. who.int/news-room/fact-sheets/detail/depression Key substance use and mental health indicators in the United States: results from the 2023 national survey on drug use and health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Published July 2024. Accessed May 2026. https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report Su YA and Si T. Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. Gen Psychiatr. 2022;35:e100724. doi:10.1136/gpsych-2021-10072 Pandya M, et al. Where in the Brain Is Depression? Curr Psychiatry Rep. 2012;14:634–642. doi:10.1007/s11920-012-0322-7 Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. doi:10.1176/ajp.2006.163. Arnaud AM, Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022;83(6):21r14328. Cao B, Zhu J, Zuckerman H, et al. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:109–117. doi: 10.1016/j.pnpbp.2019.01.002 Kale H, Ganz ML, Ghosh, R. Burden of prominent anhedonia in major depressive disorder reflected in polypharmacy, healthcare use and humanistic outcomes. Poster presentation at Psych Congress 2024, Boston, MA, United States. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9-15. doi:10.1016/S0022-3956(02)00052-3 Taddei-Allen P. Economic Burden and Managed Care Considerations for the Treatment of Insomnia. AJMC. Updated April 12, 2020. Accessed May 2026. https://www.ajmc.com/view/economic-burden-and-managed-care-considerations-for-the-treatment-of-insomnia Ağargün MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry. 1997;58(6):249-51 National Institute of Mental Health. Major Depression. Accessed May 2026. https://www.nimh.nih.gov/health/statistics/major-depression Zhdanava M, Pilon D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82(2):20m13699. doi:10.4088/JCP.20m13699 Sanacora G, Zarate C, Krystal J, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426-437. doi:10.1038/nrd2462 Treatment Advocacy Center. Schizophrenia Fact Sheet. Accessed May 2026. www.tac.org/reports_publications/schizophrenia-fact-sheet/. Tandon, Rajiv et al. "The schizophrenia syndrome, circa 2024: What we know and how that informs its nature." Schizophrenia research vol. 264 (2024): 1-28. doi:10.1016/j.schres.2023.11.015 Birchwood, M. "Early intervention and sustaining the management of vulnerability." The Australian and New Zealand Journal of Psychiatry vol. 34 Suppl (2000): S181-4. doi:10.1080/000486700241 National Alliance on Mental Illness. Understanding Schizophrenia. Accessed May 2026. https://www.nami.org/types-of-conditions/schizophrenia/ Alphs L, et al. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable therapy. Int Clin Psychopharmacol. 2016;31(4)202-209. doi:10.1097/YIC.0000000000000125 INVEGA SUSTENNA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc. INVEGA TRINZA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc. INVEGA HAFYERA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc. Recourt K, de Boer P, Zuiker R, et al. The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder [published correction appears in Transl Psychiatry. 2019 Oct 2;9(1):240. doi:10.1038/s41398-019-0585-4 Nollet M, Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs. 2013;27(6):411-422. doi:10.1007/s40263-013-0064-z Brooks S, Jacobs GE, de Boer P, et al. The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. J Psychopharmacol. 2019;33(2):202-209. doi:10.1177/0269881118822258 SOURCE Johnson & Johnson
Jim Cramer called the JNJ dip a buying opportunity live on air, but the data behind his reasoning had already been published hours earlier, and the stock's recent performance tells a very different story than a typical defensive play.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On Tuesday morning’s Squawk on the Street, Jim Cramer told viewers to step in on a mid-session drop in Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction). “J and J down six off of a weakness in the drug group. Nothing particular,” Cramer said, adding “I’m going to buy some of that because they’ve got something for schizophrenia.” He tied the call to the Psych Congress conference running September 15-19 in New Orleans, where he expects fresh data on Caplyta and Spravato.
The dip was real. JNJ was down 2.33% on the session to $268.82, part of a broader pharma selloff that included Amgen down 7.6%, Bristol Myers Squibb down 3.1%, and the health care ETF XLV down 1.9%.
Buy the Dip, or Buy the Leader? The framing worth pausing on is what Cramer left out. JNJ is up 53.76% over the past year and up 31.99% year to date, hitting an all-time high last week. Compare that with the two names he most often positions JNJ against as a hedge:
NVIDIA (NASDAQ:NVDA): up 32.63% over the past year, 22.06% YTD. Apple (NASDAQ:AAPL): up 32.32% over the past year, 16.59% YTD. On August 27, Cramer told a viewer holding Alphabet, Nvidia, and Apple to add JNJ as their health care counterweight, saying of the tech giants “own them. Don’t trade them.” The ballast is beating the ships.
Psych Congress Data Was Already Out Cramer told viewers JNJ “will reveal some documents about how Caplyta is doing versus manias”. In fact, the company had already published the release. At 8 a.m. ET on September 8, JNJ put out “Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026,” hours before the Cramer segment aired.
One indication note for investors: Spravato, which Cramer highlighted, is approved for treatment-resistant depression and major depressive disorder with suicidal ideation, not schizophrenia. Caplyta, acquired via the April 2025 Intra-Cellular Therapies deal, is the schizophrenia and bipolar depression asset. On the Q2 call, management said new patient starts were up 122% versus prior year, and cited 70.9% growth for the franchise.
Fundamentals Under the Trade The dip-buy thesis rests on a business that has been accelerating. Q2 2026 worldwide sales were $25.3 billion, up 5.6% operationally, with Innovative Medicine at $16.4 billion. Oncology led: Darzalex sales exceeded $4 billion, and Tremfya reached $2 billion, growing 71%.
CEO Joaquin Duato raised the 2026 outlook to reported sales of $101.1 billion at the midpoint and reported EPS of $11.60 to $11.75, with the company still targeting double-digit growth by the end of the decade. Q1 2026 revenue of $24.06 billion beat consensus by 1.89%, with adjusted EPS of $2.70 versus $2.68 expected, per the company’s Q1 2026 8-K.
For income investors, JNJ paid its $1.34 quarterly dividend on September 8, extending what management calls its 64th consecutive year of dividend increases, the kind of multi-decade streak we screened for in our free Dividend Kings guide. Reddit’s dividend-focused community reflects that positioning, with a bullish sentiment score of 72.
What to Watch Next Between now and year-end, the catalyst calendar includes the Icotide readout in psoriatic arthritis, the Caplyta bipolar mania readout, and the Enterprise Business Review scheduled December 8, 2026, where management is expected to detail the planned Orthopaedics separation. Cramer’s dip call is worth evaluating on its merits, but investors weighing it should note this “defensive” name has been outperforming the broader market.
Contact [email protected] for any questions or corrections.
Disney rozšiřuje kapacity parků a plaveb v rámci desetiletého plánu za 60 mld. USD; ve fiskálním 3. čtvrtletí 2026 výnosy segmentu Experiences vzrostly o 10 % a provozní zisk o 20 %.
Key Takeaways Disney is expanding parks and cruise capacity under its $60B, 10-year Experiences investment plan.Fiscal Q3 Experiences revenues rose 10% and operating income 20%, with U.S. attendance up 3%.Weak Asia attendance and about $9B in fiscal 2026 capex make execution and ROIC key investor watchpoints. The Walt Disney Company (DIS - Free Report) is expanding its parks pipeline to add capacity, strengthen guest spending and create a longer runway for Experiences growth. Disney is several years into its $60 billion, 10-year investment plan for Parks, Experiences and Products, with spending focused on theme park and resort expansion, new attractions and cruise capacity. The strategy is already showing results, as Experiences revenues increased 10% year over year in the fiscal third quarter of 2026, while operating income jumped 20%. The pipeline includes major attractions at Disney's U.S. parks, including Villains Land in Orlando and the Avengers Campus expansion in Anaheim, along with additional cruise capacity.
The expansion offers multiple avenues for growth. Domestic attendance increased 3% in the quarter, while per-capita guest spending rose 4%, showing Disney can benefit from both higher visitation and greater spending per visitor. New attractions and lands can also generate additional revenues from admissions, resorts, food and beverages, merchandise and other guest spending. Cruise expansion adds another capacity-driven growth opportunity within Experiences. Importantly, management expects attractive returns from the investment program, making execution and ROIC key measures for investors.
However, international attendance remains a key risk, particularly in Shanghai and Hong Kong, where weaker consumer conditions are weighing on demand. Large capital requirements are another concern, as the company expects fiscal 2026 capital expenditures of approximately $9 billion, primarily reflecting higher Experiences spending on parks, resorts and new attractions.
Overall, ongoing park expansion projects could accelerate Disney's long-term growth, provided the new capacity ensures a sufficient influx of visitors and spending to generate attractive returns on invested capital.
Competitors Challenging DIS in Theme ParksDisney is facing competition as major U.S. operators expand their attractive facilities, invest in new experiences, and strive to build closer engagement with visitors.
Comcast (CMCSA - Free Report) is strengthening its position in the theme park market through Universal’s expanding parks portfolio. Epic Universe continues to perform well, while Universal Kids Resort is open in Frisco and its U.K. park is moving toward construction. Comcast is pursuing long-term parks growth through attractive brands, locations and continued investment in attractions and experiences.
Six Flags Entertainment (FUN - Free Report) is expanding its theme park offering through a growing pipeline of attractions and experiences. Its 2026 lineup includes multiple new attractions, while construction is underway on several 2027 projects. Six Flags is also broadening membership and cross-park visitation, aiming to increase guest engagement, repeat visits and long-term returns from its park investments.
DIS’s Price Performance, Valuation & EstimatesDisney shares have declined 7.5% year to date compared with a 9.7% drop in the Zacks Consumer Discretionary sector.
DIS’s YTD Price Performance
Image Source: Zacks Investment Research
Disney trades at a forward 12-month P/S ratio of 1.72 compared to the Media Conglomerates industry's multiple of 1.24. DIS carries a Value Score of B.
DIS’s Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for DIS’ 2026 revenues is pegged at $101.38 billion, indicating 7.36% year-over-year growth. The consensus mark for earnings is pegged at $6.91 per share, indicating an upward revision over the past 30 days and indicating 16.53% year-over-year growth.
Image Source: Zacks Investment Research
DIS stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Altria uvádí, že prémiový segment tvoří asi 85 % ziskovosti v cigaretovém segmentu, takže klíčovým tahounem zůstává Marlboro. Jeho podíl v celé kategorii ve 2. čtvrtletí 2026 klesl o 1,5 procentního bodu na 39,5 %.
Key Takeaways Altria's premium segment accounts for about 85% of cigarette profitability, making Marlboro a key driver.Marlboro's total cigarette share fell 1.5 points to 39.5% as discount retail share rose to 33.8%.Basic gained 2.3 points to 2.9%, while smokeable adjusted OCI rose 2.4% to $3.02 billion. Altria Group, Inc. (MO - Free Report) is keeping the cigarette strategy centered on the premium segment, which accounts for about 85% of profitability in the cigarette category. That makes Marlboro’s position especially important as cigarette consumers continue to trade down toward discount offerings amid pressure on discretionary income.
In the second quarter of 2026, Marlboro held a 59.6% share of the premium segment, unchanged from a year earlier and up 0.1 percentage point sequentially. However, Marlboro’s share of the total cigarette category fell 1.5 percentage points year over year to 39.5%. At the same time, industry discount retail share rose 2.6 percentage points to 33.8%, reflecting continued trade-down among adult nicotine consumers.
Altria is addressing the shift toward discount cigarettes through a broader PM USA portfolio strategy. Basic’s retail share increased 2.3 percentage points year over year to 2.9% in the second quarter, while targeted promotional support expanded to roughly 35,000 stores during the first half of 2026. The strategy seeks to participate in the discount segment while limiting the impact on Marlboro.
Despite the mix shift, smokeable price realization was 4.5% in the quarter, supported by strong Marlboro net pricing. Smokeable products adjusted OCI increased 2.4% to $3.02 billion, while adjusted OCI margin expanded 0.3 percentage point to 64.8%. The premium segment therefore remains central to cigarette profitability even as discount participation grows.
How Altria Compares With Philip Morris and TPBPhilip Morris International Inc. (PM - Free Report) also showed premium-brand resilience in second-quarter 2026. While international combustible pricing rose 10%, Philip Morris’ Marlboro share reached a record 11% of the international cigarette category, up 0.3 percentage points year over year. Philip Morris also maintained a 25.3% cigarette category share, with international combustible gross profit increasing 8% organically in the quarter despite unfavorable geographic mix.
Turning Point Brands, Inc. (TPB - Free Report) is also leaning on premium positioning across nicotine products. While Modern Oral investments focus on shelf placement, retail visibility and brand equity to build long-term premium potential, Turning Point Brands described Stoker’s as the segment’s only truly premium product for value-oriented consumers. Turning Point Brands reported Stoker’s segment net sales up 54.5%, with adjusted gross profit rising 40.7% year over year.
Altria’s Price Performance, Valuation & EstimatesShares of Altria have fallen 3.4% in the past three months against the industry’s growth of 2.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 11.90X, down from the industry’s average of 14.92X.
Adamera podala žádosti o nároky Bromley a rozšířila South Hedley Property o více než 4 700 hektarů. Nová plocha navazuje na Copper Mountain a leží ve 40km strukturním koridoru k cíli Max Copper-Gold.
Vancouver, British Columbia – TheNewswire - September 8, 2026 – Adamera Minerals Corp. (TSX-V: ADZ; OTC: DDNFF) (“Adamera” or the “Company”) announces it has filed applications for the Bromley claims, adding over 4,700 hectares contiguous to the Company’s 100%-owned South Hedley Property. This newly staked ground expands the northwestern edge of the property 12 kilometres (km) westward, connecting to the eastern claim boundary of Hudbay Minerals Inc.’s Copper Mountain mine claims.
The Bromley claim applications cover an approximately 12 x 4 km corridor concealed beneath a sequence of younger volcanic rock, where Adamera has identified distinct magnetic features. This area is positioned along an approximately 40 km east-west trend that Adamera interprets as a structural and metallogenic corridor connecting the producing Copper Mountain mine to the historic Nickel Plate mine near Hedley, British Columbia. The Company’s Max Copper-Gold Target is positioned within this corridor.
“This staking reflects our broader vision for the district. The locations of Copper Mountain, Nickel Plate, and our Max copper-gold target are not random. We believe a 40 km structure along the southern margin of the Bromley Batholith controlled the emplacement of the smaller intrusions that carry the copper and gold. Younger volcanic rocks covering this zone have largely kept it untested, and this is the type of opportunity we like to focus on,” said Mark Kolebaba, President and CEO of Adamera.
Rationale for Staking
A district-scale corridor: The Company interprets an east-west structural and metallogenic corridor, approximately 40 km in length, extending from the producing Copper Mountain mine through the Max Copper-Gold Target to the historic Nickel Plate (Hedley) mine. This corridor roughly tracks the southern margin of the Bromley Batholith and is interpreted as a deep-seated east-west cross-structure located within the Quesnel Trough. The corridor is considered a conduit for mineralizing magmas.
A long-lived magmatic conduit: The Company’s interpretation suggests this 40 km east-west structural corridor acted as a deep crustal conduit over a 15-million-year metallogenic epoch. This long-lived weakness may have facilitated the earlier emplacement of the mineralizing intrusions at Copper Mountain and Nickel Plate, and ultimately controlled the emplacement of the Bromley Batholith along the trend. Economic copper-gold mineralization in this district is driven by smaller, highly fractionated intrusions tapping this structural corridor, making the covered southern margin of the Bromley Batholith a prospective target.
Covering the missing link: The Bromley claim applications cover the interpreted southern margin of the Bromley Batholith, an area approximately 12 x 4 km in extent. While younger, post-mineralization cover conceals this zone, Adamera has identified distinct magnetic features within the corridor, providing early geophysical support for targets.
Contiguous with an active target: These new applications extend directly westward from the Company’s South Hedley Property, where an ongoing induced polarization (IP) survey has defined a chargeability anomaly ranging from 3 to 4 km in width. This land expansion covers the interpreted structural corridor extending westward from this new zone.
Next Steps
This geological model is based on interpretation and needs to be tested through exploration work. The Bromley claim applications are currently subject to approval. Upon approval, anticipated initial work on the new claims would include prospecting, sampling, and potential airborne geophysics to define drill targets.
South Hedley Project
South Hedley is a copper-gold property near Princeton, British Columbia, within the Quesnel Trough. Work to date has advanced two targets: the Max Copper-Gold Target, a covered porphyry target defined by coincident copper-gold soil geochemistry, magnetics and IP; and Glix, a gold skarn target defined by soil geochemistry, electromagnetic and magnetic survey data. The IP survey at Max copper-gold target is currently underway. Drill permit applications for both targets were submitted in February 2026 and remain pending.
Qualified Person
Martin St. Pierre, P. Geo., a qualified person as defined by National Instrument 43-101 and a consultant to the Company, has reviewed and approved the technical content of this news release. The Copper Mountain and Nickel Plate mines are located on properties adjacent to or near the South Hedley Property. Information regarding those properties is drawn from public sources and has not been independently verified by Adamera. Mineralization on those properties is not necessarily indicative of mineralization on the South Hedley Property.
About Adamera
Adamera Minerals Corp. is targeting critical metals in the U.S. and copper-gold in southern British Columbia. In Washington State, the Company is advancing a tungsten portfolio intended to support a secure domestic supply for U.S. markets. In Canada, Adamera is exploring the South Hedley Copper-Gold Project and maintains additional gold projects in its portfolio.
On behalf of the Board of Directors,
Mark Kolebaba
President & CEO
For additional information please contact:
Email: [email protected]
Website: www.Adamera.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements in this press release, other than purely historical information, including statements relating to the Company’s future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development, including the risk that the Bromley claim applications may not be approved. As a result, actual results may vary materially from those described in the forward-looking statements.
¹ Logan, J.M., and Mihalynuk, M.G., 2014. Tectonic controls on Early Mesozoic paired alkaline porphyry deposit belts (Cu-Au) within the Canadian Cordillera. Economic Geology, v. 109, p. 827-858.
, /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality" or the "Company") (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced the launch of an underwritten, secondary offering (the "Offering") of 13,000,000 shares (the "Shares") of its common stock, par value $0.0001 per share (the "Common Stock"), subject to market and other conditions. The Shares are being offered by Arrow Holdings S.à r.l. and MFA Global S.à r.l. (collectively, the "Selling Stockholders"), entities controlled by TDR Capital LLP, acting in its capacity as investment fund manager. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of Common Stock.
Additionally, subject to the completion of the Offering, the Company intends to purchase from the underwriters shares of its Common Stock (the "Repurchase Shares") that are subject to the Offering with an aggregate purchase price of up to $30,000,000, at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders in the Offering (the "Stock Repurchase"). The completion of the Stock Repurchase is expected to occur concurrently with the closing of the Offering. The Repurchase Shares will be held by the Company as treasury shares following the completion of the Stock Repurchase. The Company expects to fund the Stock Repurchase with cash on hand together with borrowings under its ABL Credit Facility.
Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC are acting as book-running managers for the Offering.
The Offering is being made pursuant to an effective shelf registration statement on Form S-3, including a base prospectus, that was initially filed with the Securities and Exchange Commission (the "SEC") on April 10, 2019 and subsequently declared effective by the SEC on May 16, 2019 and is available on the SEC's website at www.sec.gov. The Offering may only be made by means of a prospectus supplement and the accompanying prospectus that will form a part of the registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to the Offering will be filed with the SEC and will be available on the SEC's website. Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may be obtained from: Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; Deutsche Bank Securities Inc., Attn: Prospectus Department, 1 Columbus Circle, New York, NY 10019, by telephone at (800) 503-4611, or by email at [email protected]; and J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at [email protected] and [email protected].
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company, nor shall there be any sale of securities of the Company in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Certain statements made in this press release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside our control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: operational, economic, including inflation, political and regulatory risks; our ability to effectively compete in the specialty rental accommodations and hospitality services industry, including growing the HFS - South, Workforce Hospitality Solutions and Government segments; our ability to execute, expand, and manage WHS projects supporting critical mineral development, power generation, and data center infrastructure projects, including risks related to construction execution, permitting, labor availability, and timely completion of community buildouts; our ability to achieve margin improvement through the effective servicing of contracts in our WHS segment; effective management, utilization, and performance, of our communities (including workforce hubs); natural disasters and other business disruptions including outbreaks of epidemic or pandemic disease; the duration of any future public health crisis, related economic repercussions and the resulting negative impact to global economic demand; the effect of changes in state building codes on marketing our buildings; changes in demand within a number of key industry end-markets and geographic regions, including natural resources, critical minerals, and data center/AI infrastructure; changes in customer capital spending, project schedules, or end-user demand that may result in delays, non-renewals, or cancellations of contracts, including the contract that is terminable for convenience in the Government segment; our reliance on third party manufacturers, suppliers and service providers; our ability to attract and retain key personnel and maintain workforce availability for specialized hospitality and construction operations; increases in raw material, food, labor or other operating costs; the effect of impairment charges on our operating results; our future operating results fluctuating, failing to match performance or to meet expectations; our exposure to various possible claims and the potential inadequacy of our insurance coverage; unanticipated changes in our tax obligations; our obligations under various laws and regulations, including those applicable to government contracts; the effect of litigation, judgments, orders, regulatory or customer bankruptcy proceedings on our business; our ability to successfully acquire and integrate new operations; global, national or local economic and political developments, including any changes in policy under the current or any future U.S. presidential administrations; federal government budgeting and appropriations; our ability to effectively manage our credit risk and collect on our accounts receivable; our ability to fulfill Target Hospitality's public company obligations; cybersecurity threats, incidents, or failures of our management information systems; and risks related to our liquidity, access to capital markets, and obligations under existing or future debt agreements, including compliance with financial covenants. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contact Information
Investor Contact:
Mark Schuck
(832) 702 – 8009
[email protected]
ExxonMobil prostřednictvím dceřiné společnosti Pioneer Natural Resources nabízí hotovostní odkup všech svých nesplacených dluhopisů splatných v letech 2030 a 2031 v objemu 2,1 miliardy USD. Odkupované dluhopisy budou zrušeny.
ExxonMobil Holdings Corporation ("ExxonMobil") (NYSE: XOM) today announces that its wholly owned subsidiary, Pioneer Natural Resources Company (the "Offeror") is offering to purchase for cash any and all of its outstanding $1,100,000,000 1.900% Senior Notes due 2030 (the “2030 Notes”) and $1,000,000,000 2.150% Senior Notes due 2031 (the “2031 Notes”, and together with the 2030 Notes, the “Notes”).
Holders will receive a price equal to the Total Consideration based on the applicable Reference Yield and the applicable Fixed Spread plus Accrued Interest (each as defined below) (in the case of each of the 2030 Notes and the 2031 Notes, a "Tender Offer" and together, the “Tender Offers”).
Each Tender Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 8, 2026 (the "Offer to Purchase"). Terms not defined in this announcement have the meanings given to them in the Offer to Purchase.
Upon the terms and subject to the conditions set forth in the Offer to Purchase, the Offeror is offering to purchase any and all of the Notes, as set forth in the table below. Notes purchased in the Tender Offers will be cancelled. Neither Tender Offer is conditioned on any minimum principal amount of Notes being tendered. The consummation of each Tender Offer is subject to, and conditioned upon, the satisfaction or waiver, where permitted, of the conditions discussed in the Offer to Purchase.
Title of Notes
Principal Amount
Outstanding
ISIN/CUSIP
Reference Security(1)
Fixed Spread(1)
Bloomberg Reference
Page
1.900% Senior Notes due 2030
$1,100,000,000
ISIN NO. US723787AQ06
CUSIP NO. 723787 AQ0
4.375% UST due August 31, 2031
30 bps
FIT1
2.150% Senior Notes due 2031
$1,000,000,000
ISIN NO. US723787AR88
CUSIP NO. 723787 AR8
4.375% UST due August 31, 2031
35 bps
FIT1
(1)
The "Total Consideration" per $1,000 principal amount of Notes of each series validly tendered at or prior to the Expiration Date and not validly withdrawn and accepted for purchase will be calculated as described in the Offer to Purchase using the applicable Fixed Spread. See "Description of the Tender Offers—Total Consideration" in the Offer to Purchase. The Total Consideration does not include accrued and unpaid interest on such Notes from the last interest payment date with respect to such Notes to, but not including, the Settlement Date (the "Accrued Interest"), which will be paid in addition to the Total Consideration.
Each Tender Offer will expire at 5:00 p.m., New York City time, on September 14, 2026, unless extended or earlier terminated (such date and time, as the same may be extended or earlier terminated, the "Expiration Date"). Holders who desire to participate in the Tender Offers must validly tender their Notes at or prior to the applicable Expiration Date. Tenders of Notes may be validly withdrawn at any time on or prior to the applicable Expiration Date but tenders will thereafter be irrevocable, except in certain limited circumstances where additional withdrawal rights are required by law.
Neither Tender Offer is conditioned on any minimum principal amount of Notes being tendered. Notes may be tendered only in principal amounts equal to the minimum denomination of $1,000 and integral multiples of $1,000 in excess thereof.
Upon the terms and subject to the conditions set forth in the Offer to Purchase, Holders who validly tender and who do not validly withdraw Notes at or prior to the applicable Expiration Date and whose Notes are accepted for purchase by the Offeror will receive the "Total Consideration". The Total Consideration payable for the Notes will be a price per $1,000 principal amount of Notes, calculated with reference to the Settlement Date, that would reflect a yield to the applicable maturity date of such Notes equal to the sum of (i) the applicable Reference Yield determined at the Price Determination Time, plus (ii) the applicable Fixed Spread. The Total Consideration payable for each of the 2030 Notes and the 2031 Notes will be determined as set out in the calculation in Schedule A to the Offer to Purchase.
The "Reference Yield" means the bid side yield to maturity, determined in accordance with market convention, of the applicable Reference Security, based on the bid price for the applicable Reference Security as reported on the applicable Bloomberg Reference Page at the Price Determination Time. The sum of the applicable Fixed Spread and the applicable Reference Yield is referred to as the "Repurchase Yield".
The "Price Determination Time" is expected to be 2:00 p.m., New York City time, on September 14, 2026.
In addition to the Total Consideration, Holders whose Notes are accepted for purchase will be paid the Accrued Interest on the Settlement Date. Interest will cease to accrue on the Settlement Date for all Notes accepted in either Tender Offer. The Settlement Date will promptly follow the Expiration Date and is expected to be September 16, 2026, which is the second business day after the Expiration Date, unless extended.
Holders are advised to check with any bank, securities broker or other intermediary through which they hold their Notes as to when such intermediary needs to receive instructions from a Holder in order for that Holder to be able to participate in either Tender Offer before the deadlines specified herein and in the Offer to Purchase. The deadlines set by any such intermediary and the Depository Trust Company for the submission and withdrawal of tender instructions will also be earlier than the relevant deadlines specified herein and in the Offer to Purchase.
The results of each Tender Offer are expected to be announced promptly following the Expiration Date. This press release will be available on https://corporate.exxonmobil.com/. Copies of the Offer to Purchase are available to holders of the Notes ("Holders") through the Tender and Information Agent, Global Bondholder Services Corporation at its website https://www.gbsc-usa.com/pioneer/ or by calling (212) 430-3774 (bank and brokers call collect) or (855) 654-2014 (all others please call toll-free).
The Dealer Manager for each Tender Offer is:
Citigroup
388 Greenwich Street, 4th Floor
New York, NY 10013
Toll-Free: +1 (800) 558-3745
Collect: +1 (212) 723-6106
Email: [email protected]
Attention: Liability Management Group
The Tender and Information Agent for each Tender Offer is:
Global Bondholder Services Corporation
65 Broadway – Suite 404
New York, New York 10006 Attn: Corporate Actions
Bank and Brokers Call Collect: (212) 430-3774
All Others Please Call Toll Free: (855) 654-2014
E-mail: [email protected]
Tender Offer Website: https://www.gbsc-usa.com/pioneer/
Non-U.S. Distribution Restrictions
United Kingdom. The communication of this announcement, the Offer to Purchase and any other documents or materials relating to either Tender Offer is not being made by and such documents and/or materials have not been approved by an "authorised person" for the purposes of section 21 of the Financial Services and Markets Act 2000 (as amended, the "FSMA"). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of such documents and/or materials is exempt from the restriction on financial promotions under section 21(1) of the FSMA on the basis that it is only directed at and may only be communicated to and may only be acted upon by: (1) persons who are outside of the United Kingdom; (2) investment professionals falling within the definition contained in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"); (3) those persons who are existing members or creditors of the Offeror or other persons falling within Article 43(2) of the Order; (4) a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024 (“POATRs”), or (5) any other persons to whom such documents and/or materials may lawfully be communicated in accordance with the Order (all such persons together being referred to as "relevant persons"). This announcement and any other documents or materials relating to either Tender Offer are only available to relevant persons. Consequently, no disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) for offering, selling or distributing the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering, selling or distributing the Notes or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulations 2024. This announcement and any other documents or materials relating to the Tender Offers have been prepared on the basis that the Offer to Purchase in the UK will be made pursuant to an exemption from the prohibition on offers to the public under POATRs. This announcement and any other documents or materials relating to the Tender Offers are not a prospectus for the purposes of the POATRs. Any person who is not a relevant person should not act or rely on this document or any of its contents. Any investment or investment activity to which this announcement relates are only available to relevant persons and will be engaged in only with relevant persons.
France. Neither Tender Offer is being made, directly or indirectly, in the Republic of France (other than to qualified investors as described below). This announcement, the Offer to Purchase and any other document or material relating to either Tender Offer may not be distributed to the public in the Republic of France and have only been, and shall only be, distributed in the Republic of France to qualified investors as defined in Article 2(e) of Regulation (EU) 2017/1129, as amended (the "Prospectus Regulation") and in accordance with Article L. 411-2, 1° of the French Code monétaire et financier. None of this announcement, the Offer to Purchase nor any other documents or materials relating to either Tender Offer have been or will be submitted for clearance to the Autorité des marchés financiers.
Italy. None of the Tender Offers, this announcement, the Offer to Purchase or any other documents or materials relating to either Tender Offer have been or will be submitted to the clearance procedure of the Commissione Nazionale per le Società e la Borsa ("CONSOB") pursuant to applicable Italian laws and regulations. Each Tender Offer is being carried out in the Republic of Italy ("Italy") as an exempted offer pursuant to article 101-bis, paragraph 3-bis of the Legislative Decree No. 58 of February 24, 1998, as amended (the "Financial Services Act") and article 35-bis, paragraph 4 of CONSOB Regulation No. 11971 of May 14, 1999, as amended. Holders or beneficial owners of the Notes that are resident or located in Italy can tender their Notes for purchase through authorized persons (such as investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with the Financial Services Act, CONSOB Regulation No. 20307 of February 15, 2018, as amended, and Legislative Decree No. 385 of September 1, 1993, as amended) and in compliance with any other applicable laws and regulations and with any requirements imposed by CONSOB or any other Italian authority. Each intermediary must comply with applicable laws and regulations concerning information duties vis-à-vis its clients in connection with the Notes or the Offer to Purchase.
Belgium. None of this announcement, the Offer to Purchase nor any other documents or materials relating to either Tender Offer have been, or will be, submitted or notified to, or approved or recognized by, the Belgian Financial Services and Markets Authority ("Autorité des services et marchés financiers"/"Autoriteit voor Financiële Diensten en Markten"). Neither Tender Offer is being made in Belgium by way of a public offering within the meaning of Articles 3, §1, 1° and 6, §1 of the Belgian Law of April 1, 2007 on public takeover bids ("loi relative aux offres publiques d'acquisition"/"wet op de openbare overnamebiedingen"), as amended or replaced from time to time. Accordingly, neither Tender Offer may be, or is being, advertised and neither Tender Offer will be extended and this announcement, the Offer to Purchase and any other documents or materials relating to either Tender Offer (including any memorandum, information circular, brochure or any similar documents) may not, have not, and will not, be distributed or made available, directly or indirectly, to any person in Belgium other than to "qualified investors" ("investisseur qualifié"/"gekwalificeerde belegger") within the meaning of Article 2(e) of the Prospectus Regulation acting on their own account. Insofar as Belgium is concerned, each Tender Offer is made only to qualified investors, as this term is defined above. Accordingly, the information contained in this announcement, the Offer to Purchase or in any other documents or materials relating to either Tender Offer may not be used for any other purpose or disclosed or distributed to any other person in Belgium.
This announcement is for informational purposes only and is not an offer to purchase, a solicitation of an offer to purchase or a solicitation of consents with respect to any Notes. This announcement does not describe all the material terms of either Tender Offer and no decision should be made by any Holder on the basis of this announcement. The terms and conditions of each Tender Offer are described in the Offer to Purchase. This announcement must be read in conjunction with the Offer to Purchase. The Offer to Purchase contains important information which should be read carefully before any decision is made with respect to either Tender Offer. If any Holder is in any doubt as to the contents of this announcement, or the Offer to Purchase, or the action it should take, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to tender such Notes pursuant to either Tender Offer.
None of the Offeror, ExxonMobil, the Dealer Manager or their affiliates, or the Tender and Information Agent makes any recommendation, or has expressed an opinion, as to whether or not Holders should tender their Notes held by them pursuant to either Tender Offer, or refrain from doing so. Each Holder should make its own decision as to whether to tender its Notes and if so, the principal amount of the Notes to tender.
The Offeror has not filed this announcement or the Offer to Purchase with, and they have not been reviewed by, any federal or state securities commission or regulatory authority of any other country. No authority has passed upon the accuracy or adequacy of either Tender Offer, and it is unlawful and may be a criminal offense to make any representation to the contrary.
The Offer to Purchase does not constitute an offer to purchase Notes in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such offer under applicable securities or blue sky laws. The distribution of the Offer to Purchase in certain jurisdictions is restricted by law. Persons into whose possession the Offer to Purchase comes are required by each of the Offeror, ExxonMobil, the Dealer Manager and the Tender and Information Agent to inform themselves about, and to observe, any such restrictions.
Certain statements contained in this announcement are, or may be deemed to be, "forward-looking statements" (including for purposes of the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).
Forward-looking statements give the Offeror’s current expectations and projections about future events, including strategic initiatives and future financial condition and performance, and so the Offeror’s actual results may differ materially from what is expressed or implied by such forward-looking statements. Forward-looking statements sometimes use words such as "expects," "anticipates," "believes," "targets," "plans," "intends," "aims," "projects," "indicates," "may," "might," "will," "should," "potential," "could" and words of similar meaning (or the negative thereof). All statements, other than statements of historical facts, included in this announcement are forward-looking statements. Such forward-looking statements include, but are not limited to, statements relating to future events; projections; descriptions of strategic, operating, and financial plans and objectives; statements of future ambitions and plans; future earnings power; potential addressable markets; and other statements of future events or conditions.
Any forward-looking statements made by or on behalf of the Offeror speak only as of the date they are made and are based upon the knowledge and information available to the Offeror on the date of this announcement. These statements and views may be based on a number of assumptions and, by their nature, involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond ExxonMobil’s control or precise estimate. Subject to our obligations under U.S. law in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About ExxonMobil
ExxonMobil, one of the largest publicly traded international energy and petrochemical companies, creates solutions that improve quality of life and meet society’s evolving needs.
The corporation’s primary businesses - Upstream, Product Solutions and Low Carbon Solutions – provide products that enable modern life, including energy, chemicals, lubricants, and lower emissions technologies. ExxonMobil holds an industry-leading portfolio of resources, and is one of the largest integrated fuels, lubricants, and chemical companies in the world. ExxonMobil also owns and operates the largest CO2 pipeline network in the United States. In 2021, ExxonMobil announced Scope 1 and 2 greenhouse gas emission-reduction plans for 2030 for operated assets, compared to 2016 levels. The plans are to achieve a 20-30% reduction in corporate-wide greenhouse gas intensity; a 40-50% reduction in greenhouse gas intensity of upstream operations; a 70-80% reduction in corporate-wide methane intensity; and a 60-70% reduction in corporate-wide flaring intensity. To learn more, visit exxonmobil.com and ExxonMobil’s Advancing Climate Solutions.
Public Company Information: NYSE: XOM
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908938146/en/
Ford Motor přestavuje digitální byznys kolem BlueCruise, Ford Pro a AI asistenta, aby zvyšoval předplatné a servisní příjmy. Má už 1,6 milionu platících zákazníků digitálních služeb a 530 000 předplatných BlueCruise, z toho asi 200 000 platících zákazníků BlueCruise.
Copper Is the AI Trade No One Priced In—3 Miners With the Most to GainFord Motor NYSE: F is reshaping its software and digital-services strategy around a more connected ecosystem spanning vehicle hardware, software, mobile applications and dealer service, according to Mike Aragon, the company’s president of integrated services.
Speaking with Goldman Sachs analyst Mark Delaney, Aragon said Ford has moved away from managing digital products such as BlueCruise and Ford Pro Intelligence as separate offerings. Instead, the company is seeking to make them work as a unified system that improves over time through vehicle data, over-the-air updates and service connections.
Get Ford Motor alerts:
3 Stocks Built for Higher Rates—And 2 That Could Break“It’s not about generic products,” Aragon said. “It’s really about building a software layer on top of the vehicles that our customers already love.”
Focus on activation and engagement Aragon described Ford’s digital-services “flywheel” as consisting of four stages: scale, activate, engage and monetize. The company has about 14 million connected vehicles in its installed base, he said, providing a foundation for digital offerings including connectivity services and the BlueCruise hands-free driving system.
FB Financial's Southern Expansion and Buybacks Drive Analyst OptimismActivation at the dealership is particularly important, according to Aragon. Ford tracks how quickly customers use the specific product they purchased, such as their first BlueCruise or connectivity engagement, and seeks to remove friction from that process.
Aragon said Ford has found a correlation between dealer training, early product usage and longer-term customer engagement. Customers who do not use BlueCruise early may forget about the feature, while early and frequent use has been associated with greater retention, he said.
Ford is working with dealers through incentive payments, sales coaching and a digital delivery tool designed to help salespeople walk customers through the products and services included with their vehicles. The Ford app also provides another channel for customer education and activation.
While subscription revenue remains important, Aragon said his team places significant emphasis on engagement as a leading indicator. He said customers who use multiple parts of Ford’s ecosystem appear to be “stickier,” though he described the company’s observations as still being in the early stages.
BlueCruise and subscriber metrics Ford’s BlueCruise-equipped vehicle installed base has grown from 1.2 million vehicles last year to 1.5 million currently, Aragon said. The company has 1.6 million customers paying for digital services after vehicle purchase, excluding free trials and services included for a defined duration at the time of purchase.
About 200,000 of Ford’s 1.6 million paid subscribers are BlueCruise customers, a figure Aragon said increased 170% year over year. Ford has 530,000 total BlueCruise subscribers, including customers whose access is included with their vehicle for a duration. That figure rose 40% year over year, according to Aragon. Blended average revenue per user across Ford Pro and retail customers is now $14 per month, up from the approximately $10 monthly Ford Pro figure previously discussed by the company. Aragon said the higher blended ARPU reflects a mix of additional features, customers moving into higher-value Ford Pro offerings such as managed maintenance, and a greater contribution from BlueCruise.
He added that Ford views BlueCruise growth as evidence that digital features can influence purchase decisions. On the commercial side, he said fleet buyers are increasingly asking about fleet-management portals, vehicle data controls and uptime in addition to traditional vehicle specifications such as towing capacity and cargo space.
Ford Pro integrates vehicle, software and service offerings Ford Pro had more than 900,000 subscribers last quarter, up about 20% year over year, according to Delaney. Aragon said Ford Pro’s offerings are built around four areas: data services delivered through application programming interfaces; telematics that combine data with insights; fleet-management tools; and managed maintenance.
Managed maintenance uses telematics data to identify potential issues, schedule service and, in some cases, deploy mobile service units, Aragon said. The goal is to support fleet uptime and lower customers’ total cost of ownership.
Aragon acknowledged that Ford Pro subscriber growth has moderated in recent quarters. He said Ford recently reorganized its go-to-market approach by moving the integrated-services sales team under Ford Pro President Alicia Boler Davis. The company now intends to approach commercial customers with a combined hardware, software and service proposition rather than selling software separately after a vehicle sale.
“Let’s sell a problem, and let’s solve problems that only we can solve in a differentiated way,” Aragon said, citing uptime, fleet management and managed maintenance as examples.
AI assistant, service opportunity and global strategy Ford has launched an artificial-intelligence assistant in its app for retail and Ford Pro customers, and a Pro-specific version is embedded in the telematics platform, Aragon said. The assistant can use Ford-specific context including vehicle health data and vehicle trim information. Ford plans to launch the assistant in vehicles eventually, he said.
For fleet users, Aragon said the tool can identify vehicles with excessive idling, flag driver-safety trends and help track whether operating metrics improve over time. The assistant currently is included within Ford’s existing service packages rather than carrying a separate charge.
Aragon said Ford sees potential indirect revenue opportunities when digital vehicle-health alerts lead to dealer service work. Ford’s integrated-services business and physical-service business together represent a $15 billion operation expected to grow 8% through the end of the decade, he said, though he declined to disclose integrated-services revenue separately.
Internationally, Ford aims to build products for global scale while executing locally due to differences in regulation, vehicle mix and driver behavior. Aragon identified Ford Pro Intelligence as the company’s most mature integrated-services business outside North America because fleet needs such as uptime, safety and total cost of ownership translate across markets.
About Ford Motor (NYSE:F)Ford Motor Company NYSE: F is an American multinational automaker headquartered in Dearborn, Michigan. Founded by Henry Ford in 1903, the company became an early pioneer of mass-production techniques with the Model T and the adoption of the moving assembly line. Today, Ford designs, manufactures, markets and services a broad range of vehicles and mobility solutions under the Ford and Lincoln brands, spanning passenger cars, SUVs, pickup trucks and commercial vehicles.
Ford's business activities extend beyond vehicle production to include parts and aftermarket services, fleet and commercial sales, and automotive financing through Ford Motor Credit Company.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Ford Motor Right Now?Before you consider Ford Motor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ford Motor wasn't on the list.
While Ford Motor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Sean Duffy obvinil Ford z přílišné závislosti na čínských firmách a varoval před bezpečnostními riziky pro USA. Ford to odmítl a označil dopis za fakticky chybný.
Transportation Secretary Sean Duffy is accusing Ford Motor Co. of becoming too dependent on Chinese companies, warning CEO Jim Farley that the automaker's business ties to China threaten U.S. national security and American manufacturing.
In a letter sent Tuesday to Farley and obtained by FOX Business, Duffy criticized Ford's growing reliance on Chinese technology and manufacturing partnerships, arguing that the strategy raises national and economic security concerns.
The letter marks one of the Trump administration's strongest public rebukes of a major American automaker over its business relationships with China.
"I am writing to express the profound concern of the U.S. Department of Transportation (DOT) regarding the strategic trajectory of Ford Motor Company," Duffy wrote, adding that the company's recent decisions "paint a troubling picture of a foundational American brand actively intertwining its future with Chinese state-backed enterprises."
FORD’S US MANUFACTURING EXPANSION TO BRING ‘THOUSANDS AND THOUSANDS OF JOBS,’ LUTNICK SAYS
CEO Jim Farley takes off his mask at the Ford Built for America event at the company's truck plant in Dearborn, Michigan. (Nic Antaya/Getty Images)
Administration officials argue the concerns are twofold: that Chinese law can require companies to provide the government access to proprietary and customer data, creating potential national security risks, and that increased reliance on Chinese manufacturing comes at the expense of American workers.
Duffy pointed to several examples in the letter, including Ford's continued use of licensed battery technology from Chinese manufacturer CATL at its BlueOval Battery Park in Marshall, Michigan; the company's joint venture with Chinese-owned Geely in Spain; reported discussions with BYD over hybrid vehicle components; and the company's delayed plans to reshore Lincoln models such as the Nautilus, which Duffy said could extend until 2030.
He argued those moves deepen Ford's reliance on Chinese supply chains while helping strategic competitors expand their influence in the global auto industry.
"When a company intentionally chooses to deepen operational dependencies on strategic competitors, it fails to act as the reliable partner the American public and this DOT require," Duffy wrote.
FORD BOOSTS US LINCOLN PRODUCTION AS IT PHASES OUT IMPORTS FROM CHINA
Secretary Sean Duffy said Ford is becoming too dependent on Chinese companies. (Reuters/Brian Snyder)
Duffy also urged Ford to reduce its dependence on foreign technology.
"Iconic American companies, like Ford, are also expected to out-innovate competitors," he wrote. "To that end, they need to chart clear paths to technological self-reliance."
Ford sharply disputed Duffy's accusations, calling the letter "a wrongheaded attempt to capture headlines at the expense of a company that has done more for American manufacturing than virtually any other in the nation's history."
The automaker said its BlueOval Battery Park Michigan facility in Marshall is owned and operated by Ford, represents billions of dollars in investment and is expected to create about 1,700 American jobs. Ford also said its agreement with Chinese battery maker CATL is "a limited technology-licensing and services agreement, not a joint venture or foreign-owned manufacturing operation."
JAGUAR LAND ROVER OPENS VOLUNTARY REDUNDANCY PROGRAM IN $2.3B COST-CUTTING DRIVE
Ford further argued that Duffy's letter contains factual errors, disputing its characterization of the company's manufacturing plans and noting the White House highlighted the Marshall battery project in a recent press release. The automaker also pointed to recent comments from Commerce Secretary Howard Lutnick praising Ford's decision to expand Lincoln production in the United States.
"Ford supports the Trump administration's vision for advancing American innovation and manufacturing," the company said. "Had Secretary Duffy reached out before issuing his letter to the press, we would have been happy to share more details about Ford's U.S. commitment."
The letter comes as lawmakers and the auto industry have pushed for tighter restrictions on Chinese involvement in the U.S. automotive market.
Ticker Security Last Change Change % F FORD MOTOR CO. 14.00 -0.62 -4.24% CLICK HERE TO GET FOX BUSINESS ON THE GO
In July, the Senate Commerce, Science and Transportation Committee approved bipartisan legislation that would ban the import, sale and operation of vehicles manufactured by companies designated as foreign entities of concern, including firms based in China. The measure would also prohibit certain connected vehicle technologies developed by those countries.
Separately, the Alliance for Automotive Innovation urged congressional leaders in September to enact a permanent ban on Chinese-made vehicles in the United States.
Ford Motor Company v poslední seanci klesla o 4,24 % na 14,00 USD, zatímco S&P 500 odepsal 0,58 %. Před výsledky analytici očekávají EPS 0,41 USD a tržby 46,04 miliardy USD.
In the latest close session, Ford Motor Company (F - Free Report) was down 4.24% at $14.00. The stock trailed the S&P 500, which registered a daily loss of 0.58%. Elsewhere, the Dow lost 1.18%, while the tech-heavy Nasdaq lost 0.32%.
Shares of the company witnessed a gain of 4.43% over the previous month, beating the performance of the Auto-Tires-Trucks sector with its gain of 3.92%, and the S&P 500's loss of 0.36%.
The upcoming earnings release of Ford Motor Company will be of great interest to investors. In that report, analysts expect Ford Motor Company to post earnings of $0.41 per share. This would mark a year-over-year decline of 8.89%. Simultaneously, our latest consensus estimate expects the revenue to be $46.04 billion, showing a 2.42% drop compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates project earnings of $1.86 per share and a revenue of $177.44 billion, demonstrating changes of +70.64% and +1.95%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Ford Motor Company. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Ford Motor Company possesses a Zacks Rank of #3 (Hold).
Investors should also note Ford Motor Company's current valuation metrics, including its Forward P/E ratio of 7.88. This signifies a discount in comparison to the average Forward P/E of 18.86 for its industry.
It's also important to note that F currently trades at a PEG ratio of 0.3. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Automotive - Domestic industry held an average PEG ratio of 1.15.
The Automotive - Domestic industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 55, which puts it in the top 23% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Ford Energy má podle JPMorgan při plné kapacitě generovat přes 4 miliardy USD ročních tržeb a zhruba 250–500 milionů USD ročního provozního zisku do konce desetiletí.
Ford Motor Company (F -4.24%) stock soared nearly 50% in May, as Wall Street began seeing the legacy automotive company as a hidden-gem infrastructure play as the demand for artificial intelligence (AI) and data center energy explodes. The stock has since given back about half of its May surge, and that gives investors who see long-term growth an opportunity to jump back in at a better price.
Here's why investors should be intrigued.
Data by YCharts.
Ford Energy provides a growing, stable revenue stream In May, the Detroit automaker announced its wholly owned subsidiary, called Ford Energy, which will develop and offer a battery energy storage system (BESS) for utility customers, AI data centers, and other large industrial and commercial customers. Savvy investors may have seen this coming, but for the most part, Ford built the new business behind the scenes, securing supply chains and preparing manufacturing. Ford Energy will manufacture battery cells, assemble modules and containers, and offer sales and service support, which could be the lucrative part. That's because the automaker's Ford Energy DC block was designed to have a stable and predictable lifetime performance for about two decades.
Image source: Ford Motor Company.
To help connect the dots for investors wondering, AI data centers run intense workloads that put immense strain on the electrical grid. Ford's BESS give AI data centers security in the event of electrical grid fluctuations or blackouts, as the centers need an uninterrupted power supply. The systems will also provide power during AI workload spikes, charge when electricity is cheap, and discharge when prices peak, ultimately lowering costs and providing downtime protection.
"Energy storage is a new business, but they have the right technology," a collection of Morgan Stanley analysts led by Andrew Percoco wrote in a note. "[W]e see this as an opportunity for Ford to deploy capital into a strategic growth area with a structure that preserves operational control and regulatory alignment."
Premium Feature
Moneyball Superscore
56/100
Today's Change
(
-4.24
%) $
-0.62
Current Price
$
14.00
Lucrative or hype? So Ford developed a product that solves real problems for AI data centers, among other customers, but how lucrative could it be? According to J.P. Morgan analysts, Ford Energy at full capacity -- it's targeting production of 20 gigawatt-hours of annual energy storage capacity -- the business could generate over $4 billion in annual revenue and roughly $250 million to $500 million in annual operating profit by the end of the decade. But the benefits for Ford investors don't stop there, as Ford Energy could use its underutilized electric-vehicle (EV) battery plants, which would help push its Model e division to profitability much sooner than from building scale with EVs alone. That's a huge deal when you consider that Ford's Model e division, responsible for its EVs, has lost more than $18 billion total between 2022 and the second quarter of 2026.
EDF Power Solutions has already signed a five-year agreement with Ford Energy to purchase up to 20 gigawatt-hours of large BESS, with deliveries set to begin in 2028. Here's the kicker: While this is a great move for Ford and its investors, the company is still make-or-break in its traditional businesses. If by 2030 Ford Energy indeed generates the high end of estimates, $500 million in operating profit, it moves the needle a bit compared with Ford's 2025 adjusted earnings before interest and taxes of $6.8 billion. For investors, that leaves it as an overlooked play on AI, with the caveat that it's mostly still a traditionally low-margin automaker. However, this low-margin narrative is changing as more high-margin software-defined business spreads throughout vehicles and services.
If you're looking for a pure-play AI stock, Ford won't be that. However, if you're an industrial or automotive investor looking for upside between the many options, this is a great development to identify and include in your investment thesis, because it can move the needle and it could continue to grow high-margin business at Ford.
